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 I
I. Summary 
GABAB receptors are the G-protein coupled receptors for γ-aminobutyric acid (GABA), the 
main inhibitory neurotransmitter in the brain. They are heteromeric GPCRs which function as 
heterodimers composed of the GABAB1 and GABAB2 subunit. Presynaptic and postsynaptic 
GABAB receptors regulate Ca- and K-channels respectively via the Gβγ subunits.  
Furthermore, GABAB receptors can activate and inhibit adenylyl cyclase through the Gαi/o and 
Gβγ subunits. Proteins that interact with GABAB receptors at the plasma membrane most 
likely contribute to the functional heterogeneity observed with native GABAB responses. 
We identified members of the K+ tetramerization domain containing (KCTD) protein family as 
novel GABAB receptor interacting proteins using immuno-affinity purification experiments 
from native mouse brain tissue. In separate affinity purification experiments, these proteins 
were also found to be associated with native Ca-channels. We have shown that native 
GABAB receptor exist as heteromultimers in a high molecular weight protein complex, tightly 
associated with KCTD8, 12, 12b, and 16. 
KCTDs are able to form homo- and heterodimers, thus re-enforcing their role in complex 
formation with the GABAB receptor. We show that the KCTD-binding site is located within the 
intracellular C-term of the GABAB2 subunit and that KCTDs interact with the receptor via their 
conserved N-termini. In addition, coassembly with KCTDs leads to alterations of GABAB 
receptor properties, such as an increase in agonist potency and alterations in G-protein 
signaling. When compared, the spatial distribution and the functional properties of KCTD8, 
12, 12b, and 16 suggest overlapping but also distinct properties in the context of GABAB 
receptor function. In summary, this dissertation reveals KCTD8, 12, 12b, and 16 as important 
players within the GABAB receptor signaling complex and designates them as novel auxiliary 
subunits of the GABAB receptor. 
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II. Abbreviations 
AMPK 5’AMP-dependent protein kinase 
AP-2 activator protein-2 
ARF ADP-ribosylation factor 
ATF4 activating transcription factor 4 
BRET  bioluminescence energy transfer 
BTB Bric-a-brac, Tramtrack, Broad-complex 
Ca2+/CaM  Ca2+/Calmodulin 
CaMKII  Ca2+/Calmodulin-dependent kinase II 
cAMP  cyclic adenosine monophosphate  
Cav voltage-gated Ca2+ channel 
C/EBP  CCAAT/enhancer-binding protein 
CHOP C/EBP homologous protein 
CNS  central nervous system 
COPI coat protein I 
CREB2 cAMP response element binding-protein 2 
DIV  day in vitro 
eGFP  enhanced green fluorescent protein 
EPSC  excitatory postsynaptic current 
ER  endoplasmic reticulum 
ESI-MS/MS  electrospray-ionisation mass spectrometry 
FRET fluorescence energy transfer 
GABA  gamma-amino butyric acid 
GABAA  gamma-amino butyric acid type A 
GABAB  gamma-amino butyric acid type B 
GABAB1-/- GABAB1 deficient 
GABAB2-/- GABAB2 deficient 
GABAC gamma-amino butyric acid type C 
GABABR GABAB receptor 
GAP GTPase activating proteins 
GDP  guanosine diphosphate 
GEF  guanine nucleotide exchange factor 
GHB  gamma-hydroxybutyrate 
GPCR  G-protein coupled receptor 
GTP  guanosine-5'-triphosphate 
 III
HNK-1 human natural killer-1 
IPSC inhibitory postsynaptic current 
KCTD  K+ channel tetramerization domain containing 
Kv voltage-gated K+ channel 
LTD long term depression 
LTP  long term potentiation 
mGluR  metabotropic glutamate receptor 
VFTM venus flytrap module 
P postnatal day 
PCNA proliferating cell nuclear antigen 
PDIP1 Polymerase delta-interacting protein 1 
PDZ PSD-95/Discs-large/ZO-1 
POZ Pox virus and Zinc finger 
PTB phosphpotyrosine binding 
Shh sonic hedgehog homolog 
T1 tetramerization domain 
7TM seven transmembrane 
TGN trans-Golgi network 
TNF-α Tumor necrosis factor α 
TNFAIP1 Tumor necrosis factor, alpha-induced protein 1 
Y2H yeast-two-hybrid 
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1 Introduction 
GABA receptors 
γ-Aminobutyric acid (GABA), first identified by Robert and Frankel, is the most widely 
distributed inhibitory neurotransmitter in the central nervous system (Roberts and Frankel, 
1950). After GABA is released from presynaptic nerve terminals under the regulation of 
intracellular Ca2+, its actions are mediated by two main classes of receptors, ionotropic 
GABAA and metabotropic GABAB receptors.  
Activation of GABAA receptors leads to an increase in Cl- conductance, whereas GABAB 
receptor activation produces G-protein-mediated responses. Activation of all receptor 
subtypes induces a hyperpolarization of the cell that forms the basis of the inhibitory action of 
GABA. 
The GABAA receptors belong to the superfamily of ligand-gated ion channels that includes 
the nicotinic acetylcholine, strychnine-sensitive glycine, and 5-HT3 serotonin receptors. They 
are assembled from a large family of subunit genes (α1-6, β1-4, γ1-4, δ, ε, π, θ, ρ1-3) and 
form heteromeric chloride channels. Five subunits can combine in different permutations to 
form GABAA channels that give rise to a large variety of GABAA receptors with distinct 
pharmacological properties; 60% of GABAA receptors in the brain are composed out of two 
α1, two β2, and one γ2 subunit (Mohler, 2006). Ligands acting on the GABAA receptor are 
commonly used as therapeutics, e.g. allosteric modulators like benzodiazepines and 
barbiturates, which exhibit anxiolytic, antiepileptic, muscle relaxant, and hypnotic effects. 
The ρ-subunits do not assemble with α- or β- subunits, but form homo- and heteromeric 
channels among themselves. These receptors are therefore sometimes designated as a 
separate class of ionotropic GABA receptors, termed GABAC receptors (Chebib, 2004). They 
exhibit unique pharmacological properties such as being sensitive to cis-4-aminocrotonic 
acid, but insensitive to bicuculline and benzodiazepines. GABAC receptors are mainly found 
in the retina. Controversy remains, however, whether these receptors constitute an 
independent class of receptors or if they are a subtype of GABAA receptors. 
GABAB receptors belong to the class C (metabotropic glutamate/pheromone) of G protein-
coupled receptors (GPCRs). They are seven transmembrane (7TM) receptors that activate 
second messenger systems through G-protein coupling. G protein-coupled receptors 
constitute by far the largest family of cell surface proteins involved in signaling across 
biological membranes with approximately 950 genes in the human genome encoding 
proteins belonging to this superfamily (Takeda et al., 2002). GPCRs modulate a wide range 
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of physiological processes. They are implicated in numerous diseases and form the largest 
class of therapeutic targets. 
The GABAB receptor 
History 
GABAB receptors were first described by Bowery et al. in the late seventies. Researchers 
had observed that application of bicuculline, the first specific GABA receptor antagonist, only 
partially inhibited the effects elicited by GABA. This led to the conclusion that there must 
exist different, but foremost, bicuculline insensitive subtypes of GABA receptors later 
followed by the description of the binding site (Bowery et al., 1979; Bowery et al., 1981; Hill 
and Bowery, 1981). The first evidence that the GABAB receptor is a G-protein coupled 
receptor came from the observation that application of guanyl nucleotides reduces agonist 
affinity of GABAB receptors (Hill et al., 1984; Kerr and Ong, 1995). The development of 
GABAB receptor specific agonists and antagonists, especially the high-affinity GABAB 
radioligand antagonists, such as 125I-CGP64213 made expression cloning using a binding 
assay possible. It allowed the isolation of GABAB1a, and GABAB1b cDNAs (Kaupmann et al., 
1997), and shortly after the GABAB2 cDNA (Jones et al., 1998; Kaupmann et al., 1998). 
Molecular cloning of the GABAB receptors became eminently important as it challenged the 
traditional dogma of GPCR activation and the subsequent mechanisms of G-protein 
mediated signaling. GPCRs were traditionally conceptualized as monomeric proteins until 
GABAB receptors were shown to require heteromerization to form a functional receptor 
(Jones et al., 1998; Kaupmann et al., 1998; Kuner et al., 1999; White et al., 1998). 
Dimerization of GPCRs was at the time a novel concept and triggered a large body of work 
resulting in today’s commonly accepted view of functional dimerization for many GPCRs 
(Fan and Hendrickson, 2005; Fotiadis et al., 2004).  The GABAB receptor is perhaps the best 
example demonstrating the functional importance of oligomerization as the 
heterodimerization of GABAB1 and GABAB2 subunits is a prerequisite for the trafficking of the 
receptor to the cell surface, and the allosteric interactions between the two GABAB receptor 
subunits are critical for agonist-induced activation. These findings together with evidence 
from other GPCRs existing as oligomeric clusters have been and still are conducive to the 
changing perception of GPCR oligomerization and its significance in GPCR signaling. 
Neurological disorders and therapeutic agents 
Neurological disorders such as bipolar disorders, anxiety, epilepsy and depression often 
result from an imbalance between excitation and inhibition. Therefore GABAB receptors are 
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interesting drug targets. Although Baclofen (β-chlorophenyl-GABA, Lioresal®), the prototype 
GABAB receptor agonist, was introduced into therapeutic use already in 1972, this is still the 
only specifically GABAB targeting compound on the market. The muscle relaxant and anti-
nociceptive actions of baclofen make it to the drug of choice in spasticity associated with 
cerebral palsy, multiple sclerosis, stiff-man syndrome, tetanus and for reduction of central 
pain, as occurs in stroke. 
Recent preclinical and clinical studies have found that baclofen suppresses symptoms of 
alcohol withdrawal syndrome and effectively prevents relapse due to its ability to reduce 
alcohol intake and craving in alcoholic patients, which suggests baclofen as a promising 
pharmacological compound for the treatment of alcohol dependence (Addolorato et al., 
2006). However, baclofen treatment leads to adverse reactions such as drowsiness, nausea, 
muscle weakness, hallucinations and mental confusion. Out of numerous synthesized 
compounds specifically targeting GABAB receptors (Bowery et al., 2002), only CGP 36724, a 
GABAB receptor antagonist is currently in clinical trials for treatment of mild cognitive 
impairment (Froestl et al., 2004). GABAB receptor antagonists have also been shown in 
several animal models to have antidepressant-like effects (Cryan and Kaupmann, 2005; 
Nowak et al., 2006). 
Structure and Function 
Members of Class C GPCRs, which include the metabotropic glutamate, calcium-sensing, 
vomeronasal, taste, and a family of orphan receptors, are characterized by a long 
extracellular ligand binding domain. The N-terminal domain of GABAB receptors contains a 
venus flytrap module (VFTM) harboring the GABA binding site, that was extensively 
described after homology modeling based on X-ray structures of bacterial periplasmic 
binding domains (Galvez et al., 1999; Galvez et al., 2000). 
GABAB receptors exist as obligate heterodimers, composed of a GABAB1 and a GABAB2 
subunit. Though similar in structure, only the GABAB1 subunit binds the agonist. Dimerization 
with GABAB2, however, allosterically enhances agonist binding (Galvez et al., 2001; Liu et al., 
2004). 
The two GABAB subunits assemble via their transmembrane domains (Pagano et al., 2001) 
and interaction of their intracellular coiled-coil domains (Kuner et al., 1999). Upon agonist 
binding to GABAB1, conformational changes in the relative positions of the two VFTMs and 
heptahelical domains lead to G protein activation. G proteins bind to the third intracellular 
loop of the heptahelical domain of GABAB2 (Havlickova et al., 2002) and convey signals to 
the different effectors of GABAB action. As GABAB1 alone is retained in the endoplasmatic 
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reticulum (ER), the GABAB2 subunit is also required for surface trafficking of the functional 
heteromeric receptor (Pagano et al., 2001). An RSRR ER retention signal located next to the 
coiled-coil region of GABAB1 is responsible for intracellular retention. Heterodimerization with 
GABAB2 shields the ER retention signal and ensures that only correctly assembled GABAB 
receptors are trafficked to the cell surface (Pagano et al., 2001). This is also evident in 
GABAB2 knockout mice, whereby GABAB1 is largely retained in the ER (Gassmann et al., 
2004). 
GABAB receptors couple predominantly to Giα- and Goα-type G proteins. Following G protein 
activation, Ca2+ channels are inhibited and K+ channels activated by the βγ subunit, whereas 
the α subunit influences adenylate cyclase activity and thus changes the level of the second 
messenger cyclic adenosine monophosphate (cAMP). GABAB receptors modulate synaptic 
transmission through pre- and postsynaptic actions. At presynaptic nerve terminals, 
activation of GABAB receptors leads to inhibition of voltage-gated N-type (Cav2.2) and P/Q-
type (Cav2.1) Ca2+ channels, and thus decreases transmitter release. Presynaptic GABAB 
receptors act either as autoreceptors, which decrease the release of GABA or as 
heteroreceptors, which decrease the release of glutamate or other neurotransmitters. 
Postsynaptically GABAB receptors induce the activation of G-protein-activated inwardly 
rectifying K+ (GIRK/Kir3) channels, which leads to an increased efflux of K+ resulting in a 
slow hyperpolarization of the postsynaptic membrane. GABAB receptors induce a slow 
inhibitory postsynaptic current (IPSC) which can be distinguished from the fast IPSC 
mediated by GABAA receptors (Otis et al., 1993). 
In addition, GABAB receptors inhibit adenylate cyclases types I, III, V, and VI through the 
activation of Giα- and Goα proteins which subsequently reduce cAMP levels. In crosstalks 
with Gs-coupled receptors, GABAB receptors can also increase the activity of adenylate 
cyclase types II, IV, and VII (Bowery et al., 2002). Among the effects of altered cAMP levels 
are the facilitation of vesicle priming (Sakaba and Neher, 2003) or the modulation of cAMP-
dependent kinase, also known as protein kinase A (PKA), targeted K+ channels (Gerber et 
al., 1993). 
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Figure 1-1: Structure and physiological role of GABAB receptors. GABAB receptors form obligate 
heterodimers composed of GABAB1 and GABAB2 subunits. The GABAB1 subunit contains the GABA 
binding site whereas the GABAB2 subunit couples to the G-protein. Two isoforms, GABAB1a and 
GABAB1b, exist, differing in the two sushi domains at the N-terminus. Upon activation of GABAB 
receptors and the subsequent dissociation of the G-protein, the Gαi/o subunit inhibits adenylyl cylclase, 
whereas the Gβγ-dimer translocates and binds to effector channels. Presynaptically, GABAB receptor 
activation results in inhibition of voltage gated Ca-channels and therefore in the inhibition of 
neurotransmitter release. Postsynaptically, the coupling of the Gβγ-dimer to Kir3-type K–channels 
results in accelerated K+ efflux and therefore in hyperpolarization of the postsynaptic cell. 
Distribution and Localization 
GABAB receptors are widely distributed in the central nervous system. They are highly 
expressed in the brain and spinal cord, but also present in other tissues. GABAB receptors 
are expressed in almost all neuronal populations in the brain, and have also been detected in 
nonneuronal cells (Charles et al., 2003). Amongst the brain regions, hippocampus, thalamus, 
cortex, and cerebellum coexpress the highest amounts of GABAB1 and GABAB2 subunits 
(Durkin et al., 1999; Fritschy et al., 1999; Margeta-Mitrovic et al., 1999). 
Detailed studies in the hippocampus have revealed their subcellular localization. 
Presynaptically, the receptors have been detected at extrasynaptic sites, occasionally at 
glutamatergic terminals and, to a lesser extent, at GABAergic terminals. Postsynaptically 
GABAB receptors are found in dendritic shafts of principal neurons and interneurons, and in 
dendritic spines. The receptors are concentrated around glutamatergic synapses in spines 
but are evenly distributed over dendritic shafts of principal neurons contacted by GABAergic 
terminals (Kulik et al., 2003). GABAB receptors, therefore, are well positioned to modulate 
GABAergic and, especially, glutamatergic synapses. 
Another peculiarity of GABAB receptors is their presence at extrasynaptic sites where they 
are activated by GABA spillovers originating from interneurons. Thereby GABAB receptor-
mediated inhibition can be specifically enhanced during periods of intense neuronal activity.  
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GABA “spillover” occurs in cases of hyperexcitation accompanying, for example, epileptic 
seizures or during synchronous firing of neuronal networks. Simultaneous release of GABA 
from several interneurons, as appears during rhythmic hippocampal activity, was described 
by measurements from pairs of interneurons and pyramidal neurons in cultured hippocampal 
slices, and after blockade of GABA uptake. This results in the activation of postsynaptic 
GABAB receptors, which in turn control the oscillation frequency of the network (Scanziani, 
2000). Based on these studies, therefore, mechanisms influencing the concentration of 
GABA outside the synaptic cleft can affect GABAB receptor activation. 
Heterogeneity 
Physiological and pharmacological studies have observed a large variability in the actions of 
native GABAB receptors, particularly regarding ligand binding, responses to agonists and 
antagonists, G-protein coupling and alterations of signal transduction pathway (Bonanno et 
al., 1997; Bonanno and Raiteri, 1993; Cruz et al., 2004; Cunningham and Enna, 1996). This 
suggests a multitude of GABAB receptor subtypes as observed in other GPCRs. Research in 
the GABAB receptor field was, for many years, greatly motivated by the aim of finding new 
splice variants that could encode differences observed for agonist affinity, effector channel 
conductance, or G-protein coupling. Surprisingly, none of the identified alternatively spliced 
GABAB subunit mRNAs have so far been demonstrated to participate in native GABAB 
receptor function. Genetic studies with GABAB1 and GABAB2 knockout mice show a complete 
absence of typical biochemical, electrophysiological and behavioral GABAB responses, 
supporting the idea that the GABAB(1,2) heterodimer provides all native GABAB functions. 
The only receptor divergence which could be conclusively demonstrated comprises two 
isoforms of the GABAB1 subunit, GABAB1a and GABAB1b. These two isoforms are evolutionary 
conserved and arise from alternative transcriptional start site selection on the GABAB1 gene. 
At the extracellular N-terminus, GABAB1a, in contrast to GABAB1b, contains two sushi 
domains, which are known protein-protein interaction sites. GABAB(1a,2) and GABAB(1b,2) are 
pharmacologically not distinguishable, however GABAB1a and GABAB1b subunits show 
different spatial  and temporal expression patterns in the brain (Bischoff et al., 1999; 
Kaupmann et al., 1997). During early postnatal development, GABAB1a exceeds the GABAB1b 
isoform before it is downregulated around postnatal day 10 (P10). In parallel, GABAB1b is 
upregulated and reaches maximal expression levels at P10-20. GABAB1b is predominant 
during adulthood and forms the main receptor subtype GABAB(1b,2). Due to the lack of 
subtype-specific antibodies, it was only recently shown, through the use of mice selectively 
expressing GABAB1a or GABAB1b that the GABAB1a subunit isoform preferentially localizes to 
glutamatergic terminals, whereas GABAB1b is predominantly found on the postsynaptic side 
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(Vigot et al., 2006). Moreover, Vigot et al. showed that the differential subcellular localization 
of receptor subtypes also results in different functions. Whereas GABAB(1b,2) receptors 
predominantly  mediate postsynaptic inhibition, GABAB1a presynaptically inhibits glutamate 
release (Guetg et al., 2009; Vigot et al., 2006). In this context it is easy to anticipate that the 
sushi repeats specifically traffic GABAB1a to or anchor GABAB1a at axonal sites via for 
example, interaction with proteins of the neuronal targeting machinery. Blein et al. reported 
an interaction with the extracellular matrix protein fibulin-2, but whether this contributes to 
GABAB receptor localization is unknown (Blein et al., 2004). More interestingly, our group 
recently described a secreted GABAB1 subunit isoforms, GABAB1j, which comprises the sushi 
domains, present in GABAB1a and showed that soluble sushi domains inhibit GABAB 
heteroreceptor function at glutamatergic terminals (Tiao et al., 2008).  
Interacting molecules 
As the receptor subtypes GABAB(1a,2) and GABAB(1b,2) were pharmacologically not 
distinguishable, studies have focused on the identification of interacting molecules that could 
account for the heterogeneity observed in native GABAB receptor function. 
Extracellular interactions 
Two extracellular binding partners of the GABAB receptor have been described. First, the 
HNK-1 (human natural killer-1) carbohydrate was proposed to be part of the underlying 
mechanism of perisomatic inhibition in the hippocampus. HNK-1 carbohydrate binds to 
GABAB receptors and is carried by many extracellular matrix proteins, among them tenascin-
C and tenascin-R. HNK-1 mediated GABAB receptor activation in CA1 pyramidal cells, 
followed by K+ outflux led to an inhibition of GABA release at perisomatic inhibitory synapses 
(Saghatelyan et al., 2003). Interestingly, HNK-1 is expressed in the cerebellum only in the 
posterior zone in Zebrin II-immunopositive stripes (Marzban et al., 2004) which partially 
overlaps with GABAB receptor localization (Fritschy et al., 1999). Second, the extracellular 
matrix protein fibulin-2 was found to interact with the N-terminal sushi repeats of GABAB1a 
(Blein et al., 2004). The sushi domains exhibit the only obvious difference between the 
GABAB receptor subtypes and were therefore strongly suggested to be involved in differential 
targeting of the GABAB1 subunit, most likely through specific binding partners, like fibulin-2. 
However, fibulin-2 does not affect GABAB heteroreceptor function (Tiao et al., 2008). 
A number of interacting proteins were identified in yeast-two-hybrid (Y2H) screens using the 
intracellular termini of GABAB1 and GABAB2 as bait. Most of them were suggested to be 
implicated in GABAB receptor trafficking and cell surface expression. 
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Coiled-coil domain interactions 
Two members of the 14-3-3 family of proteins, 14-3-3η and 14-3-3ζ (Couve et al., 2001) bind 
to part of the coiled-coil domain and the ER retention signal of GABAB1. Retention of GABAB1 
in the ER was shown to be mediated through the coat protein I complex (COPI) that 
mediates retrieval from the cis-Golgi to the ER in COPI-coated vesicles. Competition for 
GABAB1 binding was reported between 14-3-3 proteins and COPI, however, only COPI 
seems to be important for surface trafficking of correctly assembled GABAB receptor 
heterodimers (Brock et al., 2005).  
Some nuclear proteins were also reported to bind the coiled-coil domain of the GABAB 
receptor subunits, such as the activating transcription factor 4 (ATF4) and cAMP response 
element binding-protein 2 (CREB2). Upon activation of the GABAB receptor, researchers 
observed a translocation of ATF4/CREB2 either into or out of the nucleus (Vernon et al., 
2001; White et al., 2000). The functional significance, however, remains to be clarified. In 
addition, GABAB receptor activation leads to an increased expression of an ATF4-responsive 
reporter gene (White et al., 2000). Interestingly, ATF4 has been found to differentially 
regulate GABAB1a and GABAB1b promoter activity (Steiger et al., 2004), which could account 
for the different expression patterns of the two isoforms. Another transcription factor, 
CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP) has been shown to 
bind specifically to the GABAB(1a,2) subtype and to accumulate GABAB(1a,2) in the ER (Sauter 
et al., 2005). CHOP and GABAB2 interact via their coiled-coil domains and in addition, the N-
terminal domain of CHOP binds to a yet unidentified intracellular part in the GABAB1a subunit. 
The fact that the intracellular domains of GABAB1a and GABAB1b are identical, argues towards 
conformational differences being the deciding factor in the selective GABAB1a and CHOP 
interaction. The coiled-coil domain of GABAB1 was recently found to associate with the brain-
specific RNA-binding protein Marlin-1. In addition, Marlin-1 binds to the 3`-untranslated 
regions of GABAB1 and GABAB2. Surprisingly, down-regulation of Marlin-1 resulted in an 
increase of GABAB2 protein but did not change GABAB1 protein levels (Couve et al., 2004). 
By regulating cellular levels of GABAB2, Marlin-1 might thus control the expression levels of 
functional GABAB receptors. Msec7-1, a guanine-nucleotide-exchange factor (GEF) for the 
ADP-ribosylation factor (ARF) family of GTPases, has been implicated in many steps of 
vesicular membrane transport (Jackson and Casanova, 2000), and was shown to increase 
cell surface expression of GABAB receptors through interaction with the cytoplasmic LL motif 
of GABAB1 (Restituito et al., 2005). Msec7-1 is involved in the export of proteins from the 
trans-Golgi network (TGN) and accordingly is proposed to regulate the transport of GABAB 
receptors from the TGN to the cell surface. 
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PDZ domain interactions 
Many interactions with the GABAB2 subunit involve a carboxyl-terminal motif (VSGL) that is 
able to interact with PDZ-domain containing scaffold proteins. PDZ (PSD-95/Discs-
large/ZO 1) domains are 90-amino acid protein-protein interaction modules that recognize 
and bind to specialized motifs in the distal carboxyl termini of target proteins such as G 
protein-coupled receptors and ion channels. One of them, tamalin (for `tagging mGluRs and 
ARF-GEF`), a scaffolding protein that binds to the C-termini of type1 metabotropic glutamate 
receptors (mGluRs) was found in a yeast two-hybrid assay to interact with GABAB2 (Kitano et 
al., 2002). The multi-PDZ domain protein Mupp1 binds with its PDZ13 domain to the GABAB2 
subunit and was recently shown to co-localize with GABAB2 in heterologous and neuronal 
cells. Disruption of the binding  decreased the stability of the receptor, which was followed by 
changes in receptor signaling (Balasubramanian et al., 2007). Suggestions for the 
mechanisms by which PDZ proteins decrease receptor stability may be a slowing down of 
the targeting rate to lysosomal and/or proteasomal compartments or blocking of proteolytic 
degradation of PDZ-binding partners. Interestingly, Mupp1 has previously been reported to 
interact with the serotonin 5-HT2C receptor via its 10th PDZ domain. As these three show 
overlapping distribution in the brain, Mupp1 might link GABAB and 5-HT2C receptors together 
and thus facilitate cross-talk between GABAB and serotonin receptors (Slattery et al., 2005; 
Torres-Escalante et al., 2004). 
Interaction with other receptors 
Two prominent examples of the interaction of GABAB receptors with other neuronal receptors 
are GABAA and mGluR1 receptors. The  γ2 subunit of GABAA receptors promotes surface 
expression of the GABAB1 subunit, also in absence of GABAB2 (Balasubramanian et al., 
2004). GABAAγ2 and GABAB1 were shown to interact as single subunits, and also the γ2 
subunit of the functional GABAA receptor was shown to bind to the GABAB1,2 heterodimer. In 
this case, the γ2 subunit enhances GABAB receptor internalization upon agonist stimulation. 
This relationship would thus provide an activation-dependent feedback mechanism. 
The crosstalk between GABAB and mGluR1 receptors has been implicated in the modulation 
of long-term depression (LTD) in the cerebellum. LTD of excitatory transmission at cerebellar 
parallel fiber-Purkinje cell synapses is a form of synaptic plasticity crucial for cerebellar motor 
learning. GABAB receptors in the dendritic spines of Purkinje cells are activated by GABA 
spillover from vicinal GABAergic interneurons. In cerebellar Purkinje cells GABAB receptors 
strongly co-localize with mGluR1 receptors and were shown to increase mGluR1 signaling 
(Kamikubo et al., 2007; Tabata et al., 2004). 
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RGS proteins 
Two members of the Regulators of G-protein signaling (RGS) protein family, RGS2 and 
RGS12, have been described to modulate GABAB receptor functions. In contrast to other 
interacting molecules there is no evidence that RGS proteins directly bind GABAB receptors. 
RGS proteins are well known for their functions as GTPase activating proteins (GAP) and act 
through modulation of the GTPase activity of Gαi/o subunits. RGS proteins were later also 
found to regulate G-protein-effector interactions, though the mechanisms are not yet clear. 
For example, expression of RGS2 and its specific interaction with Kir3 account for the larger 
K+ currents and stronger desensitization observed in dopaminergic when compared to 
GABAergic neurons (Labouebe et al., 2007). In the case of the multidomain protein RGS12, 
which contains a phosphpotyrosine binding (PTB) domain additional to its GAP domain, 
Diverse-Pierlussi and her group demonstrated that RGS12 binds via this PTB domain to the 
SNARE-binding region in loop II-III of the N-type calcium channel alpha1 subunit, that is 
phosphorylated upon GABAB receptor activation. In addition, binding of RGS12 was shown to 
accelerate GABAB mediated inhibition of the calcium channel, most likely through inhibition of 
the syntaxin-channel interaction which is important for the stabilization of the binding of the 
Gβγ subunits to the calcium channels (Richman et al., 2005). 
 
In summary, most screens for GABAB interacting molecules have so far been accomplished 
with yeast two-hybrid systems and have in majority revealed proteins that influence the 
biosynthesis, trafficking or surface expression of the receptor. But none of them could so far 
be shown to directly modulate receptor activity. Yeast two-hybrid screens might not be 
suitable to identify activity-modifying binding partners, as this technique carries several 
drawbacks. One constraint is that only parts of the receptor are used as baits, and so far only 
a limited number of receptor domains have been used to search for specific interacting 
proteins. The main reason for this may be that the functional receptor exists as a compact 
dimer of the GABAB1 and the GABAB2 subunit, which likely results in different conformations 
and the consequently exposure of different molecular interfaces for possible protein 
interactions in the assembled receptor compared to the individual subunits. Therefore, the 
identification of components of a macromolecular complex, as have been described e.g. for 
the Ca2+ channels (Dai et al., 2009), might require new proteomic approaches using native 
GABAB receptor heterodimers. 
Therefore our group decided for a proteomic approach using affinity purification combined 
with high-resolution nanoflow liquid-chromatography tandem mass spectrometry to identify 
interaction partners of the GABAB receptor. Native GABAB receptors were purified from 
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membrane preparations prepared from total rat and mouse brains using antibodies against 
GABAB1. Among the purified proteins were the GABAB1 and GABAB2 subunits, and proteins 
which are known to be involved in GABAB mediated signaling pathways, such as kinases like 
PKA, PKC and CaMKII, certain G-protein subunits and some known effector channels, like 
the voltage-gated Ca2+ channels. Purification of native GABAB receptor complexes revealed 
members of the K+ channel tetramerization domain containing (KCTD) protein family, namely 
KCTD8, 12, 12b, and 16, associated with the GABAB receptor. However, none of the hitherto 
described GABAB interacting proteins were co-purified. This could be partially due to the fact, 
that we aimed to identify interactions with functional membrane-bound receptors and purified 
exclusively membrane fractions. However, the previously described, and mostly in Y2H 
screens discovered, interactions might occur predominantly in cytosolic or nuclear 
compartments, which imply that some of them could be false positive hits. 
KCTD protein family  
T1 domain as a structural determinant  
The GABAB interacting proteins described in this dissertation constitute one subfamily of the 
potassium (K+) channel tetramerization domain containing (KCTD) protein family. The name 
refers to the conserved domain at the N-terminus of these proteins, which is highly 
homologous to the tetramerization (T1) domain of some voltage-gated K+ (Kv) channels. 
Four Kv subunits assemble to form a functional channel. The N-terminal tetramerization 
domain contains a BTB (Bric-a-brac, Tramtrack, Broad-complex) domain, also designated 
POZ (Pox virus and Zinc finger) domain, that fold and mediates subunit specific assembly. 
The BTB domain is a widely distributed protein-protein interaction module, which derives its 
name from the observation by Laski and colleagues that the Drosophila transcription factors 
Bric-a-brac, Tramtrack, and Broad Complex display a region of sequence similarity at their N-
terminus that they named the BTB domain (Godt et al., 1993; Zollman et al., 1994). At the 
same time, Bardwell and Treisman realized that some Poxvirus proteins have resemblance 
to a portion of the Zinc finger proteins; they named this region the POZ (Pox virus and Zinc 
finger) domain (Bardwell and Treisman, 1994). These identical motifs define the BTB/POZ 
domain, but are collectively abbreviated as a BTB domain. BTB domains can mediate both 
self-association as well as interaction with non-BTB partners. Proteins that contain a BTB 
domain participate in many biological functions including transcriptional regulation (Melnick et 
al., 2000), protein degradation (Furukawa et al., 2003), cytoskeletal regulation and ion 
channel function (Stogios et al., 2005). Still, a common feature that emerges from all BTB 
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domains is that they allow multiple copies of a protein to associate with each other, thus 
amplifying or modulating their functions. 
KCTD family members – functions and implications in disease 
The family of KCTD genes contains 21 and 22 members in the human and mouse genome, 
respectively. The regions encoding the N-terminus of all family members are highly 
homologous. The C-terminal regions show large differences in length and as well in amino 
acid sequences. According to their homology, KCTD proteins can be grouped into 
subfamilies as indicated in the phylogenetic tree in Figure 1-2. Since our work began on the 
characterization of KCTD8, 12, 12b, and 16 in respects to GABAB receptor interaction and 
function in 2004, a considerable number of studies on other KCTD family members has 
emerged. Often conserved protein families with large constituents are divided into 
subfamilies that share similar functions, but are compartmentalized temporally and/or 
spatially. Knowledge about the different members of the KCTD protein family, their structural 
and functional properties might elucidate the full spectrum of actions inherited by the GABAB 
interacting KCTD subfamily. 
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Figure 1-2: Phylogenetic tree showing the sequence relationships between members of the KCTD 
protein family. Mouse sequences were aligned by using Clustal method. The phylogenetic tree was 
derived from the sequence comparisons using the neighbor-joining method in Clustal X. The scale bar 
represents 0.06 amino acid substitution per site. 
KCTD 10 and 13 (Polymerase delta-interacting protein 1(PDIP1)), together with Tumor 
necrosis factor, alpha-induced protein 1 (TNFAIP1), constitute one subgroup of KCTDs. 
Apart from the T1 domain, these proteins share a proliferating cell nuclear antigen (PCNA) 
binding motif (QTKV-EFP) at the C-terminus. They interact with PCNA and the small subunit 
(p50) of DNA polymerase δ, and stimulate polymerase δ activity in the presence of PCNA. All 
three were reported to be TNF-α inducible and therefore suggested to participate in TNF-α 
induced DNA replication/repair pathways (Wang et al., 2009; Zhou et al., 2005a; Zhou et al., 
2005b). 
KCTD 2, 5, and 17 constitute another subgroup with KCTD5 being the sole member 
characterized. KCTD 5 was identified by Weger et al. as an interaction partner of the large 
regulatory proteins Rep78/Rep68 of adeno-associated virus type 2. In addition, they found 
wildtype Rep78/Rep68 proteins inducing the translocation of KCTD5 into the nucleus (Weger 
et al., 2007). In 2008 Bayon et al. showed that KCTD5 interacts specifically with cullin3 
ubiquitine ligase and might act as a substrate-specific adaptor that recruits proteins for 
ubiquitiniation and its subsequent degradation. Moreover, they showed that the BTB domain 
of KCTD5 mediates protein oligomerization (Bayon et al., 2008). KCTD5 is the first member 
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of the KCTD family, which was characterized by x-ray chrystallography. Unexpectedly the 
structure revealed a pentameric assembly and leads to speculations that the BTB domain in 
KCTD5, and most likely KCTD2 and 17, forms a pentamer. This is in direct contrast to the T1 
domains of Kv channels which form a tetramer. A difference of four amino acids seems to be 
responsible for the different structures observed (Dementieva et al., 2009). 
KCTD1 is a nuclear protein that mediates transcriptional repression and homomeric 
interactions and specifically acts as a negative regulator of the transcription factor AP-2α 
(Ding et al., 2008). In addition, Ding et al. also found that KCTD1 interacts with three major 
members of the AP-2 family and inhibits their transcriptional activities (Ding et al., 2009). In 
the same study, the authors further showed that homomeric and heteromeric interaction is 
mediated via the BTB domain. 
KCTD 11 was one of the first members of the KCTD family to be described. The group of 
Alberto Gulino identified KCTD11 as a suppressor of sonic hedgehog homolog (Shh) 
signaling and investigated its role in the formation of medulloblastomas. Chromosome 17p 
deletion, the most frequently detected genetic lesion in medulloblastoma, leads to the loss of 
KCTD11, which in turn might lead to a deregulation of the tumor-promoting Shh pathway in 
medulloblastoma. In this context Argenti et al. found that KCTD11 can antagonize the 
Hedgehog pathway which in turn regulates proliferation and apoptosis of developing granule 
cell progenitors. And the BTB domain seems to be necessary for this effect (Argenti et al., 
2005). 
In a recent study, changes in the KCTD3 gene were suggested to be one of the causes in 
patients with autism spectrum disorder (Poot et al., 2009). Moreover KCTD3 was recognized 
as an antigen in patients with renal-cell carcinoma (therein called renal carcinoma antigen 
NY-REN-45), but further evidence for an emerging role in the pathology is lacking (Scanlan 
et al., 1999). KCTD3, however, is unique in that it contains, apart from the BTB domain, 
several nuclear targeting signals and a single transmembrane domain (Scanlan et al., 1999). 
Recently, several large scale genetic screens have identified different KCTDs as markers for 
different pathologies. Expression of KCTD 9 was found to be upregulated in patients with 
severe hepatitis B (Zhou et al., 2008). KCTD 15 was identified in a screen for gene loci with 
single-nucleotide polymorphisms that are associated with obesity (Cauchi et al., 2008; Zhao 
et al., 2009). Van Bogaert et al. reported a mutation of KCTD7 in patients suffering from 
progressive myoclonic epilepsy caused by neurodegeneration (Van Bogaert et al., 2007). 
Despite the genetic links, however, underlying biological functions and mechanisms remain 
unknown. KCTD20 was recently identified in Hispanic-American participants from the Insulin 
Resistance Atherosclerosis Family Study as a candidate gene that may be associated in the 
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acute insulin response to glucose, which is used as a predictor of type 2 diabetes (Rich et al., 
2009). Also KCTD12 was found in a screen for single nucleotide polymorphisms associated 
with type 2 diabetes (Cauchi et al., 2008). However, the true contribution of these KCTDs on 
incidences of type 2 diabetes still needs to be verified. 
KCTD12 was first cloned from a fetal cochlea library and described by Resendes et al. to be 
expressed in multiple cells in murine and human cochlea and suggested to play a role in 
hearing loss (Resendes et al., 2004). Furthermore, Kawai et al. performed an extensive 
protein expression study of bone and soft tissue sarcomas in order to develop novel 
diagnostic and therapeutic biomarkers and allow molecular classification of the tumors. In 
their study, KCTD12 was identified as one of the novel tumor markers. Notably, herein 
KCTD12 was identified as a promising prognostic marker for the separation of 
gastrointestinal stromal tumor patients into low and high risk groups. Identification of low-risk 
patients adds important value to their therapy as they could profit either from adjuvant 
imatinib treatment or from the possibility of minimizing the risk of unnecessary treatment 
(Kawai et al., 2008). 
Due to their sequence homology KCTD12 is phylogenetically grouped with KCTD12b, 
KCTD8, and KCTD16. Three of the six zebrafish orthologs of this KCTD subfamily Lov, Ron, 
and Dex are expressed asymmetrically in zebrafish habenular neurons and their projections 
to the interpeduncular nucleus. Although these left-right differences are not observed in 
higher vertebrates, the zebrafish studies might lead to the understanding of the development 
and evolution of lateralized features of the vertebrate nervous system (Gamse et al., 2005). 
Moreover these studies suggest a developmental role for KCTD 12.  The identification and 
characterization of KCTD8, 12, 12b, and 16 as novel interaction partners of the GABAB 
receptor is described in detail in this thesis. 
Aim of the thesis 
Pharmacological and functional differences of GABAB receptors observed in vivo suggest a 
wider molecular repertoire than the one provided by the two currently known receptor 
subtypes GABAB(1a,2) and GABAB(1b,2). Alternative explanations, therefore, may be the 
existence of yet unidentified interacting proteins capable of modifying receptor activity, 
pharmacology, and localization. This work was initiated when a proteomics’ approach using 
native membrane bound GABAB receptors from mouse brain in an affinity purification 
experiment had isolated putative binding partners of the receptor. We decided to focus on 
four sequence-related proteins – KCTD8, 12, 12b, and 16 - that were co-purified with the 
receptor. 
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This dissertation attempts to characterize these novel GABAB receptor interacting proteins 
including the analysis of structural distinctions between these proteins as well as their 
functional significance, the identification of the critical binding sites on the receptor and each 
KCTD protein, the investigation of the functional consequences with respect to GABAB 
receptor action, and the examination of the spatial and temporal distribution pattern of the 
GABAB receptor interacting KCTDs. 
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Abstract 
The γ-aminobutyric acid receptor B (GABAB) is a heteromeric G-protein coupled receptor that 
is thought to assemble and signal through the two subunits GABAB1 and GABAB2. Here we 
show by functional proteomics that GABAB receptors in the rat brain are high molecular 
weight complexes of GABAB1, GABAB2 and members of a subfamily of the 'potassium 
channel tetramerization domain-containing' (KCTD) proteins. KCTD proteins 8, 12, 12b and 
16 exhibit distinct expression profiles in the brain and tightly associate with the C-terminus of 
GABAB2 as tetramers. This coassembly changes the properties of the GABAB(1,2) core 
receptor: the KCTD proteins increase agonist potency and markedly alter the G-protein 
signaling of the receptors by accelerating onset and promoting desensitization in a KCTD 
subtype-specific manner. Together, our results establish the KCTD proteins as auxiliary 
subunits of GABAB receptors that determine the pharmacology and kinetics of the receptor 
response. 
Introduction 
GABAB receptors are the G-protein-coupled receptors (GPCRs) for γ-aminobutyric acid 
(GABA), the main inhibitory neurotransmitter in the mammalian CNS (Bettler et al., 2004). 
GABAB receptors are expressed in virtually all neurons in the brain (Kaupmann et al., 1998) 
and influence synaptic transmission and signal propagation by regulating the activity of 
voltage-activated Ca2+ (Cav) and inward-rectifier K+ (Kir) channels via the βγ dimer of the 
activated G-protein. Inhibition of Cav2 channels suppresses neurotransmitter release and 
blocks dendritic Ca2+ spikes, while activation of Kir3 channels induces slow inhibitory 
postsynaptic potentials and mediates shunting inhibition (Perez-Garci et al., 2006, Luscher et 
al., 1997). The time course and/or pharmacology of GABAB-mediated current responses vary 
among neurons (Cruz et al., 2004) and between pre- and postsynaptic effectors (Deisz et al., 
1997), suggesting the existence of a variety of molecularly distinct receptor subtypes 
(Bonanno and Raiteri, 1993). However, molecular cloning revealed only two types of 
receptors; these are generated by isoforms of the GABAB1 subunit, GABAB1a and GABAB1b 
(Kaupmann et al., 1997), which must coassemble with GABAB2 to form functional GABAB(1a,2) 
and GABAB(1b,2) receptors (Kaupmann et al., 1998). Both types of receptors exhibit identical 
pharmacological and kinetic properties (Ulrich and Bettler, 2007) and differ approximately 
ten-fold in agonist-affinity from their native counterparts (Kaupmann et al., 1998). 
At present, the differences in kinetics and pharmacology observed between responses of 
native GABAB receptors are unresolved as are the mechanism(s) introducing functional 
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diversity into heterologously expressed GABAB(1,2) receptors. Protein phosphorylation (Couve 
et al., 2002), 'regulator of G-protein signaling' (RGS) proteins (Labouebe et al., 2007) or 
distinct composition of effector channels (Cruz et al., 2004) have been proposed to underlie 
at least some of these differences. Alternatively, native GABAB receptors may contain 
additional, as yet unknown subunits that modify their properties. To test this hypothesis a 
recently developed proteomic approach combining affinity purification of appropriately 
solubilized protein complexes and quantitative mass spectrometric analysis of their 
constituents (Berkefeld et al., 2006; Schwenk et al., 2009; Zolles et al., 2009) was applied to 
GABAB receptors. 
From this analysis, four sequence-related members of the 'potassium channel 
tetramerization domain-containing' (KCTD) family of proteins were identified as intrinsic 
auxiliary subunits of native GABAB receptors. These KCTD proteins exhibit distinct 
expression patterns in the brain and endow GABAB receptors with subtype-specific G-protein 
signaling regarding activation and desensitization kinetics as well as agonist potency. The 
KCTD-mediated expansion of the functional repertoire provides a molecular basis for the 
functional diversity of heterologously expressed and native GABAB receptors. 
Results 
Proteomic analysis of GABAB receptors from mouse brain 
For proteomic analysis of native GABAB receptors, we performed affinity-purifications (APs) 
using antibodies specific for either of the two core subunits GABAB1 (anti-GABAB1 targeting 
GABAB1a and GABAB1b) or GABAB2 (anti-GABAB2) on appropriately solubilized membrane 
fractions prepared from total rat and mouse brains. The GABAB receptors in these protein 
preparations exhibited high molecular weights of more than ~0.75 MDa as visualized by two-
dimensional gel separations using blue native polyacrylamide gel electrophoresis (BN-
PAGE) and subsequent denaturing SDS-PAGE (Figure 2-1a). Total eluates of anti-GABAB 
APs from brain membrane fractions of rats and wildtype (WT) mice as well as of mice with 
targeted deletions of the receptor core subunits (Gassmann et al., 2004; Schuler et al., 2001; 
Vigot et al., 2006) were analyzed by high-resolution nanoflow liquid-chromatography tandem 
mass spectrometry (nano-LC MS/MS). These analyses provided the identity of the proteins 
in the respective eluates as well as quantitative data on their amounts as determined from 
the extracted ion current peak-volumes (Figure 2-1b) of multiple tryptic peptides (Cox and 
Mann, 2008; Schwenk et al., 2009). The results of these MS-analyses showed that both 
GABAB1 and GABAB2 were purified by either anti-GABAB antibody at high yield (rPV score 
(see Methods), Figure 2-2b) with the large number of peptides retrieved by mass 
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spectrometry covering 69% and 61% of the accessible primary sequence of GABAB1 and 
GABAB2, respectively (S Figure 2-1a). Moreover, normalization of the peak-volumes to the 
number of MS-accessible amino acids (abundancenorm) showed that the two core subunits 
were present in both anti-GABAB APs at equimolar ratios (Figure 2-2a,b). 
In addition to GABAB1 and GABAB2, our MS-analyses identified the KCTD proteins 8, 12, 12b, 
and 16, four closely related members of a large family of soluble proteins (21 and 22 different 
genes in the human and mouse genome, respectively) that share conserved domains in their 
N- (T1-domain, homology to Kv-type K+ channels) and C-termini (C-terminal domain, Figure 
2-1c, S Figure 2-2). KCTD isoforms 8, 12, and 16 were copurified with both anti-GABAB 
antibodies from rats and WT mice at similarly high yields as GABAB1 and GABAB2 
(abundancenorm values, Figure 2-2a, b; sequence coverages of 79%, 97% and 80%, 
respectively; for details see S Figure 2-1b), while KCTD12b was retrieved in markedly 
smaller amounts (Figure 2-2b). No KCTD-specific peptides were detected in APs with anti-
GABAB1 (Figure 2-1b) and anti-GABAB2 (not shown) from brains of GABAB1-/- and GABAB2-/- 
knock-out animals, respectively. In addition, KCTD proteins were not retrieved in anti-
GABAB1 APs from GABAB2-/- brains, where MS-analyses detected considerable amounts of 
GABAB1 protein (Figure 2-1b). Together, these results strongly suggested that KCTD proteins 
8, 12, 12b, and 16 are integral constituents of native GABAB receptors via interactions with 
the GABAB2 subunit. 
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Figure 2-1: Proteomic analysis identifies four KCTD proteins as subunits of native GABAB 
receptors. 
a, Scheme of the proteomic approach used for analysis of GABAB receptors from total rat and mouse 
brain. Upper panel: SDS-PAGE separation of solubilized (S) and insoluble (P) protein fractions 
obtained with the solubilization buffer CL-91 from brain membrane fractions of wildtype (WT) and the 
indicated knock-out mice. Lower panel: Two-dimensional gel separation of solubilized GABAB 
receptors from rat brain. Size (BN-PAGE) and molecular mass (SDS-PAGE) as indicated. Western 
blots in both panels were probed with the anti-GABAB1 antibody. Solubilized membrane fractions were 
used for APs with the indicated antibodies, total eluates of these APs were analysed by nano LC-
MS/MS. b, Peak-volumes (integral of MS signal intensity in the m/z-retention time plane; normal and 
isotope peaks) of the indicated peptides (z = +2, no modifications) determined from MS-spectra during 
nano LC-MS/MS analysis of anti-GABAB1 APs from brain membrane fractions of WT and the indicated 
knock-out mice. Note that the KCTD12 peptide was only obtained from WT material. c, Structural 
scheme illustrating the conserved domains and dendrogram (Clustal method) of the identified 
subfamily of KCTD proteins. d, Two-dimensional gel separation as in (a) Western blotted with the 
indicated antibodies. Note the close co-segregation of KCTD proteins 12 and 16 with GABAB1 and 
GABAB2. 
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Figure 2-2: GABAB receptors are robustly associated with a subset of KCTD proteins in the rodent 
brain. 
a, Double logarithmic plot of normalized abundance (abundancenorm) values determined for proteins in 
APs with anti-GABAB1 and anti-GABAB2. Grey circles denote unspecific background proteins, filled 
circles are proteins specifically copurified with both antibodies, while half-filled symbols represent 
proteins specifically copurified with only one of them (left side filled with anti-GABAB2, lower half filled 
with anti-GABAB1). b, Relative peak volumes (rPV, see Methods) and logarithmic abundancenorm 
values of the GABAB receptor core subunits and the KCTD proteins 8, 12, 12b, and 16 obtained in 
APs from rat brain membranes with the indicated antibodies. rPV values > 10 indicate specific 
copurification; values with asterisks refer to abundancenorm values corrected for homology between 
KCTD isoforms 12 and 12b. 
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Coassembly of KCTD proteins with native and heterologously expressed 
GABAB receptors 
Coassembly of the identified KCTD proteins with native GABAB receptors was further 
corroborated by reverse APs using antibodies specific for either KCTD12 (anti-KCTD12; S 
Figure 2-3) or KCTD16 (anti-KCTD16; S Figure 2-3), the most abundant KCTDs in the anti-
GABAB APs (Figure 2-2), on membrane fractions from rat and mouse brain. MS-analyses of 
the respective eluates showed that both anti-KCTD antibodies, besides enriching their target 
proteins, effectively copurified GABAB1 and GABAB2 as wells as the other KCTD isoforms 
(Figure 2-2b). In fact, the two GABAB receptor core subunits were the most abundantly 
copurified proteins apart from KCTDs and the only GPCR subunits detected by mass 
spectrometry. The KCTD-GABAB coassembly was further confirmed by Western blot analysis 
of two-dimensional gel separations of brain membrane fractions using the anti-GABAB and 
anti-KCTD antibodies. As illustrated in Figure 2-1d, both KCTD12 and KCTD16 strictly co-
migrated with the GABAB core subunits, although their signals exhibited only partial overlap 
with each other. This suggests that a portion of both KCTDs may be integrated into the same 
GABAB complexes, while the remaining KCTD proteins 12 and 16 participate in distinct 
GABAB receptors of either higher (KCTD16) or lower (KCTD12) molecular size (Figure 2-1d). 
Interestingly, all GABAB receptors resolved on native gels appeared associated with the 
KCTD proteins and markedly exceeded the molecular weight predicted for GABAB(1,2) 
heterodimers (~250 kDa). These results together with the abundant copurification pointed 
towards direct coassembly of the KCTD proteins with GABAB receptors. This was tested in 
APs from membrane fractions prepared from cultured HEK293 cells that heterologously 
expressed various combinations of differentially tagged GABAB1 (Myc-tag), GABAB2 (HA-tag) 
and KCTD12 (FLAG-tag) proteins. The results showed that the KCTD-GABAB coassembly is 
mediated by direct interaction between the KCTD and GABAB2 proteins (Figure 2-3a), in line 
with the AP results from knock-out animals (Figure 2-1b). 
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Figure 2-3: Molecular interface and stoichiometry of the GABAB-KCTD interaction. 
a, SDS-PAGE separation of input and eluate of anti-FLAG APs Western blotted with the indicated 
antibodies. Input are membrane fractions from HEK293 cells coexpressing combinations of 
differentially tagged GABAB1 (Myc-tag), GABAB2 (HA-tag) and KCTD12 (FLAG-tag). The 
GABAB1(ASAA) mutant was used to prevent retention of the protein in the endoplasmic reticulum 
(Pagano et al., 2001). Note selective interaction between KCTD12 and the GABAB2 protein. b, 
Experiment as in (a) using FLAG-tagged KCTD12 and HA-tagged C-terminal deletions or point 
mutations of GABAB2 as input. Similar results were obtained with KCTDs 8, 12b, and 16 (data not 
shown). c, Native PAGE separation of a binding assay using bacterially synthesized and purified T1- 
and C-terminal domains of KCTD12 (KCTD12-T1, KCTD12-Cterm), and the C-terminus of GABAB2 (aa 
849-940). Proteins were visualized by Coomassie staining. Note that binding only occurred between 
KCTD12-T1 and GABAB2-Cterm. d, Size exclusion chromatography (SEC) of the GB1-tagged KCTD12-
T1-domain (Tag-KCTD12-T1); pure BSA (MW of 69 kDa) was added for comparison and size 
calibration. Inset: Sedimentation equilibrium analysis of the monodisperse SEC fraction of Tag-
KCTD12-T1 (protein MW of 20.4 kDa); data were obtained with a protein concentration of 0.5 mg/ml at 
12.000 rpm. Continuous line represents fit of the data yielding the indicated MW. e, SEC analysis of 
the bacterially synthesized and purified complex of KCTD12-T1 and the GABAB2 C-terminus (aa 745-
940); purified KCTD12-T1 was added for comparison. Left inset: SDS-PAGE of the indicated SEC-
fraction (KCTD12-T1+GABAB2-C745-940, yellow bar); the gel was stained with Sypro Orange. Right 
inset: Stoichiometry of the complex constituents obtained either from fluorescence intensity 
measurements (Sypro analysis) or from quantitative MS-analyses of gel separations as in the left 
inset; data are mean ± SD of 3 experiments. Note that both methods yielded a stoichiometry of about 
4:1 for KCTD12-T1 : GABAB2-C745-940. 
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Structural determinants and stoichiometry of the GABAB-KCTD 
interaction 
The structural determinants that mediate the interaction between KCTD proteins and GABAB2 
were identified by APs from HEK293 cells coexpressing FLAG-tagged KCTD12 and a series 
of deletion and point mutants of HA-tagged GABAB2. These experiments revealed a six 
amino acid stretch (amino acids 901-906) at the very C-terminus of the GABAB2 protein as a 
critical interaction determinant, with an aromatic residue at position 902 being of particular 
importance (Figure 2-3b). Tyrosine (WT) or phenylalanine at this position promoted 
interaction with KCTD12, while replacement with alanine abolished it (Figure 2-3b). 
Subsequent binding assays with the C-terminus of GABAB2 (amino acids 849-940) and the 
conserved structural domains of KCTD12 (Figure 2-1c), all synthesized in bacteria and 
purified to homogeneity, were used to identify the interaction site(s) on the KCTD proteins. 
Native gel separations of these samples showed that the T1-domain of KCTD12 (KCTD12-
T1) robustly assembled with the GABAB2 C-terminus, whereas the C-terminal domain of 
KCTD12 failed (Figure 2-3c).  
To investigate the stoichiometry of the GABAB receptor components, purified GB1-tagged 
KCTD12-T1 (Tag-KCTD12-T1) as well as purified complexes of KCTD12-T1 and the full-
length C-terminus of GABAB2 (KCTD12-T1+GABAB2-C745-940), obtained by bacterial 
coexpression, were analysed by size-exclusion chromatography, analytical 
ultracentrifugation and quantitative mass spectrometry. As shown in Figure 2-3d, the tagged 
KCTD12-T1 eluted as a monodisperse protein fraction in size-exclusion chromatography 
and, in subsequent sedimentation equilibrium analyses, displayed a molecular weight of 82.9 
± 4.3 kDa (mean ± SD of 4 different runs, see Methods), a value very close to the weight 
calculated for a tetramer of Tag-KCTD12-T1 proteins (weight of the monomer is 20.4 kDa). 
Similarly, the KCTD12-T1+GABAB2-C745-940 complex, purified via the KCTD12-T1 subunit, 
eluted as a monodisperse peak in size-exclusion chromatography. Analysis of its subunit 
stoichiometry via mass spectrometry- or fluorescence-based quantification (see Methods) 
following separation by SDS-PAGE revealed a ratio for KCTD12-T1 : GABAB2-C745-940 of 
approximately 4:1 (Figure 2-3e). This result confirmed the tetrameric assembly of KCTD12-
T1 and suggested that each KCTD-T1 tetramer offers one binding site for the C-terminus of 
GABAB2. 
Together, proteomic and biochemical analyses indicated that the KCTD proteins 8, 12, 12b 
and 16 are integral constituents of native GABAB receptors through intimate association of 
KCTD homo- and/or heterotetramers with the C-terminus of the GABAB2 subunit. When 
related to the size on BN-PAGE gels, this arrangement suggests that native GABAB 
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receptors are most likely dimeric assemblies (Maurel et al., 2008) of monomers made up of 
GABAB1, GABAB2 and a KCTD-tetramer (estimated monomer weight of ~350-400 kDa). 
Expression pattern of KCTD proteins in the CNS 
Next, the expression profiles of the four identified KCTD proteins in the CNS were 
investigated by in-situ hybridization. As illustrated in Figure 2-4a, the four KCTDs exhibited 
distinct, but partially overlapping expression patterns. Transcripts encoding the KCTD 
proteins 12 and 16 were detected throughout most regions of the brain, with particular 
abundance in the neocortex, the hippocampal formation (granule cells in the dentate gyrus, 
pyramidal cells in the CA1/CA3 regions), the cerebellum (Purkinje cells (KCTD12), Golgi 
cells (KCTD16)) and the septum (KCTD12). KCTD8 mRNA was predominantly observed in 
the olfactory bulb and in the granule cell layer of the cerebellum, whereas transcripts for 
KCTD12b appeared restricted to the medial habenula (Figure 2-4a). The subcellular 
distribution of the KCTD proteins 12 and 16 was assessed by the anti-KCTD antibodies used 
in pre-embedding immuno electron microscopy (EM) and immunolabeling of freeze-fracture 
replicas of the hippocampal CA1 region (stratum radiatum). Both techniques localized the 
anti-KCTD12 and anti-KCTD16 immunoreactivity to the plasma membrane of pre- and 
postsynaptic compartments of putative principal cells that were also stained with the anti-
GABAB1 antibody (Figure 2-4b, c). Thus, abundant anti-KCTD12/16 immunoreactivity was 
found at the peri- and extrasynaptic membranes of dendritic shafts and spines of pyramidal 
cells and at the presynaptic membrane specialization of putative glutamatergic synapses 
(Figure 2-4b, c). Interestingly, in all locations immunoparticles revealed a similarly clustered 
organization for GABAB1, KCTD12 and KCTD16 (Figure 2-4b, c), consistent with the known 
clustering of native GABAB receptors (Kulik et al., 2006) and their heteromultimeric assembly 
from these subunits reported here. 
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Figure 2-4: Expression profile and subcellular localization of KCTD proteins in the brain.  
a, Distribution of transcripts encoding the indicated KCTD proteins in the adult mouse brain as 
obtained by in-situ hybridization with digoxigenin-labelled antisense probes on horizontal sections of 
the medial tier of the brain (overview (left), hippocampal formation (middle) and cerebellum (right)). 
Transcripts of KCTD proteins 12 and 16 are found throughout the brain with particular abundance in 
the neocortex and hippocampus; note the distinct pattern in the cerebellum (KCTD12 in Purkinje cells 
(arrowheads), KCTD16 in Golgi cells (arrows). KCTD8 mRNA is detected in the olfactory bulb and the 
granule cell layer of the cerebellum, whereas transcripts for KCTD12b appeared restricted to the 
medial habenula (open frame, enlarged in inset). DG, dentate gyrus; gcl, granule cell layer; ml, 
molecular cell layer. Scale bars are 200 μm (overviews) and 40 μm (hippocampus and cerebellum). 
b, Electron micrographs of immunoreactivities for the indicated KCTD proteins and GABAB1 in the 
stratum radiatum of the hippocampal CA1 region detected by pre-embedding immunogold EM. 
Immunogold particles were most abundant at the extrasynaptic plasma membrane (filled arrowheads) 
of dendritic spines (s) and dendritic shafts (Den) of pyramidal cells, but also at the presynaptic 
membrane specialization (open arrowheads) of boutons (b) of putative excitatory cells. 
c, GABAB1 and KCTD proteins are organized in clusters (arrowheads) over the surface of dendrites 
(Den) of CA1 pyramidal cells as assessed by the SDS-FRL technique. Insets are enlargements of the 
indicated frames. Scale bars (b, c) are 0.2 μm. 
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Modulation of G-protein signaling of GABAB receptors by KCTD proteins 
To test whether coassembled KCTD proteins alter the functional properties of GABAB 
receptors, GABAB(1,2) or GABAB(1,2)-KCTD heteromultimers were coexpressed in Xenopus 
oocytes or CHO cells together with the Gβγ-regulated effector ion channels Kir3 or 
Cav2.1/Cav2.2 (corresponding to P/Q- and N-type). Figure 5a shows typical current traces 
recorded in whole oocytes from heteromeric Kir3.1/3.2 channels in response to 60s-
applications of 1 mM GABA to GABAB receptors assembled either from GABAB1 and GABAB2 
(GABAB) or from these core subunits and the KCTD proteins 16, 12, and 12b 
(GABAB+KCTDx). While all receptor types effectively activated Kir3 channels, the respective 
K+ currents markedly differed in their time-course: currents activated by GABAB+KCTD16 
and GABAB+KCTD8 decreased only slightly over the application period (~10% of maximum), 
very similar to KCTD-less GABAB receptors, whereas the responses of both 
GABAB+KCTD12 and GABAB+KCTD12b receptors displayed pronounced desensitization (> 
70% of maximum; P < 0.001, Dunnett's multiple comparison test, Figure 2-5a, c). The extent 
of the KCTD12-induced desensitization was essentially independent of the agonist-
concentration in the range between 10 μM and 1 mM (rel. desensitization after 60 s was 0.72 
± 0.06 (n = 12), 0.70 ± 0.01 (n = 12) and 0.70 ± 0.08 (n = 8) for 1 mM, 100 μM and 10 μM 
GABA, respectively). Closer analysis showed that adequate description of the desensitization 
time course of GABAB+KCTD12-triggered currents required two exponential functions with 
time constants of 4.6 ± 1.5 s (mean ± SD, n = 8; relative contribution of 0.27 ± 0.14) and 22.7 
± 4.5 s (n = 8; relative contribution of 0.73 ± 0.14; Figure 2-5c). Interestingly, KCTD12/12b-
mediated desensitization also affected the 'basal Kir3 current' (activated by free Gβγ (Peleg et 
al., 2002), S Figure 2-4), as visualized by its transient decrease observed upon removal of 
the agonist (Figure 2-5a).  
The results on KCTD subtype-specific properties of GABAB-receptor signaling were closely 
reproduced when the Kir3 channels were replaced as effector system by Cav2.1 or Cav2.2 
channels. Thus, while activation of GABAB, GABAB+KCTD16 or GABAB+KCTD8 led to stable 
inhibition of the Cav channels over the application period, activated GABAB+KCTD12 or 
GABAB+KCTD12b receptors decreased the Cav channel activity only transiently reflecting 
the pronounced receptor desensitization (~60% of maximum; Figure 2-5b, c). 
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Figure 2-5: G-protein signaling of GABAB receptors is determined by KCTD proteins associated 
with the GABAB2 subunit. 
a, K+ currents recorded at -50 mV in response to applications of 1 mM GABA from whole oocytes 
coexpressing GABAB, Kir3.1/3.2 channels and the indicated KCTD proteins. Extracellular K+ 
concentration was 100 mM; current and time scaling as indicated. b, Experiments as in (a) but with 
oocytes coexpressing GABAB, Cav2.2 channels and the indicated KCTD proteins; the bath solution 
contained 10 mM Ba2+. Data points are maxima of currents elicited every 3 s by voltage-steps from -
100 mV to 0 mV (shown on the right for the indicated time points), successive GABA applications are 
denoted by the horizontal bars. Current scale is 0.1 nA, time scaling as indicated. c, Bar graphs 
summarizing the relative desensitization determined for the indicated subunit combinations. Data 
points are mean ± SD of 6-12 (GABAB+Kir3.1/3.2), 8-13 (GABAB+Cav2.2) and 3-7 (GABAB+Cav2.1) 
experiments. Upper right panel: Time constants (τdesens) and their relative contribution obtained from 
bi-exponential fits to the Kir3.1/3.2 current decay recorded in experiments as in (a) with KCTD12; data 
points are mean ± SD of 8 measurements. d, Summary of relative Kir3.1/3.2 desensitization 
determined with the indicated receptors in the absence and presence of KCTD12. Inset: 
Representative Kir3.1/3.2 current responses activated with GABAB-KCTD12 receptors harboring either 
the GABAB2 WT (grey) or the GABAB2(Y902A) mutant subunit (black). Note that desensitization is 
abolished in the GABAB2(Y902A) mutant precluding assembly with KCTD12. 
The KCTD12-induced desensitization, however, was only observed if WT GABAB2 was 
coassembled into the receptor complexes. Mutant GABAB2 that precluded interaction with the 
KCTD proteins (Figure 2-3b), effectively prevented desensitization by the coexpressed 
KCTD12 protein and instead promoted G-protein signaling indistinguishable from KCTD-less 
GABAB receptors (Figure 2-5d). Moreover, KCTD12 failed to exert any obvious effect on the 
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G-protein signaling of D2 dopamine receptors and purinoreceptors of the P2Y2-subtype, 
although both GPCRs effectively activated the coexpressed Kir3 channels in Xenopus 
oocytes (Figure 2-5d). 
Another set of experiments used CHO cells, because they allowed for faster solution 
exchange (time constant of ~12 ms) and offered a different cellular background for the 
receptor mediated G-protein signaling. Figure 6a shows representative traces of receptor-
activated Kir3 currents, illustrating that the pronounced differences in kinetics and in extent of 
desensitization seen with the four KCTD subtypes in oocytes were closely recapitulated in 
CHO cells (at the end of a 25s-application of 0.1 mM baclofen; Figure 2-6a). In particular, 
approximation of the KCTD12-induced desensitization by exponential functions required two 
components with time constants of 1.5 ± 0.4 s (mean ± SD, n = 10; relative contribution of 
0.42 ± 0.14) and 8.9 ± 2.1 s (n = 10; relative contribution of 0.58 ± 0.14; Figure 2-6a). 
Furthermore, rapid solution exchange was used to resolve onset and activation phases of the 
receptor responses. Representative Kir3 currents (Figure 2-6b, inset) indicated that all four 
KCTD proteins markedly accelerated the GABAB response, although to different extents. 
Thus, the values (mean ± SD) determined for the 20-80% rise time of the Kir3 currents 
revealed that KCTD8 speeded the activation by ~3-fold, while KCTD12 accelerated it by 
almost 10-fold (20-80% rise times of 2.90 ± 0.72 s (n = 17), 1.05 ± 0.36 s (n = 11) and 0.36 ± 
0.12 s (n = 13) for GABAB, GABAB+KCTD8 and GABAB+KCTD12 receptors, respectively; P 
< 0.001, Dunnett's multiple comparison test; Figure 2-6b). In addition to their impact on the 
kinetics, KCTDs 12 and 16 significantly influenced the agonist concentration-dependence of 
the GABAB responses as determined by apparent dose-response relationships with baclofen. 
As shown in Figure 2-6c, KCTD12 and KCTD16 shifted the respective EC50 values (fits to the 
mean currents) towards lower concentrations by factors of about 7 and 3, respectively.  
Finally, the KCTD effects were examined in cultured hippocampal neurons that have robust 
Kir3-mediated GABAB responses (Sodickson and Bean, 1996). Here, recordings using fast 
solution exchange (time constant of ~22 ms) showed that the baclofen-elicited K+ currents 
exhibited rapid onset with values for the 20-80% rise time of 0.36 ± 0.11 s (n = 26) and a 
steady-state desensitization of 34 ± 9% (n = 38; Figure 2-6d). Both values suggested 
endogenous expression of KCTD proteins that was confirmed by quantitative PCR revealing 
transcripts of KCTDs 8, 12 and 16 (S Figure 2-5). Upon transfection with the four KCTD 
isoforms, a significant increase in steady-state desensitization was only obtained with KCTDs 
12 and 12b (80 ± 7% (n = 15) and 70 ± 8% (n = 7), respectively; P < 0.001, Dunnett's 
multiple comparison test; Figure 2-6d), in close agreement with the results from CHO cells 
and Xenopus oocytes. Moreover, KCTDs 12 and 12b also induced a significant decrease of 
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the 20-80% rise times (0.16 ± 0.05 s (n = 11) and 0.21 ± 0.05 s (n = 7) for KCTD 12 and 12b, 
respectively; P < 0.001, Dunnett's multiple comparison test; Figure 2-6d). 
Taken together, these results indicated that KCTD proteins may extensively modify the 
kinetics of the G-protein signaling as well as the agonist-potency at GABAB receptors. The 
effects of the KCTD proteins are independent of the cellular background or the effector 
system, but require tight assembly with the receptor core, similar to the interactions between 
the auxiliary and the pore-forming subunits of ion channels and transporters (Arikkath and 
Campbell, 2003; Jentsch, 2008; Rettig et al., 1994; Schwenk et al., 2009). 
 
Figure 2-6: Kinetics and agonist-potency of the GABAB response is controlled by KCTDs in CHO 
cells and neurons. 
a, Upper panel: K+ currents through Kir3.1/3.2 channels recorded at -50 mV in response to 
applications of 0.1 mM baclofen from whole CHO cells coexpressing GABAB, Kir3.1/3.2 channels and 
the indicated KCTD proteins. Extracellular K+ concentration was 2.5 mM; current and time scaling as 
indicated. Lower panel: Summary plot as in Figure 2-5c; data are mean ± SD of 6-31 (relative 
desensitization) and 10 experiments (τdesens and relative amplitude). b, Onset of the response given as 
20-80% rise time of Kir3.1/3.2 currents activated by GABAB without or together with the indicated 
KCTD proteins. Data points are mean ± SD of 6-17 experiments. Inset: Representative current onsets 
at the indicated time scale. c, Apparent dose-response relations obtained with GABAB (open circles) or 
with GABAB and KCTD proteins 12 and 16. Data points are mean ± SD of 7-13 experiments; lines are 
fit of a logistic function with values for EC50 and Hill coefficient of 68.7 μM and 1.02 (GABAB), 21.0 μM 
and 0.75 (GABAB +KCTD16), 9.9 μM and 0.63 (GABAB+KCTD12). d, Upper panel: Currents through 
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Kir3 channels recorded in experiments as in (a) from cultured hippocampal neurons without (native) or 
after transfection with KCTD12 (red trace) or KCTD16; current and time scaling as indicated. Lower 
panels: Bar graphs summarizing relative desensitization (left) and onset (right) of the Kir3 currents as 
in (a) and (b); data points are mean ± SD of 7-38 experiments. 
Discussion 
We identified four closely related KCTD proteins as intrinsic auxiliary subunits of native 
GABAB receptors that are demonstrated to form high-molecular weight complexes from 
KCTD tetramers and the core subunits GABAB1 and GABAB2. The KCTD proteins endow the 
receptor complexes with subtype-specific properties of their G-protein signaling and provide 
a molecular basis for functional diversity of GABAB receptors in the mammalian brain. 
KCTD proteins - novel auxiliary subunits of GABAB receptors in the brain 
For investigation of the molecular composition of native GABAB receptors, we used a 
proteomic approach that combines APs of efficiently solubilized high-molecular weight 
complexes (as controlled by BN-PAGE; Figure 2-1d) from WT and knock-out brains with 
quantitative evaluation of nano-LC MS/MS analysis (Berkefeld et al., 2006; Schwenk et al., 
2009; Zolles et al., 2009). This unbiased approach, besides isolating equimolar amounts of 
the expected GABAB1 and GABAB2 core subunits (Figure 2-2), identified the KCTD proteins 
8, 12, 12b and 16 as specific partners of GABAB receptors, while it failed to retrieve 
previously suggested interacting proteins (Bettler et al., 2004). So far, neither of these KCTD 
proteins has been implicated in GABAB physiology or any other cellular process, although for 
KCTD12 downregulation in patients with autism has been reported (Hu et al., 2009), as well 
as a high-level expression in the developing cochlea and brain (Resendes et al., 2004). 
Further proteomic analysis showed that the KCTD proteins partner with both types of GABAB 
receptors, GABAB(1a,2) and GABAB(1b,2) (as indicated by effective copurification from GABAB1a  
-/- and GABAB1b-/- brains), and that this partnership is exclusive among GPCRs; no other 
GPCRs were identified in our anti-KCTD APs, in which the GABAB core subunits were the 
most abundantly copurified proteins (Figure 2-2). Moreover, quantification of MS-data and 
native gel electrophoresis revealed that the vast majority of GABAB receptors in the 
mammalian brain is coassembled with the identified KCTD proteins into high molecular 
weight complexes (Figure 2-1d, Figure 2-2). The interaction occurs at the C-terminus of 
GABAB2 that appears to bind homo- and heterotetrameric assemblies of KCTD proteins 
(Figure 2-2, Figure 2-3). This quaternary structure (Figure 2-3) is in line with the recently 
resolved structure of KCTD5 (as KCTDs 8, 12, 12b and 16 lack the residues required for 
pentamer formation, similar to the tetramerizing T1-domains of Kv-type K+ channels 
(Dementieva et al., 2009)).  
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Subsequent functional analyses revealed that the KCTD proteins influence the G-protein 
signaling of the GABAB receptor complexes by increasing agonist sensitivity, accelerating the 
onset of the receptor response and determining kinetics and extent of desensitization (Figure 
2-5, Figure 2-6). Therefore, the KCTD proteins engender GABAB receptors with distinct 
functional properties.  
Molecular mechanism of KCTD action  
The KCTD-mediated effects strictly required direct interaction between both GABAB2 and 
KCTD (lack of effect in the GABAB2 mutants (Y902A) and (5A); Figure 2-5d), but were 
independent of the cellular background (with likely different decoration of G-proteins), the 
effector system (Kir3, Cav2) and the type of agonist (GABA or baclofen; Figure 2-5, Figure 
2-6). Based on these observations, the KCTD action may be envisaged to take place at the 
receptor itself, where the KCTD tetramers are positioned to interact with both the C-terminus 
of GABAB2 (Figure 2-3) and the heterotrimeric G-protein at the intracellular loops 2 and 3 of 
this core subunit (Duthey et al., 2002). Upon agonist binding to GABAB1, the KCTD protein 
may promote two distinct actions: (i) a faster initial GDP/GTP exchange at Gα leading to an 
accelerated activation of the effector, and (ii) a subsequent transition of the receptor into an 
'inactivated state' that precludes further GDP/GTP exchange and thus leads to a decrease of 
the effector activity - seen as apparent desensitization. Alternatively, the subtype-specific 
induction of desensitization may result from an enhanced GTPase activity of Gα induced by 
the KCTD tetramer, similar to the action of RGS proteins (Chuang et al., 1998; Tinker, 2006). 
Implications for GABAB receptor signaling in the CNS 
Under physiological conditions, activation of pre- and postsynaptic GABAB receptors is 
thought to be triggered by GABA either 'spilled over' from synapses upon repetitive and/or 
synchronous firing(Nicoll, 2004) or released from synapses in response to single action 
potentials (monosynaptically evoked or unitary inhibitory responses (Otis et al., 1993; Price 
et al., 2008; Tamas et al., 2003)). Activation by either pathway will be accentuated by the 
KCTDs, as they increase agonist potency and speed up receptor-effector coupling (Figure 
2-6). This should be the case for both the Cav channels as the major presynaptic effector 
and the Kir3 channels, the predominant effector on the postsynaptic side (Figure 2-4, Figure 
2-5). Under experimental conditions, GABAB receptors have often been activated by slow 
bath application of baclofen, which promotes extensive desensitization of KCTD12-
containing receptors (Figure 2-5, Figure 2-6) and would, therefore, be expected to result in a 
marked underestimation of the GABAB-mediated effects. Whether the GABAB effects, 
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however, are indeed different between neurons expressing KCTD16 and those expressing 
KCTD12 remains to be elucidated. 
The functional significance of the identified KCTD proteins, as well as their impact on the 
appearance of GABAB receptor complexes are reminiscent of auxiliary subunits of ion 
channels and of the receptor activity-modifying proteins (RAMPs) identified for the calcitonin 
and calcitonin-like GPCRs (McLatchie et al., 1998). Although largely different from each 
other, KCTDs and RAMPs suggest that the functional properties of other GPCRs may also 
be affected by specific auxiliary subunits that can be identified by a proteomic approach 
similar to the one used here. In conclusion, our results establish the KCTD proteins 8, 12, 
12b and 16 as auxiliary subunits of GABAB receptors and novel determinants of GABAB-
mediated signaling in the CNS. 
Methods Summary 
The proteomic approach including preparation of source material, APs and high-resolution 
mass spectrometry, as well as immuno EM and electrophysiological recordings were done as 
described in references (Berkefeld et al., 2006; Schwenk et al., 2009; Zolles et al., 2009). 
Specifications and further details are described in the Methods. 
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Methods 
Molecular biology 
The cDNAs used were all verified by sequencing and had the following genebank accession 
numbers: Y10370 (GABAB1), AJ011318 (GABAB2), AY615967 (KCTD8), AY267461 
(KCTD12), AL831725 (KCTD12b), NM_026135 (KCTD16), X57477.1 (Cav2.1), D14157.1 
(Cav2.2), NM_017346.1 (Cav β1b), AF286488.1 (α2δ), NM_016574.2 (D2 receptor), 
  
Native GABAB receptors are heteromultimers with a family of auxiliary subunits
41
L14751.1 (P2Y2 receptor); the Kir3.1/3.2 construct is as described (Wischmeyer et al., 
1997). 
In situ hybridizations were done with 10 μm cryosections of freshly frozen mouse tissue using 
digoxigenin-labeled riboprobes that were generated by transcription of cDNAs of mouse 
KCTDs 8, 12, 12b and 16 in sense and antisense direction followed by alkaline hydrolyzation 
of the probes to an average length of 200–400 bases (Schaeren-Wiemers and Gerfin-Moser, 
1993). 
Biochemistry  
Plasma membrane-enriched protein fractions were prepared from freshly isolated rat or 
mouse brains and solubilised with ComplexioLyte buffers CL-75 or CL-91 (LOGOPHARM 
GmbH, Germany) as given in (Schwenk et al., 2009); for rat and WT mice, preparations from 
at least 15 individual brains were pooled, for membrane fractions of knock-out mice 
preparations pooled from 10 brains were used. 
BN-PAGE. Two-dimensional gel electrophoresis was done as detailed in (Schwenk et al., 
2009) with CL-75 used for solubilisation. For Western analysis, the blot was split into two 
molecular weight ranges and analysed with anti-GABAB1 (Engle et al., 2006) or anti-GABAB2 
(BD Transduction Laboratories; high MW range) and anti-KCTD12 or anti-KCTD16 (low MW 
range). 
Affinity purification. Solubilised membrane fractions (2 mg, CL-91) were incubated for 2 hours 
at 4°C with 20 μg immobilized affinity purified anti-GABAB1, anti-GABAB2 (Chemicon/Millipore, 
AB5394), anti-KCTD12 (target sequence: aa 145-166 of KCTD12 (accession AY267461); S 
Figure 2-3), anti-KCTD16 (target sequence: aa 8-23 of KCTD16 (accession NM_026135); S 
Figure 2-3) or control IgG (Upstate/Millipore). After brief washing, bound proteins were eluted 
with Laemmli buffer (DTT added after elution), shortly run into SDS-PAGE gels and digested 
with trypsin as described (Schwenk et al., 2009). For anti-FLAG APs cleared lysates of 
HEK293 cells were incubated overnight at 4°C with immobilized anti-FLAG antibody (Sigma). 
After separation by SDS-PAGE, purified proteins were Western analyzed with the following 
antibodies: anti-FLAG (Sigma), anti-HA (Covance), anti-Myc (Roche) and peroxidase-
coupled secondary antibodies (Amersham Biosciences). 
In-vivo protein synthesis and binding assays. Distinct domains of KCTD12 and GABABB2 
were expressed in Escherichia coli BL21(DE3) as following constructs (in modified pET16b, 
pET30 vectors): KCTD12-T1 (residues 27-131 of KCTD12 with a N-terminal His6-tag), Tag-
KCTD12-T1 (residues 27-131 of KCTD12 fused to His6-GB1 protein), KCTD12-Cterm 
(residues 202-327 fused to His6-GB1 protein) and GABAB2-Cterm (residues 849-940 or 745-
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940 fused to His6-GB1 protein). Proteins were purified to homogeneity by metal chelate 
affinity columns (Ni-Sepharose), anion-exchange (MonoQ) and size-exclusion 
chromatography (SEC, Superdex 200, 10/300 GL) run in Tris-buffer (20 mM Tris/HCl pH 8, 
150 mM NaCl, 2 mM DTT). For binding studies, the respective purified proteins were mixed 
in about equimolar ratios and incubated for 30 minutes at room temperature. After addition of 
0,01% Coomassie G-250 complex formation was determined by native PAGE (12%) 
separation. 
Analytical ultracentrifugation. 0,5 mg/ml of Tag-KCTD12-T1 dissolved in 150 mM NaCl and 
20 mM Tris/HCl (pH 7,4) was loaded onto a Beckman Optima-XLA (An60-Ti rotor) equipped 
with absorption optics. Sedimentation equilibrium runs were performed at 12.000 rpm and 
15.000 rpm. The molecular masses were determined by fitting the data with a single ideal 
species model (Rivas et al., 1999). 
Determination of stoichiometry. For determination of subunit stoichiometry in KCTD12-
T1+GABAB2-C745-940 complexes, SEC fractions were separated by SDS-PAGE and either 
stained with Sypro Orange (Bio Rad) for fluorescence-based analysis of protein bands or 
silver stained and digested with trypsin for quantitative LC-MS/MS analysis. The molar ratio 
of the two subunits was obtained by (i) comparing the fluorescence signals measured for 
each subunit and divided by the respective molecular mass (Sypro analysis) or by (ii) 
quantitative MS-analysis (see below) using a purified chimeric protein (fusion of KCTD12 and 
GABAB2 expressed in Xenopus oocytes) as a 1:1 reference (Schwenk et al., 2009).  
Mass spectrometry 
LC-MS/MS analysis. High-resolution mass spectrometry was performed as detailed in 
(Schwenk et al., 2009); database searches used the SwissProt database (Mammalia, 
release 56.8) supplemented with the TrEMBL entry Q8C7J6 for KCTD12b. 
Protein quantification. Two methods, relative peak volumes (rPV) and normalized protein 
abundance (abundancenorm, Figure 2-2b), were used for protein quantification, both based on 
peak volumes (= intensity of MS signal x retention-time x m/z-width) of individual tryptic 
peptides (Cox and Mann, 2008; Schwenk et al., 2009). rPV values compare the amount of 
each protein identified in APs with the anti-GABAB and anti-KCTD antibodies from rat and 
mouse WT brains with the respective amount determined in APs either with IgGs (rat) or with 
the anti-GABAB and anti-KCTD antibodies from GABAB core subunit knock-out animals. rPV 
values are calculated as the median of the ratios of the six most consistent tryptic peptides of 
each protein (if the MS signal of a given peptide was not detected in the controls, the 
detection threshold of the spectrometer (3000 volume units at the settings used) served as 
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the denominator in rPV calculations). Any protein with an rPV value >10 (APs from rat) or >5 
(APs from mouse) were regarded specifically purified by the respective antibody. 
Abundancenorm values compare the molar amounts of different proteins and are calculated as 
the sum of all assigned peak volumes divided by the number of MS-accessible amino acids 
(sequence of tryptic peptides with masses between 740 and 3000 Da under the MS settings 
used). For KCTD12b, the abundancenorm value had to be corrected to account for the 
significant number of peptides shared with the markedly more abundant KCTD12; the actual 
contribution of KCTD12b was estimated from the mean peak volume ratio of KCTD12b-
specific peptides versus KCTD12-specific peptides.  
MS-based subunit stoichiometry in KCTD12-T1+GABAB2-C745-940 complexes was determined 
as the median of the ratios calculated with the 4 top-ranked and calibrated (reference protein 
described above) peptides of GABAB2-C745-940 and the 5 top-ranked and calibrated peptides 
of KCTD12-T1 (a total of 20 ratios). 
Sequence coverage. Sequence coverages (SC) of GABAB1a, GABAB2 and the KCTD proteins 
were calculated as SC = Ni / (Ni + Nan), where Ni is the number of amino acid residues of the 
identified peptides (with Mascot Score ≥ 20) and Nan is the number of MS-accessible but not 
identified amino acids (see above) of the respective sequence. 
Electron microscopy 
Pre-embedding immunoelectron microscopy. Hippocampal sections of adult Wistar rats (n = 
8) were treated for single immunogold labeling with affinity-purified anti-GABAB1, anti-
KCTD12 and anti-KCTD16 as described (Kulik et al., 2003); the secondary antibody was 
coupled with 1.4 nm gold particles, signal enhancement was done with a HQ Silver kit 
(Nanogold; Nanoprobes, Stony Brook, NY).  
SDS-digested freeze-fracture replica immunolabeling (SDS-FRL). Adult Wistar rats (n = 6) 
were processed for immunolabeling as described (Masugi-Tokita et al., 2007). After digestion 
in 2.5% SDS solution replicas were incubated first with anti-GABAB1, anti-KCTD12, or anti-
KCTD16 and subsequently with a 10 nm gold-coupled secondary antibody (1.30; British 
Biocell International, Cardiff, UK).  
Electrophysiological recordings and data analysis 
Electrophysiological recordings from whole oocytes were performed at room temperature 
(22-24 °C) as described previously (Schwenk et al., 2009; Zolles et al., 2006). Currents were 
low-pass filtered at 1 kHz, and sampled at 2 kHz; capacitive transients were compensated 
using the compensation unit of the amplifier (TurboTec 10CX; npi, Tamm, Germany) and a 
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P/4 protocol. Extracellular solution was composed as follows (mM): 100 KCl, 17.5 NaCl, 10 
HEPES, and 1.8 CaCl2 (pH 7.3) for Kir 3.1/3.2 channels and 3 KCl, 102 NaCl, 10 HEPES, 
and 10 BaCl2 (pH 7.3) for Cav channels, respectively. Solution exchange time was within 
~1s. 
Experiments on CHO cells stably expressing GABAB and cultured hippocampal neurons 
were performed at room temperature (23-24º C) 1-3 days or 1-2 weeks (DIV14-21) after a 
transfection, respectively. Cells were continuously superfused with an extracellular solution 
(ECS) composed of (in mM): 145 NaCl, 2.5 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, 25 Glucose; 
pH 7.3, 323 mosm. Neurons were superfused with ECS supplemented with 5 μM DNQX, 0.5 
μM TTX, 0.3 μM strychnine, 100 μM picrotoxin, 5 μM D-CPP. Patch pipettes had resistances 
between 3-4 MΩ when filled with intracellular solution composed of (in mM) 107.5 potassium 
gluconate, 32.5 KCl, 10 HEPES, 5 EGTA, 4 MgATP, 0.6 NaGTP, 10 Tris phosphocreatine; 
pH 7.2, 297 mosm. Series resistance (< 5 MΩ) was compensated by 80%. GABAB responses 
were evoked by fast application of baclofen (Dittert et al., 2006) and recorded with an 
Axopatch 200B patch-clamp amplifier; filtering and sampling frequencies were set to 1 kHz 
and 5 kHz, respectively.  
Relative desensitization was calculated as the reduction in effect (increase for Kir currents, 
decrease for Cav currents) measured during prolonged agonist applications (60s or 25s): 1- 
(agonist-induced effect at the end of application / maximal agonist-induced effect) x 100%. 
Desensitization time constants were derived from bi-exponential fits to the decay phase of 
Kir3.1/3.2 currents during agonist application. Curve fitting and further data analysis was 
done with Igor Pro 4.05A Carbon; data are given as mean ± SD/SEM as indicated in text and 
figures legends. Statistical significance was assessed using ANOVA with the Dunnett's 
multiple comparison test. 
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Supplemental figures 
a b 
S Figure 2-1: Primary sequences of GABAB1a, GABAB2 (a) and the KCTD proteins 8, 12, 12b and 16 
(b). Peptides identified by mass spectrometry are in red; those accessible to but not identified in 
MS/MS analyses are in black, and peptides not accessible to the MS/MS analyses used are given in 
grey. The GABAB2 residue highlighted in green was identified as valine or arginine (polymorphism). 
The genebank accession numbers of the indicated proteins were: NP_112290.2 (GABAB1a), 
NP_113990.1 (GABAB2), NP_001093642.1 (KCTD8), EDM02446.1 (KCTD12), XP_001065910.1 (and 
FT174274.1, KCTD12b), XP_225971.4 (KCTD16). 
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S Figure 2-2: Primary sequence alignment of the indicated KCTD proteins as obtained with the 
Clustal method. Regions highlighted in red and blue denote the conserved T1- and C-terminal 
domains, respectively; the green boxes highlight the epitopes used for the generation of anti-KCTD12 
and anti-KCTD16. 
 
S Figure 2-3: Evaluation of subtype-specificities of the anti-KCTD12 and anti-KCTD16 antibodies. 
SDS-PAGE separated lysates of HEK293 cells expressing the indicated FLAG-tagged KCTD proteins 
were Western probed with anti-FLAG, anti-KCTD12 and anti-KCTD16. An antibody targeting KCTD 
isoforms 8, 12, 12b and 16 (anti-panKCTD) was added for comparison. 
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S Figure 2-4: Basal (prior to and after agonist application) and GABA-activated Kir3 currents 
recorded in oocytes coexpressing GABAB and KCTD12 together with Kir3.1/3.2 channels. Currents 
were elicited by voltage ramps from -50 to 50 mV (2s duration) and the maxima (at -50 mV) were 
plotted over time. Current traces shown on the right were recorded at the indicated time points. Note 
that both basal and agonist-triggered currents are mediated by Kir3.1/3.2 channels. 
 
S Figure 2-5: Expression analysis of the indicated KCTD proteins in cultured hippocampal neurons 
by quantitative PCR. Data are mean ± SD of 3 different cultures. qRT-PCR was carried out using the 
Roche LightCycler with the FastStart DNA Master SybrGreen (Roche, Basel, Switzerland); the primer 
sequences used were:  
mKCTD8 (5′-CAACCAGTACCGAGACGACA-3′) and (5′-TGTTCTTGCTTGGGT-GACACT-3′); 
mKCTD12 (5′-AGACATTTCTGTACCTTCCACCA-3′) and (5′-TTA-TACTAATGGCCCAATCTTTAACA-
3′); mKCTD16 (5′-GGTCGAGCTATACTGAG-TACGTCTT-3′) and (5′-TCTTGCAGCAGCAGTCACA-
3′); 60s: (5′-GGAAGTA-CCAGGCAGTGACAG -3′) and (5′-GCAGGCATGAGGCAAACAG-3′). cDNA 
copy numbers for each gene were quantified by using standard curves of known quantities of plasmids 
containing the corresponding PCR products. 60s ribosomal protein L13A was used for normalization. 
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Abstract 
GABAB receptors are the G-protein-coupled receptors (GPCRs) for gamma-aminobutyric 
acid (GABA), the main inhibitory neurotransmitter in the brain. GABAB receptors are obligate 
heterodimers, and as such considered a prototypic receptor for many GPCRs. Recently, a 
functional proteomics approach identified a family of potassium channel tetramerization 
domain containing (KCTD) proteins as auxiliary subunits of native GABAB receptors. These 
proteins, KCTD 8, 12, and 16 are intrinsic components of high molecular weight GABAB 
receptor complexes isolated from synaptic plasma membranes and where shown to 
determine the functional properties of GABAB receptors in heterologous cells and neurons. In 
this report, we demonstrate that the multi-domain organization of these auxiliary subunits 
provide the means for the assembly of high molecular weight GABAB receptor complexes. 
Structure function analysis shows that the N-terminal tetramerization domain of the KCTD 
proteins binds to the GABAB receptor, whereas the C-terminal conserved domain is involved 
in homo- and heteromerization. Moreover, we identified the C-terminal domain of KCTD12 as 
the critical determinant for the modulation of GABAB receptor desensitization in organotypic 
hippocampal slice cultures. Finally, two-photon scanning microscope analysis of the neuronal 
distribution of the GABAB receptor auxiliary subunits illustrates a differential distribution in 
pre- and postsynaptic structures. This indicates that the composition of native GABAB 
receptors is differentially regulated depending on their subcellular localization in neurons. 
Taken together, our findings demonstrate the complex nature of the novel GABAB receptor 
auxiliary subunits, which may underlie the functional heterogeneity of native GABAB 
receptors. 
Introduction 
GABAB receptors are the G-protein coupled receptors (GPCRs) for gamma-aminobutyric acid 
(GABA), the main inhibitory neurotransmitter in the brain. GABAB receptors exist as obligate 
heterodimers, comprising the GABAB1 subunit which binds the agonist GABA and the 
GABAB2 subunit which is essential for surface trafficking of the receptor and mediates G-
protein coupling (Jones et al., 1998). Two isoforms of the GABAB1 subunit exist: GABAB1a 
and GABAB1b, that differ in a pair of sushi repeats present only in the extracellular N-terminus 
of GABAB1a (Kaupmann et al., 1997, 1998; White et al., 1998). Presynaptic and postsynaptic 
GABAB receptors regulate Ca2+- and K+-channels, respectively, via the Gβγ subunits. 
Furthermore, GABAB receptors can activate and inhibit adenylyl cyclase via the Gαi/o and 
Gβγ subunits. Postsynaptically, GABAB receptors couple to Kir3-type K+ channels 
hyperpolarizing the postsynaptic membrane (Kaupmann et al., 1998). Presynaptically, 
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GABAB receptors inhibit Ca2+ channels leading to decreased neurotransmitter release. Thus 
they regulate excitatory and inhibitory neurotransmission (reviewed by Bettler et al., 2004). 
Previous studies have sought explanations for the functional heterogeneity of native GABAB 
receptors by isolating protein interactors and examining the functional consequences 
(reviewed in Tiao and Bettler, 2006). Despite the identification of numerous GABAB receptor 
interactors from the intracellular milieu, protein interactions isolated within the context of a 
native environment remains a challenge. Recently, a class of novel GABAB receptor 
interacting proteins, KCTD8, 12, 12b, and 16, were discovered using a proteomics approach, 
and were proposed to act as auxiliary GABAB receptor subunits altering receptor functions 
(Schwenk et al., 2009). It was shown that these proteins bind specifically to the intracellular 
region of the GABAB2 subunit. These novel GABAB receptors interacting proteins belong to 
the K+-channel tetramerization domain (KCTD) containing protein family whose members 
characteristically contain an N-terminal tetramerization (T1) domain that is homologous to the 
T1 domain of some voltage-gated K+ (Kv) channels. Apart from this domain, the four 
GABABR interacting KCTDs are phylogenetically distinct from the other family members; 
KCTD8, 12, 12b, and 16 also share high sequence homology within their C-termini, thus 
forming a KCTD subfamily. 
A study by Schwenk et al. has shown that KCTD8, 12, and 16 are tightly associated 
members of native GABAB receptor complexes, and moreover that these GABAB interacting 
proteins alter GABAB receptor mediated functions (Schwenk et al., 2009). In the present 
study we identify the structural determinants of these proteins which are required for 
interactions among the KCTDs, for the interaction with the GABAB2 subunit, and as well for 
mediating changes in GABAB receptor function. We show that these proteins interact with 
each other in vitro and in vivo, and their ability to form homo- and heteromers. We found that 
KCTD8, 12 and 16, unlike other members of the KCTD protein family, oligomerize through 
their C-termini. Additionally we demonstrate that the T1 domain is responsible for interaction 
with the GABAB2 subunit. The GABAB interacting KCTDs have been shown to alter GABAB 
receptor function (Schwenk et al., 2009). Stimulation of GABAB receptors followed by G-
protein activation leads, within milliseconds, to the opening of Kir3-type K+ channels. With 
persistent stimulation of the GPCR the amplitude of current may decrease with time. This 
reduction in current level is referred to as ‘‘desensitization’’ and represents an adaptive 
response of the cell to prevent excessive G-protein signaling. Synaptic activation of GABAB 
receptors in the dendrites of neurons produces a slow inhibitory postsynaptic potential (IPSP) 
that is carried by Kir3-type K+ channels (Sodickson et al., 1996). Postsynaptic GABAB 
receptors are postulated to be located extrasynaptically, requiring elevated levels of synaptic-
released GABA, such as might occur during stimulation of multiple interneurons (Scanziani et 
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al., 2000). During such sustained activation, GABAB receptors may undergo desensitization. 
In our study we examined the effects of KCTD8, 12, and 16 on the kinetics of GABAB-
mediated Kir3-type K+ currents and assessed whether KCTD8, 12, and 16 induce or 
modulate desensitization of K+ currents. We aimed to work under conditions in which the 
physiological neuronal networks are highly preserved, and therefore chose hippocampal 
organotypic slice cultures as experimental system. We found that in this system KCTD12 
induces desensitization of GABAB-mediated K+ currents and that the C-terminus of KCTD12 
is necessary for this effect. Finally, we characterized the subcellular distribution of KCTD8, 
12 and 16. While all three proteins are distributed throughout the cytosol of the neuron, 
differential distributions could be observed in axonal and in dendritic compartments. The 
ability of the GABAB interacting KCTDs to form heteromeric complexes combined with the 
different effects of the individual KCTDs on GABAB receptor function and their differential 
distribution in neuronal compartments may provide one possible mechanism to constitute 
different subtypes of GABAB receptor complexes which differentially regulate physiological 
fine tuning of the GABAB response. 
Results 
KCTD8, 12, and 16 form homomeric and heteromeric complexes 
The T1-domain of Shaker K+-channels is known to interact with other T1-domains, albeit the 
exact function of this domain remains controversial (Shen and Pfaffinger 1995; Kobertz and 
Miller 1990, Li et al 1992; Sewing et al. 1996; Gulbis et al., 2000). It was therefore proposed 
that KCTD proteins are capable of forming homo- and hetero-oligomers. To this end, we 
expressed KCTD proteins in HEK293 cells to examine the interaction among KCTD8, 12, 
and 16. Indeed, co-immunoprecipitation experiments with FLAG- and Myc-tagged KCTD 
proteins show that KCTD8, 12, and 16 can form homomeric (Figure 3-1A) as well as 
heteromeric complexes (Figure 3-1B). For quantification, proteins were also expressed in the 
yeast-two-hybrid system and results corroborate with the co-immunoprecipitation data 
(Figure 3-1A). Furthermore, the quantitative data indicates a very strong homomeric 
interaction between KCTD12 molecules, followed by a weaker interaction of KCTD8 
homodimers. Likewise, KCTD12 forms the strongest heterodimeric interactions followed by 
KCTD8. The non-GABAB2 interactor KCTD10 forms a strong homomeric complex, but does 
not interact with KCTD8, 12 or 16 (S Figure 3-1B). In the yeast, interactions involving 
KCTD16 are consistently weak, likely due to an incompatibility of the GAD-KCTD16 fusion 
protein with the yeast two-hybrid system (S Figure 3-1A and B). To confirm homo- and 
hetero-dimerization of endogenous KCTD proteins, mouse whole brain cytosolic lysates were 
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prepared, KCTD proteins were immunoprecipitated with antibodies specific for KCTD8, 12, 
and 16 and co-immunoprecipitated proteins were visualized on Western blots. Co-
immunoprecipitation of endogenous proteins shows that all KCTD proteins examined co-
precipitate with each other (Figure 3-1C), which confirms the data obtained in heterologous 
systems. 
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Figure 3-1: KCTD8, 12, and 16 form homo- and heterodimers. 
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(A) KCTD homodimerization and (B) heterodimerization: Cell lysates of HEK293 cells co-expressing 
differentially epitope tagged wild-type KCTD8, 12, and 16 were immunoprecipitated with anti-c-Myc 
antibody, separated by SDS-PAGE and immunoblotted with anti-FLAG antibody. Total 
immunoprecipitated c-Myc epitope tagged protein were immunoblotted using anti-c-Myc antibody. (C) 
Endogenous KCTD8, 12, and 16 protein homo- and heterodimerization. Wild-type mouse KCTDs were 
immunoprecipitated from cytosolic brain protein lysates with specific rabbit anti-KCTD8, 12, and 16 
antibodies and visualized by immunoblotting using guinea-pig anti-KCTD8, 12, and 16 specific 
antibodies. Representative blots of at least three independent experiments are shown. 
KCTD complex formation is mediated via the C-terminus 
As the KCTDs can be roughly divided into two parts, the N-terminus, containing the T1 
domain and the C-terminus containing a domain that is conserved within the GABAB 
interacting KCTDs, joined by a short peptide linker (S Figure 3-2A), we used molecular 
means to isolate the domain critical for homo- or heteromeric complex formation. To mimic a 
full-length protein conformation, we generated KCTD chimeras composed of either the N-
terminus (including the conserved T1 domain) of KCTD8, 12 or 16 fused to the C-terminus 
(peptide sequences C-terminal of the T1-domain) of the non-interacting KCTD10 or the N-
terminus (including the conserved T1 domain) of the non-interacting KCTD10 fused to the C-
terminus (peptide sequences C-terminal of the T1 domain) of KCTD8, 12 or 16 (Figure 3-2A). 
We took advantage of KCTD10, as its structure is similar to KCTD8, 12, and 16 but it does 
neither bind to the GABAB receptor nor to one of the GABAB interacting KCTDs. The chimeric 
proteins were co-expressed in heterologous cells and protein interaction identified using co-
immunoprecipitation. The results demonstrate that the C-terminus of KCTD8, 12, and 16 
contains the pre-requisite peptide residues critical for homodimerization (Figure 3-2B) and 
heterodimerization (Figure 3-2C). Unlike previous postulations concerning the role of T1-
domains in Shaker K+-channel protein interaction, the T1 domain of KCTD8, 12, and 16 is 
not required for homo- and/or hetero-dimerization. Rather, in KCTD8, 12, and 16 the C-
termini are essential for the dimerization of KCTD proteins. 
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Figure 3-2: The C-terminus of KCTD8, 12, and 16 confers protein interaction. 
(A) Schematic of recombinant chimeric-proteins generated for mapping KCTD8, 12, and 16 
dimerization domain. To map the homodimerization domain (B) and the heterodimerization domain 
(C), KCTD chimeric (c-Myc tagged) and wild-type (FLAG tagged) proteins were co-expressed in 
HEK293 cells. For co-immunoprecipitation, cell lysates were incubated with anti-Myc antibody and 
immunoblotted using anti-FLAG antibody. Representative blots of at least three independent 
experiments are shown. 
  
The C-terminus of KCTD12 promotes desensitization of GABAB receptors in neurons
61
Interaction with GABAB2 is mediated via the T1-domain 
Previously, it was shown that KCTDs bind specifically with the extreme C-terminal domain of 
the GABAB2 subunit (Schwenk et al., 2009). It remains, however, unidentified which KCTD 
domain is critical for GABAB2 binding. To decipher the region in KCTD8, 12, and 16 that is 
responsible for interaction, we used chimeric proteins described above. In co-
immunoprecipitation experiments, chimeric proteins containing either the KCTD12 (chi12x10) 
and/or KCTD16 (chi16x10) T1-domain were able to maintain interaction with GABAB2 (Figure 
3-3). In contrast, chimeric proteins lacking the T1-domain of KCTD12 (chi10x12) or KCTD16 
(chi10x16) were unable to interact with GABAB2. Interestingly, similar to the negative 
KCTD10 control, both chi8x10 and chi10x8 chimeric proteins were unable to interact with 
GABAB2. Based on these results, the interaction of KCTD12 and KCTD16 with GABAB2 is 
mediated via the T1 domain, whereas both the T1 as well as the C-terminus of KCTD8 are 
necessary for GABAB2 interaction. 
 
Figure 3-3: The T1-domain in KCTD8, 12, and 16 is critical for the interaction with the GABAB2 
subunit. 
To isolate the GABAB2 interacting domain, KCTD chimeric proteins were co-expressed with GABAB2 
(GB2) in HEK293. For co-immunoprecipitation, cell lysates were incubated with a rabbit anti-Myc 
antibody and immunoblotted using a mouse anti-Myc and an anti-GB2 antibody. Representative blots 
of at least three independent experiments are shown. 
KCTD8, 12, and 16 are differentially distributed throughout the neuron 
Previously, qualitative data using electron microscopy revealed co-localization of KCTD12 
and KCTD16 with pre- and post-synaptic GABAB receptors (Schwenk et al 2009). To quantify 
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the subcellular distribution of KCTD8, 12, and 16 in neuronal structures, we co-expressed the 
individual KCTDs tagged with a green fluorescent protein (GFP) tag at the N-terminus and an 
ubiquitously distributed tdimer2-RFP protein (gift from R. Tsien) in organotypic hippocampal 
slice cultures. GFP alone was used as control. We imaged CA1 pyramidal neurons using a 
custom build two-photon laser scanning microscope. We found all three KCTDs distributed 
throughout the cytosol of hippocampal CA1 neurons (S Figure 3-3). Subsequently we 
focused on four main neuronal structures; dendrites, spines, axons and boutons (Figure 
3-4A). After normalizing to the dendrite, GFP-KCTD8, GFP-KCTD12 and GFP-KCTD16 
showed significant accumulation in the dendritic spines (Figure 3-4B). In addition, GFP-
KCTD16 was also enriched significantly in boutons (Figure 3-4C). All three KCTD proteins 
studied displayed uniform distribution in the axon (Figure 3-4D). Different from the known 
nuclear KCTD family members including KCTD1 (Ding et al., 2009), KCTD10 (Wang et al., 
2009) and KCTD13 (He et al., 2001), the GABAB receptor interacting KCTDs are not present 
in the nucleus (S Figure 3-3). As the KCTD proteins are localized throughout the cytosol and 
the main neuronal compartments, this places them in the same locality as the cytosolic side 
of pre- and postsynaptic GABAB receptors, suggesting a functional relationship between the 
two proteins. 
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Figure 3-4: KCTD8, 12, and 16 are differentially distributed in hippocampal CA1 pyramidal 
neurons. 
Expression of GFP-tagged KCTD8, 12, and 16 in hippocampal organotypic slice cultures. Maximum 
intensity projections of dendrites and axons in the CA1 region of the hippocampus expressing GFP-
KCTD8, GFP-KCTD12 or GFP-KCTD16 (A) in combination with the freely diffusible tdimer2 RFP are 
shown. The ratio of green-to-red fluorescence (G/R) is coded in rainbow color. Scale bar, 2 μm. The 
spine, bouton, and axonal expression levels of GFP-tagged KCTDs were each normalized to the 
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dendritic expression level (A), and distribution compared with ubiquitously expressed GFP. All the 
GFP-tagged KCTD proteins show significant enrichment in dendritic spines (B). Predominantly GFP-
KCTD16 is accumulated in the bouton (C) and all proteins are evenly distributed in the axon (D). n = 
number of individual neurons imaged, all statistics are one-way ANOVA. 
KCTD8, 12, and 16 differentially modulate GABAB receptor-mediated 
desensitization 
Previously, KCTD-mediated GABAB receptor desensitization was analyzed in heterologous 
cell lines, Xenopus oocytes and dissociated neurons (Schwenk et al 2009). This study 
hypothesized that exogenous expression of KCTD12 protein in CA1 pyramidal neurons can 
also promote GABAB receptor desensitization. To investigate this phenomenon in an intact 
tissue and neuronal cell-type specific paradigm, we used patch-clamp recording to record 
responses in transfected CA1 pyramidal neurons in hippocampal organotypic slices. 
In non-transfected CA1 pyramidal neurons, 40 s pressure application of 100 μM GABA 
induced an outward Kir3-type K+ current that weakly desensitized (Figure 3-5A). Bath 
application of GABAB receptor antagonist CGP54626A abolished the current indicating that 
GABA selectively activated GABAB receptors in our conditions (Figure 3-5A and C). 
Overexpression of KCTD8 and KCTD16 had no effects on GABAB response kinetics and 
amplitudes (Figure 3-5A and C). In contrast, in neurons overexpressing KCTD12 GABA-
induced currents desensitized substantially during 40 s of continuous agonist application 
without effects on amplitudes (Figure 3-5A and C). Activation of A1 receptors with adenosine 
(100 μM, 40 s), which converge on the same Kir3-type K+ channels (Lüscher et al., 1997), 
induced a non-desensitizing current in non-transfected and KCTD12 overexpressed cells. 
Adenosine-mediated currents were abolished in the presence of A1 receptors antagonist 
DPCPX (Figure 3-5B and C). This indicates that the desensitization of GABAB currents 
mediated by KCTD12 is not a consequence of functional alterations in Kir3-type K+ channels. 
Despite the fact that KCTD8, 12, and 16 bind to GABAB receptors, our results show that only 
KCTD12 induces desensitization of the receptor in CA1 pyramidal neurons. 
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Figure 3-5: KCTD12 induces desensitization of GABAB receptors in transfected CA1 hippocampal 
pyramidal neurons 
(A) Representative Kir3-type K+ currents induced by pressure application of GABA (100 μM, 40s) in 
control or neurons transfected with KCTD8, 12 or 16. In neurons overexpressing KCTD12, GABAB 
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responses showed an increased desensitization during agonist application (indicated above the 
current trace) when compared with non-transfected neurons (control) or neurons transfected with 
KCTD8 or KCTD16. GABA-induced outward K+ currents were blocked by bath application of CGP 
54626A (5 μM, red traces). 
(B) K+ currents induced by A1 receptors activation had similar kinetics in all conditions, suggesting that 
effector K+ channels are not altered by KCTD proteins. Adenosine-induced currents were blocked by 
bath application of the antagonist DPCPX (1 μM, red traces). Currents were recorded at -50 mV and in 
the presence of TTX (0.5 μM), bicuculline (10 μM), picrotoxin (100 μM), strychnine (1 μM) and 
kynurenic acid (2 mM). 
(C) Summary histogram of the desensitization and the amplitude of GABA- and adenosine-induced 
currents. Desensitization is expressed as the ratio between the amplitude of the current at the end of 
the agonist application (I(t)) and the peak maximal current (Imax). The desensitization of GABAB-
mediated currents was similar in control and neurons transfected with KCTD8 or KCTD16, but was 
significantly increased in neurons transfected with KCTD12 (control: 96.2 ± 1.1%, n=19; KCTD8: 95.5 
± 0.9%, n=15; KCTD12: 64.6 ± 2.7%, n=15; KCTD16: 93.7 ± 2.1%, n=10; ***p<0.001). (KCTD12 
compared with control, KCTD16 and KCTD8, ANOVA/Scheffe post-hoc test). In all conditions, the 
maximal amplitude of GABAB-mediated K+ currents remained constant (control: 84.3 ± 6.8 pA, n=19; 
KCTD8: 71.2 ± 10.5 pA, n=15; KCTD12: 81.1 ± 18.1 pA, n=15; KCTD16: 75 ± 19 pA, n=10; p>0.05). 
As a control, K+ currents evoked by 100 μM adenosine had similar kinetics (control: 98.9 ± 1.1%, n=4; 
KCTD8: 97.6 ± 0.6%, n=3; KCTD12: 97.9 ± 0.5%, n=5; KCTD16: 96.7 ± 1.1%, n=7; p>0.05) and 
amplitudes (control: 33.4 ± 10.2 pA, n=4; KCTD8: 31 ± 2.8 pA, n=3; KCTD12: 29.8 ± 11.3 pA, n=5; 
KCTD16: 47.8 ± 18.7 pA, n=7; p>0.05) in all conditions. Values are mean ± SEM. 
The C-terminus of KCTD12 is critical for the desensitization of  
GABAB-mediated currents 
In addition to the T1-domain, the KCTD proteins contain another highly conserved region in 
the C-terminus (S Figure 3-2A). To isolate the KCTD12 peptide regions responsible for 
promoting the desensitization of GABAB-mediated K+ currents, we transfected hippocampal 
organotypic slice cultures with two KCTD12 truncation mutants and recorded GABA evoked 
responses. In neurons transfected with the C-terminus of KCTD 12 (KCTD12v125- *328, S 
Figure 3-2A), GABAB-mediated K+ current kinetic was comparable to non-transfected cells 
showing that the protein needs to bind to the GABAB receptor through the T1 domain to 
induce desensitization (Figure 3-6A, F and G). Similarly, the N-terminus of KCTD 12 
(KCTDM1-L125, S Figure 3-2A) did not change the GABAB response kinetic (Figure 3-6B, F and 
G). Taken together, results of the KCTD12 truncation mutants suggest that the full-length 
KCTD12 protein is required to alter GABAB receptor functions. 
Consistent with the absence of interaction between GABAB receptors and KCTD10, we did 
not observe GABAB receptor-mediated desensitization with chi10x12 consisting of the N-
terminus of KCTD10 and the C-terminus of KCTD12 (Figure 3-6F). But also when the N-
terminus of KCTD12 was fused to the C-terminus of KCTD10 (chi12x10), GABAB response 
did not desensitize (Figure 3-6F). This supports that binding of KCTD12 to the GABAB 
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receptor is not sufficient for the observed desensitizing effect, but also suggests that the C-
terminus of KCTD12 is necessary to induce desensitization. 
Regarding the results obtained by functional assays using truncated KCTD12 mutants, or the 
chimeric KCTD proteins, chi12x10 and chi10x12, it needs to be considered that they all have 
their inherent caveats, namely non-interaction due to the truncations and the non-interacting 
nature of KCTD10. To definitively exclude these pitfalls, we generated additional chimeras: 
chi12x16 and chi16x12 (S Figure 3-2). As KCTD16 is a GABAB interacting KCTD but does 
not induce desensitization of GABAB–mediated of K+ currents, this makes it a good candidate 
for generating chimeras with KCTD12. First, we confirmed the interaction of the chi12x16 
and chi16x12 with wild-type KCTD12 and KCTD16 (Figure 3-6C) by co-immunoprecipitations 
from transfected HEK293 cells. Following confirmation of protein interaction, we 
subsequently recorded GABAB-mediated responses in transfected CA1 pyramidal neurons in 
hippocampal organotypic slice cultures. Similar to chimera chi12x10, also the chimera 
chi12x16 where the N-terminus of KCTD12 was fused to the C-terminus of KCTD16, did not 
induce desensitization of the GABAB–mediated response (Figure 3-6E and F). Strikingly, the 
chimera containing the N-terminus of KCTD16 and the C-terminus of KCTD12 (chi16x12) 
induced desensitization of GABAB-mediated currents similar to the full-length KCTD12 
(Figure 3-6D and F). We did not observe an effect on the amplitudes of the K+ currents in any 
neurons transfected with the different chimeras (Figure 3-6G). 
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Figure 3-6: The C-terminal domain of KCTD12 is involved in the desensitization of GABAB 
response in CA1 hippocampal neurons 
GABAB-mediated K+ currents recorded in CA1 neurons transfected with (A) KCTD12v125- *328 (C-
terminus) or (B) KCTD12M1-L125 (N-terminus). In both conditions, truncated KCTD12 did not increase 
the desensitization of GABA-induced K+ currents (A, B and F). 
(C)Homo- and heterodimerization of chi16x12 chimeric protein, and wild-type KCTD12 and KCTD16 
protein were confirmed by co-immunoprecipitation. 
(D-E) Functional analysis of KCTD-chimeric proteins combining the N-terminus of KCTD16 with the C-
terminus of KCTD12 (chi16x12) (D) and the reverse construct (chi12x16) (E). In CA1 neurons, the 
chimera, chi16x12, increased the desensitization of GABAB-mediated currents whereas the chimera, 
chi12x16, had no effect. 
(F) Summary histogram showing that cells transfected with the chimera, chi16x12, had a significant 
increase in GABAB-mediated current desensitization compared with cells transfected with KCTD12v125- 
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*328, KCTD12M1-L125 and chimeras chi12x10, chi10x12, chi16x12, chi12x16, (KCTD12v125- *328: 94.2 ± 
1.8%, n=6;  KCTD12M1-L125: 95.8 ± 2.5%, n=6; chi12x10: 96.6 ± 0.6%, n=16; chi10x12: 93.4 ± 1.8%, 
n=6; chi16x12: 67.5 ± 3.8%, n=7; chi12x16: 96 ± 1.8%, n=10;, ***p<0.001, chi16x12 compared with all 
other conditions, ANOVA/Scheffe post-hoc test). 
(G) GABAB-mediated K+ currents were of similar amplitudes in all conditions (KCTD12v125- *328: 91.4 ± 
14.9 pA, n=6; KCTD12M1-L125: 93.7 ± 15.4 pA, n=6; chi12x10: 75.8 ± 7.5, n=16; chi10x12: 58.3 ± 9.6, 
n=6; chi16x12: 72.8 ± 18.5 pA, n=7; chi12x16: 70.1 ± 13.5 pA, n=10; p>0.05, chi16x12 compared with 
all other conditions, ANOVA/Scheffe post-hoc test). Values are mean ± SEM. 
To exclude the potential effects of endogenous KCTD proteins in neurons, we performed the 
same experiments in a CHO cell line stably expressing GABAB1,2 receptors and transiently 
co-transfected Kir3-type K+ channels (Kir3.1/Kir3.2) with full-length KCTD12 and the chimeric 
proteins, respectively. In CHO cells transfected with KCTD12, K+ currents induced by 
pressure application of 100 μM GABA showed a prominent desensitization compared with 
currents recorded in control cells. Similar to observations in neurons, the increase in 
desensitization of the GABAB-mediated response was mimicked when chi16x12, but not 
when chi12x16 was expressed in the CHO cells (Figure 3-7A and B). In summary, the 
electrophysiological recordings indicate that KCTD12 mediates desensitization of GABAB–
mediated K+ currents through the C-terminus of the protein. 
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Figure 3-7: When expressed in CHO cells, KCTD12 and the chimera, chi16x12, increase 
desensitization of GABAB-mediated Kir3-type K+ currents 
(A) Representative traces of K+ currents induced by pressure application of the agonist GABA (100 
μM, 40 s) in CHO cells stably expressing GABAB1,2 and transiently transfected with kir3.1/kir3.2 alone 
(control), co-transfected with KCTD12 or the chi16x12 chimera. Full-length KCTD12 and the chimera, 
chi16x12, increased the desensitization of GABAB-mediated K+ current in comparison to control. In 
contrast, the chimera chi12x16 had no effect on the kinetic of the GABAB-mediated response. Currents 
were recorded at a holding potential of -50 mV (B) Summary histogram of the desensitization of K+ 
currents recorded in CHO cells in control condition, or transiently transfected with KCTD12, chi16x12 
or chi12x16. The desensitization of GABAB-mediated K+ currents was significantly increased in cells 
expressing KCTD12 and chi16x12 but not chi12x16 (control: 67.5 ± 4.8%, n=9; KCTD12: 33.2 ± 3%, 
n=8; chi16x12: 33.4 ± 3.9%, n=9; chi12x16: 59.2 ± 3.8%, n= 9, ***p<0.001, KCTD12 and chi16x12 
compared with control, ANOVA/Scheffe post-hoc test). Values are mean ± SEM. 
Discussion 
We have characterized protein oligomerization and subcellular localization of KCTD8, 12, 
and 16. We identified the KCTD inherent structural requirements for the interactions among 
the KCTDs, as well as for the interaction with the GABAB receptor. These GABAB interacting 
KCTDs are capable of forming both homo- and heterodimers in heterologous and native 
tissues. Unlike other T1-domain containing proteins, KCTD8, 12, and 16 do not require the 
T1-domain for interaction among each other; rather the C-terminal conserved domain is 
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critical in facilitating protein-protein interaction. Furthermore, the same domain is important 
for inducing GABAB receptor-mediated desensitization in cells overexpressing KCTD12. 
Critical domains required for KCTD-KCTD and KCTD-GABAB receptor 
interactions 
A previous study had identified four members of the KCTD family as auxiliary subunits of the 
GABAB receptor and had shown that these KCTD proteins are part of a large receptor 
oligomer (Schwenk et al., 2009); however the study did not address the interaction between 
KCTDs and the critical domain(s) involved. The large KCTD protein family contains a N-
terminal region that is homologous to the T1-domain of voltage-gated K+ (Kv) channels, a 
domain that is also homologous to the BTB (bric-a-brick, tramtrack, broad complex) fold; a 
protein-protein interaction module involved in self-association and interaction with non-BTB 
partners (Stogios et al., 2005). Based on this, KCTD8, 12, and 16 were hypothesized to form 
homo- and/or heterodimers. Indeed, results from in vitro and in vivo protein interaction 
experiments confirmed this hypothesis. Our data moreover shows that the C-terminus, 
including a domain that is conserved within the GABAB interacting KCTDs, is critical for 
homo- and heteromerization of KCTD8, 12, and 16. An unexpected finding, however, was 
the non-essential role of the T1-domain in homo- and heterodimerization of the GABAB 
interacting KCTD proteins. A recent crystal structure study undertaken by Dementieva et al. 
supported the concept of oligomerization in KCTDs (Dementieva et al., 2009). Furthermore, 
the authors showed that KCTD5 crystals form a pentamer instead of the anticipated tetramer. 
The same study, however, determined the assembly of the KCTD5 pentamer to be mediated 
via the T1-domain surface. Likely causes for the discrepancies are: different protein 
expression systems and a truncated recombinant protein were used to demonstrate protein-
protein interactions. The T1-domain, however, is not trivial in terms of interaction with GABAB 
receptors. Rather it is essential for KCTD12 and 16 to specifically interact with the GABAB2 
subunit. A critical GABAB2-interaction domain could not be mapped for KCTD8 using the 
chimeras, a result that suggests a native full-length protein conformation as a pre-requisite 
for interaction. Our study thus points to a KCTD-GABAB receptor complex whereby the large 
protein complex is held together by the T1-domain interacting with the GABAB2 subunit and 
the KCTDs associating through their C-termini. 
KCTD12 specifically regulate GABAB receptor-mediated desensitization 
Desensitization describes the phenomenon whereby the response of a given receptor 
declines over time despite the continuous presence of the agonist. It is well known that 
GPCRs undergo either rapid or slow desensitization (reviewed in Tiao et al., 2001). The 
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phenomenon was reported as an intrinsic property of GABAB receptors by Couve et al., 
whereby the phosphorylation of the GABAB2 subunit was claimed to stabilize surface 
receptors and alleviates receptor desensitization (Couve et al., 2002), however, a definitive 
mechanism(s) remains elusive. Receptors can either undergo endocytosis or surface 
redistribution to elicit slow or fast desensitization respectively. GABAB receptors, however, 
are relatively stable at the neuronal plasma membrane (Fairfax et al., 2004), which would 
suggest receptor redistribution as one of the most likely contributor to GABAB receptor 
desensitization. A previous report from our laboratory had linked KCTD12 with regulating 
rapid GABAB receptor-mediated desensitizing responses (Schwenk et al., 2009). In the 
present study we aimed to investigate the functional properties of the GABAB interacting 
KCTDs within an intact neuronal network, providing a more physiological background. In 
hippocampal organotypic slice cultures, we analyzed amplitudes and desensitization of 
GABAB receptor-mediated K+ currents. We found GABAB receptor-mediated desensitization 
only present when KCTD12 is exogenously expressed, and not upon expression of KCTD8 
or KCTD16. In addition, we measured amplitudes and desensitization of GABAB receptor-
mediated K+ currents in comparison to adenosine evoked K+ currents. In neither case did we 
observe an effect on the Kir current activated by adenosine receptor activation, thus 
confirming specificity of the KCTD12-mediated effect on GABAB receptors. 
We used various KCTD12 truncations and chimeric mutants to map the domain(s) 
responsible for the desensitizing GABAB receptor response. Neither the N-terminus, nor the 
C-terminus of KCTD12 alone was sufficient to induce the desensitizing effect. Most 
importantly, the chimera, chi16x12, containing the T1-domain of KCTD16 linked to the C-
terminus of KCTD12 was able to elicit the GABAB receptor-mediated desensitizing of K+ 
currents, whereas chi12x16 was incapable of eliciting such responses. The critical functional 
domain(s) thus lies within the C-terminus of the KCTD12 protein. To date, a fast 
desensitizing GABAB receptor response is considered to be in the order of minutes (≤5min) 
(Cruz et al., 2004). This study presented evidence of a novel expedited desensitizing 
response that can be initiated in the order of seconds. Based on this study, it is postulated 
that the KCTD12 T1-domain plays a structural role, i.e. to maintain an intact large protein 
complex similar to T1-domain's role in some Kv channels (Strang et al., 2001, Long et al., 
2005, Gulbis et al., 2000) and KCTD5 (Dementieva et al., 2009). In contrast, it is speculated 
that the C-terminus is responsible for providing functional diversity for the protein complex, 
likely by acting as high density binding site that interact/traps other membrane and/or surface 
proteins. It would be intriguing to identify these proteins and elucidate the mechanisms 
governing GABAB receptor-mediated desensitization. 
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Alternative physiological roles for KCTD8 and KCTD16 
Our study and previously reported data from Schwenk et al. (Schwenk et al., 2009) have 
attributed GABAB receptor-mediated desensitization to KCTD12, however, not all KCTDs that 
interact with GABAB receptors have the same function. Overexpressing KCTD8 and KCTD16 
in neurons and immortalized cell lines did not induce GABAB receptor desensitization. 
However, KCTD8 and 16 were, like KCTD12, shown to increase agonist potency and 
accelerate the onset of GABAB-mediated Kir responses (Schwenk et al., 2009). KCTD8 and 
KCTD16, therefore, are likely to regulate other aspects of the GABAB receptor physiology. 
Similar conclusions can be drawn from differential localizations of KCTD proteins. Previous 
localization studies in immortalized cell lines had placed KCTD1 in both the cytosol and 
nucleus (Ding et al., 2009), KCTD5 (Weger et al., 2007, Bayon et al., 2008) and KCTD11 (Di 
Marcotullio et al., 2004) in the cytosol, and KCTD10 (Wang et al., 2009) and KCTD13 (He et 
al., 2001) in the nucleus. In this study, we quantitatively analyzed the KCTD8, 12, and 16 
distributions in hippocampal CA1 pyramidal neurons. Like the GABAB receptors (Vigot et al., 
2006), the KCTD8, 12, and 16 proteins are also widely distributed in neuronal compartments, 
albeit with differential distribution patterns: KCTD8, 12, and 16 displaying enrichment in the 
spine, and KCTD16 is additionally enriched in the bouton. Unlike some family members, 
none of the GABAB receptor-interacting KCTDs was found to be present in the nucleus. The 
distinct subcellular expression patterns imply that KCTDs can modulate GABAB receptor 
physiology based on their differential subcellular distribution. Therefore, the acute regulation-
response at the level of the receptor may be a consequence of synergistic actions from all 
three GABAB interacting KCTD proteins, KCTD8, 12, and 16. 
Materials and Methods 
Cell culture and co-immunoprecipitation 
HEK293 cells were cultured in Dulbecco’s Modified Eagles Medium (DMEM) supplemented 
with 5% foetal calf serum (FCS) (PIAA), 4500 mg/l of L-glutamine, in a humidified 
atmosphere of 5 % CO2 at 37oC. Cells were transfected at 70-80 % confluency using 
Lipofectamine 2000 (Invitrogen). Typically, for a 6-well transfection reaction, 1 µg of total 
plasmid DNA, at equal ratios for co-transfection, and 3 µl of Lipofectamine were used 
(according to the manufacturer’s instructions). We tagged KCTDs with either the 3x c-Myc or 
FLAG epitope at the N-terminus and inserted the cDNAs into the mammalian expression 
vector pCI (Promega). For co-immunoprecipitations rotein lysates were prepared from 
cultured cells 48 h following transfection. Following removal of culturing media and washing 
in PBS, cells were lysed in a modified RIPA lysis buffer (150 mM NaCl, 1% Nonidet P-40, 
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0.5% sodium deoxycholate supplemented with Complete protease inhibitor cocktail (Roche)) 
on a rotating platform at 4oC for 30 min. The lysate was then cleared by centrifugation at 
10,000xg for 20 min at 4oC. Prior to immunoprecipitation, lysate was pre-cleared with protein 
A sepharose (Amersham) for 1 h at 4oC. Protein A sepharose precoupled with anti-Myc 
polyclonal antibody was added to the pre-cleared protein lysate and rotated overnight at 4oC. 
The immune complex was washed 3 times with RIPA lysis buffer, followed by one wash in 
PBS buffer and then resuspended in an equal volume of 2x Lämmli buffer. Samples were 
heated to 95oC and centrifuged for 5 min each prior to loading onto 12 % SDS-
polyacrylamide gels. For Western blot analysis of immunoprecipitates we used mouse 
monoclonal anti-FLAG (Sigma) or rabbit polyclonal anti-c-Myc (Convance) and peroxidase-
coupled secondary antibodies (Amersham Biosciences). Blots were developed using the 
enhanced chemiluminescence detection system (Pierce) and exposed to Fuji maximum 
resolution X-ray films (Fujifilms). For endogenous protein co-immunoprecipitation 
experiments brain tissue from adult wild-type Balb/c mice was first homogenized 
mechanically in sucrose buffer (in mM: 320 sucrose, 10 Tris-HCl pH7.4, 0.25 DTT, 1 EDTA; 
1% (v/v) SDS) and large cell debris were removed by low speed centrifugation (1000xg for 
20 min). Membrane fraction was isolated from the supernatant by ultracentrifugation at 
48,000xg for 40 min at 4oC and lysed in modified RIPA lysis buffer for 30 min at 4oC. Lysate 
was cleared by centrifugation at 15,000xg for 30 min at 4oC. Protein co-immunoprecipitations 
were performed as described earlier; antibodies used for the co-immunoprecipitation 
experiments were described previously (Schwenk et al. 2009). Briefly, anti-KCTD8, -12 and -
16 specific antibodies raised in rabbit and guinea pig were used for immunoprecipitation and 
immunoblotting, respectively. 
CHO cells and transfection 
CHO-K1 cells stably expressing human GABAB1b and rat GABAB2 receptor subunits, provided 
by Novartis Pharma, were maintained in DMEM, 500 μM glutamine, 40 μg/ml L-proline, 0.5 
mg/ml G418, 0.25 mg/ml Zeocin and 10% FCS in 5 % CO2 at 37°C. Concatemers of 
Kir3.1/3.2 subunits (ref Wischmeyer E et al., 1997) and KCTD12/chimeras were subcloned 
into pcDNA3.1 and pCI (Promega) vectors respectively. To visualize transfected cells, 
mutEGFP was included in the transfection mix; cDNAs were cotransfected into 90% 
confluent cells using Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer’s 
instructions. 
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Hippocampal slice culture and bio-ballistic transfection 
Transverse hippocampal organotypic slices were prepared from Wistar rats (400 μm thick) or 
Balb/c mice (350 μm thick) at postnatal day 3 and 5, respectively (Stoppini 1991) and 
maintained for 15-20 days in 5 % CO2 at 37°C. After 7 days in vitro, cultures were biolistically 
co-transfected using the Helio Gene Gun system (Bio-Rad) with GFP-KCTDs and tdimer2-
RFP expression vectors (gift from R.Tsien).   
All neuronal protein expression was under the control of the neuron-specific human 
synapsin-1 promoter (gift from K. Svoboda) for 7-8 days. For image acquisition we used a 
custom-built two-photon laser scanning microscope, based on a BX51WI microscope 
(Olympus, Japan) and a pulsed Ti:Sapphire laser (Chameleon XR, Coherent, Scotland) 
tuned to λ = 890 nm, controlled by an open source software package (ScanImage) written in 
Matlab (Pologruto et al., 2003), and as described by Vigot et al 2006 with minor 
modifications. Briefly, fluorescence was detected in epifluorescence (LUMPlan W-IR2 60⋅1.2 
NA, Olympus) and transfluorescence mode (achromatic aplanatic condenser, 1.2 NA, 
Olympus) using 4 photomultiplier tubes (R2896, Hamamatsu, Japan). We used 725DCXR 
dichroic mirrors and E700SP blocking filters to reflect emitted photons into a secondary 
beamsplitter, containing a 560DCXR dichroic, 525/50 (green) and 610/75 (red) band-pass 
filters (AHF Analysentechnik AG, Tübingen, Germany). The slice was placed into a perfusion 
chamber and superfused continuously (2 ml/min) with ACSF (in mM: 119 NaCl, 2.5 KCl, 
4 CaCl2, 4 MgCl2, 26.2 NaHCO3, 1 NaH2PO4, 11 glucose, gassed with 95% O2 and 5% CO2 
at room temperature). 
For analysis, stacks of images (512⋅512 pixels) from secondary dendritic branches and thin 
axons were obtained from transfected CA1 pyramidal neurons (Z-step: 0.5 μm). Maximum 
intensity projections of green and red stacks were constructed. For the ratio images, we used 
a hue/saturation/brightness model, where hue was determined by the green/red ratio (using 
a rainbow color table), and the intensity in the red channel was used to set the brightness. 
For quantitative analysis, we calculated the green-to-red ratio in a region of interest (dendrite 
or axon) after subtracting the background fluorescence. To compensate for differences in 
laser power and expression level, we normalized the ratio in the axon by the average 
dendritic ratio. Spines were identified by anatomy from tdimer2-RFP images. GFP-KCTD 
positive spines were defined as having intensity in the green channel at least 3 standard 
deviations above background. 
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Electrophysiology 
Visualized whole-cell patch-clamp recording was used to investigate GABAB receptor 
function. Postsynaptic Kir3-type K+ currents were recorded 7 days after transfection of 
hippocampal organotypic slice cultures from the somata of CA1 pyramidal neurons visualized 
using an infrared-sensitive camera (Till Photonics) and oblique illumination optics (BX51WI; 
Olympus, Tokyo, Japan). Cells transfected with KCTD proteins and GFP were identified 
using FITC filter (Olympus). Currents were recorded at 30-32°C in ACSF containing (in mM): 
119 NaCl, 2.7 KCl, 1.3 MgCl2, 2.5 CaCl2, 1 NaH2PO4, 26,2 NaHCO3, 11 Glucose, pH 7.3, 
equilibrated with 95%O2/5%CO2. The patch pipettes were filled with a solution containing (in 
mM): 140 K-gluconate, 4 NaCl, 5 HEPES, 2 MgCl2, 1.1 EGTA, 2 Na2-ATP, 5 
phosphocreatine, 0.6 Na3-GTP, at pH 7.25 (adjusted with KOH). K+ currents induced by 
GABA (100 μM) or adenosine (100 μM) were evoked at -50 mV in the presence of TTX (0.5 
μM), kynurenic acid (2 mM), picrotoxin (100 μM), bicuculline (10 μM) and strychnine (1 μM). 
GABA and adenosine were applied for 40 s by a pressure pipette (standard patch pipette; 3 
PSI, Picospritzer III, Intracell). CGP54626A (5μM) and 8-cyclopentyl-1,3-dipropylxanthine 
(DPCPX, 1 μM) were applied by superfusion into the recording chamber. 
Whole-cell patch clamp recording in CHO cells was performed 24-48 h after transfection in 
ACSF and with intra-pipette solution described above. GABAB-mediated currents were 
evoked using pressure application of the agonist GABA (100 μM, 40s) at a holding potential 
of -50 mV. 
Data were acquired with an Axopatch 200B (Molecular Devices), filtered at 2 kHz and 
digitized at 10 kHz using Digidata 1322A interface (Molecular Devices). Whole-cell currents 
were analyzed using Clampfit 9.2 (Molecular Devices). CGP54626A received from Novartis 
Pharma. DPCPX from Tocris Cookson, TTX from Latoxan. All other reagents were from 
Sigma-Aldrich. 
Yeast two-hybrid system 
The yeast two-hybrid system used for identifying protein-protein interactions was first 
described by Field and Song (1989). A modified system based on the LexA DNA binding 
domain (Bartel et al. 1993) was used in this study with the yeast strain L40 (Invitrogen): 
MATa HIS3⊗200 trp1-901 leu2-3,112 ade2 LYS2::(LexAop)4 - HIS3 URA3::(LexAop)8-LacZ 
GAL4 (Hollenburg et al 1995). For small-scale transformation of yeast, 10 ml of YPAD (1% 
(w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) dextrose, 0.1% (w/v) adenine) was 
inoculated with a colony of L40 yeast. Following overnight incubation at 30oC, the yeast 
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culture was diluted with 40 ml of YPAD and incubated for a further 2 h to attain mid-log 
growth phase with an OD600nm of ~1.0. Yeast cells were collected by centrifugation at 1,600xg 
for 5 min at room temperature and washed twice with 50 ml of TE (10 mM Tris-Cl pH7.5, 0.1 
mM EDTA). Yeast cells were made competent by incubating at room temperature for 10 min 
in solution of 100 mM LiAc in TE.  The DNA transformation mix contained 1 µg of plasmid 
DNA, 10 µg of denatured sheared salmon sperm DNA (Roche, Germany), 100 µl of 
competent L40 yeast and 700 µl of PEG-solution (100mM LiAc/TE/, 20% (v/v) PEG-4000). 
The mixture was incubated at 30 oC for 30 min and dimethyl sulfoxide (DMSO) added to a 
final concentration of 10% (v/v) prior to heat shocking at 42oC for 7 min. Immediately after 
heat shock the yeast cells were collected by centrifugation at 10,000xg for 10 sec and cells 
were washed once with sterile TE before being resuspended in TE buffer. One fifth of the 
suspension was plated onto yeast drop out media Yc (0.65 % (w/v) yeast nitrogen base, 2 % 
(w/v) dextrose, 0.5 % (w/v) ammonium sulfate in 1.5% (w/v) agar and supplemented with 
amino acids as required and incubated at 30oC until colony formation. 
β-Galactosidase filter assay. Yeast colonies were picked onto selective yeast media, grown 
overnight at 30oC and transferred to nitrocellulose filters (Schleicher & Schuell, Germany). 
Yeast colonies were permeabilised by two rounds of freeze-thawing in liquid nitrogen, before 
being exposed to Z buffer pH 7.0 (in mM: 60 Na2HPO4, 40 NaH2PO4, 10 KCl and 1 MgSO4) 
mixed with 40 mg/ml X-gal, 38 mM β-mercaptoethanol at 30oC. Color intensity was 
ascertained at 30 min, 1 h and 3 h. 
β-Galactosidase agarose overlay assay. To enable uniform and consistent qualitative 
exposure of yeast cells to X-gal, colonies were picked and resuspended in 100 µl of sterile 
water. Once resuspended, 5 µl was dotted onto yeast selective media and grown overnight. 
A solution containing 0.2 mg/ml X-gal, 50 µl/100 ml β-mercaptoethanol, 0.5 M potassium 
phosphate buffer, 6 % (v/v)  dimethylformamide, 0.1 % (v/v) sodium dodecyl-sulphate (SDS) 
and 5 % (w/v) low melt agarose was layered onto the colonies and the plates were incubated 
at 30oC until color development. 
β-Galactosidase liquid assay. Liquid cultures were assayed for β-galactosidase activity to 
verify and quantify protein-protein interactions. The β-galactosidase activity was measured 
using o-nitro-phenyl-β-D-galactopyranosid (ONPG) as a substrate. Overnight cultures of 
yeast transformants in Yc/-WL were used and the cells from 1 ml of culture were collected by 
centrifugation at 10,000xg for 10 sec.  The cell pellet was resuspended in 700 µl of Z-buffer 
before being lysed by the addition of 50 µl chloroform and 20 µl of 10 % (w/v) SDS. 160 µl 
ONPG (0.66 mg/ml) was added and color development was allowed to proceed for 1 h at 
30oC. The reaction was quenched by the addition of 400 µl of 1 M Na2CO3. After clearing the 
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reaction by centrifugation at 10,000xg for 10 min, the amount of o-nitrophenol was measured 
photometrically at 415nm. The following formula was used to calculate β-gal units (Miller, 
1972): 
Arbitory β−galactosidase unit = 1000 x {OD415nm/(t x V x OD595nm)} 
(t = time for yellow color to develop, V = volume of yeast culture used in assay) 
Each sample was measured in quadruplicates. 
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Supplemental figures 
 
S Figure 3-1: KCTDs were co-expressed in L40 yeast strain to examine protein-protein interaction in 
a yeast two-hybrid system. Interactions were accessed in both quantitative (A) and qualitative (B) 
yeast two-hybrid systems. For negative protein interaction controls, KCTD8, 12, and 16 were tested 
against the GABAB receptor non-interacting KCTD10. Background reporter activity was verified in L40 
alone. 
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S Figure 3-2: Homology between the peptide sequence of KCTD8, 12, and 16 were examined using 
ClustalW2 multiple alignment tool. The T1-domain (single underline) and the C-terminal conserved 
domain (double underline) of KCTD8, 12, and 16 are indicated (A). The nomenclature of recombinant 
mutants used in this study is outlined (B). 
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S Figure 3-3: Expression of GFP-tagged KCTD8, 12, and 16 in organotypic slice culture. Maximum 
intensity projections of the soma of a CA1 hippocampal pyramidal neuron expressing GFP-KCTD8, 
GFP-KCTD12 or GFP-KCTD16 in combination with the freely diffusible tdimer2-RFP are shown. 
Fluorescence signal from GFP-tagged KCTDs was detected throughout the cytosol, but is absent in 
the nucleus of the neuron. In contrast, the freely diffusible tdimer2-RFP is ubiquitously expressed. 
Scale bars, 10 μm. 
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Abstract 
Four members of the potassium (K+) channel tetramerization domain containing (KCTD) 
protein family, namely KCTD8, 12, 12b, and 16, were recently identified to be associated with 
the GABAB receptor and shown to differentially modulate the kinetics of GABAB receptor 
dependent signaling such as activation of G-protein coupled inwardly rectifying potassium 
(Kir) channels. Here, we describe for the first time a comparative expression pattern of the 
designated auxiliary GABAB receptor subunits - KCTD8, 12, 12b, and 16 - in the mouse 
brain. We performed a systematic expression analysis using in situ hybridization and 
describe the distribution patterns in context of GABAB receptor distribution. We demonstrate 
that the distribution of these GABAB interacting KCTD isoforms widely overlaps with GABAB 
receptor expression and furthermore that the individual KCTD proteins exhibit unique 
expression patterns in the mouse brain. Comparisons between the adult and postnatal day 5 
expression patterns showed that individual neurons express variable subsets of KCTD 
subunits. In conclusion, this study supports the hypothesis that GABAB receptors exist as 
complexes comprising either one or more KCTD and that the GABAB-mediated functional 
properties of individual neurons are conferred by the specific subset of KCTDs expressed in 
a cell. 
Introduction 
Potassium (K+) channel tetramerization domain containing (KCTD) proteins are an 
evolutionarily conserved family of cytosolic proteins. Twenty-one isoforms have been 
identified in humans and 22 in rodents. Their name emerged as the N-termini of KCTD 
proteins contain a tetramerization domain (T1), which is present in some voltage-gated K+ 
(Kv) channels. In Kv channels T1 domains are known to be responsible for subfamily specific 
co-assembly of the subunits (Xu et al., 1995) and axonal localization (Rivera et al., 2005). 
Apart from the T1 domain, KCTD proteins share no similarities to the transmembrane ion 
channel subunits. They are soluble proteins with variable C-termini (Dementieva et al., 
2009).  
KCTD8, 12, 12b, and 16 were identified as specific interaction partners of the GABAB 
receptor (GABABR) by affinity purification and high-resolution nanoflow liquid-
chromatography tandem mass spectrometry (nano-LC MS/MS) analysis and proven to be 
auxiliary subunits of the GABAB receptor as they affect the functional properties of the 
receptor (Schwenk et al., 2009). These four KCTDs share a common structural organization 
with an N-terminal tetramerization domain, that mediates the interaction with the GABAB 
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receptor, a central variable linker region, and a conserved C-terminal domain that is involved 
in homo- and heteromerization of these KCTDs (Tiao et al., 2009). 
γ-Aminobutyric acid type B (GABAB) receptors are the G-protein-coupled receptors for 
GABA, the main inhibitory neurotransmitter in the mammalian central nervous system, and 
are implicated in a variety of neurological and psychiatric disorders. The functional GABAB 
receptor is a heterodimer of the GABAB1 and the GABAB2 subunit. The GABAB1 subunit binds 
the agonist GABA, whereas GABAB2 is necessary for surface trafficking of the receptor and 
coupling to the G-protein. The activated GABAB receptor couples to a multitude of signal 
transduction pathways. GABAB receptors are involved in the fine tuning of inhibitory synaptic 
transmission. Presynaptic GABAB receptors inhibit neurotransmitter release by down-
regulating high-voltage activated Ca2+ channels, whereas postsynaptic GABAB receptors 
decrease neuronal excitability by activating a prominent inwardly rectifying K+ (Kir) 
conductance that underlies the late inhibitory postsynaptic potentials. Numerous studies 
described a large variety of GABAB mediated effector kinetics observed under physiological 
conditions. However, the only heterogeneity at the receptor level emerges from the two 
GABAB1 isoforms, GABAB1a and GABAB1b. Thus, a major task in recent years aimed to 
identify the mechanisms underlying different receptor localization and pharmacological 
properties. Recently, Schwenk et al. demonstrated that the majority of native GABAB 
receptors assemble into a high molecular weight complex that constitutively contains either 
one or more GABAB interacting KCTD proteins (Schwenk et al., 2009). Binding of KCTDs to 
the GABAB receptor could explain the obvious differences in the electrophysiological and 
pharmacological characteristics of native GABAB receptors compared with the recombinant 
receptors. KCTD proteins were shown to determine the pharmacology and kinetics of the 
GABAB receptor response. They increase agonist potency and alter the G-protein signaling 
of the receptor. Interestingly, KCTD proteins induce rapid onset and pronounced 
desensitization in a subtype-specific manner. For example, all four KCTD proteins accelerate 
the activation kinetics, while only 12 and 12b markedly increase desensitization of the 
GABAB mediated responses. The latest results strongly suggest that the cellular subset of 
KCTDs assembled with the GABAB heteromer largely determines the G-protein signaling of 
the receptor complexes, and thus, generate GABAB receptors with distinct functional 
properties. As this is the first described function for this subfamily of KCTDs, we largely 
emphasize in this study the distribution of the KCTDs in context of the GABAB receptors. In 
comparison with the previously described GABAB receptor localization and function in the 
analyzed brain structures, we investigated the exact expression pattern of the novel auxiliary 
GABAB receptor subunits to further elucidate GABAB receptor function. 
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We systematically determined the mRNA expression patterns of KCTD8, 12, 12b, and 16 in 
the adult mouse brain to identify brain areas that might express only one KCTD or specific 
subsets of KCTDs, which may consequently display different GABAB receptor complexes 
with specific functional properties. Although the biological functions of KCTD proteins remain 
to be further elucidated, the robust expression of transcripts in fetal tissues in contrast to the 
low levels in adult, as described for KCTD12 (Resendes et al., 2004), suggest that they play 
an important role during development. For example, KCTD12 (Pfetin/Ron) is implicated in the 
maturation of inner ear neurons as indicated by its linkage to a progressive dominant 
auditory neuropathy (Resendes et al., 2004). The role of GABAB receptors in brain 
development, especially in synapse formation and maturation, and the establishing of 
neuronal circuitries, has emerged during the last years (Lopez-Bendito et al., 2003; Lopez-
Bendito et al., 2008; Lujan et al., 2005). Concomitantly, several studies have shown 
alterations in GABAB receptor subunit expression and localization during postnatal 
development (Fritschy et al., 2004; Lopez-Bendito et al., 2002; Lopez-Bendito et al., 2004; 
Lujan and Shigemoto, 2006). Overall, before postnatal day 10 GABAB1a transcripts are more 
abundant than GABAB1b transcripts, opposite to what is observed in adult mice (Fritschy et 
al., 1999; Malitschek et al., 1998). To investigate if KCTDs might potentially be involved in 
these postnatal changes, we additionally looked at the spatial expression patterns of KCTD8, 
12, 12b and 16 transcripts at postnatal day 5. 
Materials and Methods 
Animals and brain sections 
The study was carried out on the brain tissue of adult and postnatal day 5 (P5) BALB/c mice. 
All animal use procedures were subjected to institutional review and approved by the 
Veterinary office of the State Basel-Stadt (Switzerland). Mice were anesthetized with 
isoflurane (Baxter, Deerfield, IL) inhalation prior to decapitation, and the tissues were rapidly 
dissected, embedded in O.C.T. compound (Sakura Finetek, Zoeterwoude, the Netherlands), 
and snap frozen in liquid nitrogen. Heads of P5 mice were embedded in whole. Sections of 
10 μm thickness were cut with a Microm HM 560 Microtom (Microm, Walldorf, Germany). 
Cloning and in situ hybridization 
Synthetic digoxigenin-labeled riboprobes (DIG-cRNA) were generated from recombinant 
pGEM-Teasy (Invitrogen) plasmid containing a cDNA insert of mouse KCTD8 (AY615967, 
bps 1-216, 1-1088), mouse KCTD12 (NM_177715, bps 2709-4998), mouse KCTD12b 
(NM_17542, bps 1-298, 1137-1637, 1879-2325, 3233-3708), and mouse KCTD16 
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(XM_909931, bps2423-4735, 4736-6465). Riboprobes against rat neuron specific enolase 
(NSE) were generated from recombinant pBluescript plasmid 294 (Schaeren-Wiemers et al., 
1997). Transcription was performed from both sides with either T3 or T7 RNA polymerase, 
generating antisense or sense (control) cRNA probes, respectively. The DIG-labeled cRNA 
probes were alkaline hydrolyzed to an average length of 200–400 bases. In situ hybridization 
was performed on cryosections of freshly frozen tissue as described previously (Schaeren-
Wiemers and Gerfin-Moser, 1993). To classify the expression levels the color reaction for the 
alkaline phosphatase was stopped at different time points between 24 hours and 4 days. 
Image acquisition and processing 
Slides were analyzed with a Leica light DMRE transmission microscope (Leica, Wetzlar, 
Germany) and collected by means of a high-resolution digital camera ColorView IIIu and 
AnalySIS software (SIS GmbH, Münster). Images were adjusted for brightness and contrast 
and assembled as plates using Adobe PhotoShop CS2 (v. 9.0.2) and Adobe Illustrator CS2 
(v. 12.0.1; Adobe Systems, San Jose, CA). Brain structures were named according to 
Paxinos (Paxinos G, 2001). 
Qualitative and semi-quantitative analysis of expression 
The range of observed expression strengths of each KCTD was classified based on six 
categories: very strong expressing cells (++++), strongly expressing cells (+++), moderately 
expressing cells (++), weakly expressing cells (+), and cells with no detectable signal (-). A 
punctuated staining signifying single cell expression pattern was indicated with (o) (Table 
4-1). Only KCTDs with strong overall expression and low exposure times were classified as 
very strong. If gene expression was low and required longer exposure, cells with an 
exceptionally strong signal were categorized as moderately expressing. Nevertheless, since 
labeling effectiveness and affinity of the oligonucleotides can vary, a comparative analysis 
between the different KCTDs is only qualitative. On the other hand, this methodology allows 
the reliable comparison of expression strength of individual isoforms in different brain 
regions. The judgments were made relative to the intensity of the NSE hybridization signal 
(Schaeren-Wiemers et al., 1997). NSE is expressed by all neurons and thus resembles the 
density of neuronal cells in the different brain areas. 
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Results 
Expression patterns of KCTD genes in adult mouse brain 
The spatial expression pattern of KCTD 8, 12 and 16 was analyzed in adult and postnatal 
day 5 (P5) mouse brain by in situ hybridization (ISH) using digoxigenin-labeled cRNA probes. 
To compare the differential gene expression patterns in the brain, in situ hybridization 
analysis was performed on horizontal and coronal brain sections. Riboprobes were 
preferentially designed in the non-coding and low homology regions of the genes to prevent 
cross-reactivity. For KCTD8 and 16 two, for KCTD12b four independent probes were used to 
verify their specificity. For each transcript, the two antisense probes showed the same 
hybridization pattern, indicating that the antisense probes specifically recognize the 
corresponding transcripts (data not shown). Sense probes did not show hybridization signals 
(data not shown).  Herein, we summarize the expression patterns of KCTD8, 12, and 16 with 
an emphasis on particular brain structures. The ISH analysis allows the reliable comparison 
of expression strength of individual KCTDs between different brain regions (Table 4-1, adult; 
Table 4-2, P5). However, due to variations in the sensitivity between different probes, a 
comparative analysis between the different KCTDs can only be qualitative. A summary of the 
different expression patterns of KCTD8, 12, and 16 is provided in Table 4-1. 
Overall, KCTD8 is expressed in only a few brain areas, such as the medial habenula (MH) 
(Figure 4-1B), the granule cells of the cerebellum and certain brain stem nuclei, whereas 
KCTD12 and KCTD16 mRNA are widely distributed throughout the whole brain (Figure 4-1C 
and D, respectively). Transcripts of KCTD12 are primarily observed in the cerebellum, the 
hippocampal formation (HF) (Fig 1C), and the septum. KCTD16 shows highest expression 
levels in the cortex (CTX), the thalamus (TH) and the hippocampal formation (Figure 4-1D). 
The distribution patterns of the KCTDs revealed areas and neurons with different subsets of 
KCTDs. The pyramidal cells of the hippocampus and dentate gyrus, for example, express 
high levels of KCTD12 and 16 mRNA, or the medial habenula, which contains KCTD8, 12, 
and 12b.  In contrast, the different cell types of the cerebellum express predominantly the 
mRNA of one single KCTD subunit. Interestingly, the expression patterns of KCTDs at 
postnatal day 5 markedly differ to their distribution in the adult, which is particularly evident in 
the cerebral cortex; an overview is shown in Table 4-2. We performed in situ hybridization 
analysis also for KCTD12b, and identified that this particular KCTD subunit is only expressed 
in medial habenula (Figure 4-8E), and is therefore only mentioned in this context. At P5 no 
KCTD12b mRNA was detected in any of the analyzed tissues. 
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Figure 4-1: Distribution of KCTD mRNA in adult mouse brain. Brightfield images showing the 
distinct localization of KCTD8, 12, and 16 on coronal sections detected with in situ hybridization (ISH) 
using digoxigenin-labelled cRNA probes specific for KCTDs compared to the expression pattern of 
neuron-specific enolase (NSE). CTX, cortex; HP, hippocampus; HTM, hypothalamus; MH, medial 
habenula; TH, thalamus. Scale bar = 2 mm. 
Olfactory system – predominant expression of KCTD12 in ensheating 
glia 
GABAB receptors show overall a low expression level in the olfactory bulb, but they are 
strongly expressed in olfactory receptor neurons (ORN) (Panzanelli et al., 2004). Axons of 
ORNs enter the olfactory bulb via the olfactory nerve layer, and have specifically been shown 
to contain GABAB receptors. Generally low hybridization signals were detected for KCTD8 
and 16 in the main olfactory bulb; but considerable expression was observed in the 
glomerular layer (GL; Figure 4-2B, arrows), and in the glutamatergic mitral cells (MC; Figure 
4-2D, arrowhead), which are known to form `dendro-dendritic` synapses with GABAergic 
granule cells providing the `output` stations of the olfactory bulb. The expression pattern of 
KCTD12, however, exhibits a punctuate pattern in the granular (GCL) and in the mitral cell 
layer (MCL) (Figure 4-2B), which suggest expression in a subtype of mitral cells (arrow). In 
contrast to the other two subunits, KCTD12 is highly expressed in the olfactory nerve layer 
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(Figure 4-2C, open arrows). These non-neuronal cells, presumably ensheating glia cells, 
strongly express KCTD12 in the adult, as well as at postnatal day 5 (Figure 4-2E). Analysis 
of P5 animals revealed that KCTD12 and 16 were also expressed in the main olfactory 
epithelium (MOE) (Figure 4-2F-H). The MOE contains the olfactory nerve neurons in which 
expression of KCTD12 could be observed, suggesting KCTD12 to be associated with GABAB 
receptors in the axons of olfactory receptor neurons (Figure 4-2G, open arrowheads). High 
levels of KCTD12 and KCTD16 transcripts can also be found in most target regions of the 
projection fibers of the main olfactory bulb, such as the anterior olfactory nucleus, olfactory 
tubercle, taenia tecta, piriform and entorhinal cortices (Table 4-1). In the main olfactory bulb, 
the very high expression of KCTD12 transcripts in olfactory ensheating cells is one of the 
most striking features (Figure 4-2C and E), which could indicate a role of KCTD12 in glia-
neuronal crosstalk, thus influencing guidance of olfactory nerve axons entering the glomeruli 
of the olfactory bulb. 
 
Figure 4-2: KCTD expression in the olfactory system of adult mouse brain. KCTDs exhibit low 
expression in the main olfactory bulb. The expression pattern of neuron-specific enolase (NSE) is 
shown on an adjacent section for comparison (A). The non-neuronal olfactory ensheating cells (OEC) 
show strongest levels of KCTD 12 mRNA (C, open arrows and E). In the main olfactory epithelium 
(MOE) KCTD12 (G) and 16 (H) are present, KCTD12 in olfactory receptor neurons (G, open 
arrowheads). EPL, external plexiform layer; GCL, granule cell layer of the olfactory bulb, GL, 
glomerular layer; MCL, mitral cell layer; ONL, olfactory nerve layer; Scale bars = 200μm. 
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Table 4-1: Distribution of KCTD8, 12, and 16 in various brain regions. Hybridization signals were 
analyzed on coronal sections of adult mice. Regions were identified using a mouse brain atlas 
(Paxinos G, 2001). Intensities of hybridization signals were indicated as follows: ++++, very strong; 
+++, strong; ++, moderate; +, weak; o, punctate staining signifying single cell expression pattern;  
-, no detectable signal. 
KCTD8 KCTD12 KCTD16 KCTD8 KCTD12 KCTD16
Olfactory nerve layer(ensheating glia) - ++++ -
Glomerular layer ++ + +
External plexiform layer - + - Anterodorsal - + -
Mitral layer ++ ++ / o ++ Laterodorsal - - +++
Granular layer + + + Anteroventral - - +++
Anterior olfactory n. - ++ ++ Medial group
Olfactory tubercle - + ++ Mediodorsal n. + ++ +++
Islands of Calleja - - ++ Paraventricular - + -
Piriform area, layer II - ++ +++ Ventral group
Basal forebrain Ventral posteromedia - ++ +++
Caudate putamen + + +++ Ventral posterolateral - + +++
Globus pallidus - + - Subparafascicular nucleus - + +++
Nucleus accumbens + ++ + Posterior group - + +++
Ventral pallidum - + + Rhomboid n. - ++ +++
Claustrum - - +++ Reunions n. - + ++
Endopiriform nucleus (ventral part) - - +++ Reticular thalamic nucleus - - ++
Amygdala Geniculate group
Basolateral nuclei Medial geniculate nuclei - + ++
Anterior - + ++ Lateral geniculate nuclei, dorsal - - +++
Posterior - +++ +++ Lateral geniculate nuclei, ventral - - +
Basomedial nuclei - + + Medial habenula ++++ + -
Central nucleus + +++ + Lateral habenula + + +
Medial nucleus + + ++ Hypothalamus
Anteroventral - - + Medial preoptic area - +++ -
Posterodorsal + ++ ++ Lateral preoptic area - +++ -
Lateral nucleus - + +++ Nucleus of the diagonal band - ++ -
Cortical amygdalar area - ++ ++++ Magnocellular preoptic nucleus - +++ +
Piriform amygd. Area, layer II - ++ ++++ Dorsomedial hypothalamic + + ++
Bed nucleus stria terminalis - +++ + Lateral hypothalamic area - ++ +
Septal area Posterior hypothalamic n. - ++ +
Lateral septum - ++++ ++ Mammillary bodies - - ++++
Medial septum - +++ - Zona incerta + + +++
Hippocampal formation Midbrain/Pons/Medulla
Pyramidal layer CA1 + +++ ++++ Substantia nigra, Pars compacta - + +
Pyramidal layer CA2 - ++++ +++ Substantia nigra, Pars reticulata - + +
Pyramidal layer CA3 - +++ +++ Ventral tegmental area - + +
Dentate gyrus, granular layer - ++++ ++++ Interpeduncular nucleus + + ++
Hilar cells/polymorphic layer + +++ +++ Mesencephalic reticular nucleus - - -
Subiculum dorsal/ventral ++ + ++ Olivary pretectal nucleus - - ++
Entorhinal area, layer II - +++ +++ Anterior pretectal nucleus - + ++
Induseum griseum - +++ +++ Nucleus of the optic tract + + +
Taenia tecta - ++ ++ Superior colliculi
Cortex Superficial gray layer + + ++
Frontal Optical layer + + +++
Layer I-III + + / o +++ Periaqueductal grey - + +
Layer V + + - Raphe nucleus dorsalis/central + + ++
Layer VI - o ++ Inferior colliculus + + +++
Layer VIb, isocortex - o ++ Parabigeminal nucleus + +++ -
Parietal N. of the lateral lemniscus - + ++
Layer I-II + + / o ++++ Locus coeruleus - + +
Layer III - - ++++ Vestibular nuclei + + +
Layer IV - - +++ N. prepositus + + +
Layer V + + / o + Parabrachial n. + + +
Layer VI - o +++ External cuneate nucleus + ++ -
Layer VIb, isocortex - o +++ Spinal nucleus of trigeminal ++ ++ +
Cerebellum Facial motor nucleus + + +
Molecular layer - - - Dorsal motor n. of the vagus nerve + + +
Granular layer Hypoglossal nucleus ++ ++ +
Granule cells ++ - - Dorsal cochlear nucleus ++ +++ +
Golgi cells - - +++ ventral cochlear nucleus ++ + +
Purkinje cells - ++++ - Pontine reticular nuclei + ++ +
Deep cerebellar nuclei + + ++ Superior olivary complex - + +
Inferior olivary complex - ++ -
N. of the trapezoid body - ++ -
Anterior group of the dorsal thalamus
 Olfactory bulb
Dorsal thalamus
Thalamus
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Basal ganglia – implications for distinct GABAB-KCTD complexes related 
to Parkinson disease and epilepsy 
Different compositions of KCTDs could be identified in the dorsal part of the basal ganglia 
(caudate putamen and globus pallidus) (for comparison see Table 4-1). For instance the 
caudate putamen reveals low expression of KCTD8 and KCTD12 mRNA, whereas high 
expression of KCTD16 mRNA was detected. On the contrary, cells in the globus pallidus only 
express KCTD12 mRNA, suggesting that KCTD12 could play a specific role in the regulation 
of pallidal GABAB receptor activation-dependent regulation of movement and synaptic activity 
in the basal ganglia known to be a potential therapeutic target for treatment of parkinsonian 
akinesia (Chen et al., 2008). 
In the ventral part of the basal ganglia, KCTD8 is uniquely expressed at low levels in the 
nucleus accumbens. In the same region, KCTD12 is expressed at moderate and 16 at low 
levels, whereas the ventral pallidum exhibits low levels of only KCTD12 and KCTD16 mRNA. 
Intriguing are also the exclusive expression and the very high levels of KCTD16 in the 
claustrum (CLA) (Figure 4-3D), which is a telencephalic subcortical structure that projects to, 
and receives projections from a number of cortical areas, including the primary motor, 
premotor, prefrontal, auditory, and visual cortex (Crick and Koch, 2005). Notably, the 
claustral complex is involved in propagation of epileptiform activity from the amygdala 
(Sheerin et al., 2004; Zhang et al., 2001), and the severity of seizures is related to the 
inhibitory GABAergic activity. Together with findings of Davila et al., which identified a 
specific GABAergic subpopulation in the claustrum (Davila et al., 2005), the specific 
expression of KCTD16 might indicate that this subunit may play a role in GABAB mediated 
processes that are altered in temporal lobe epilepsies. 
Septal area – KCTD12 and 16 are the predominant auxiliary GABABR 
subunits 
In the medial septal nucleus (MS) moderate levels of KCTD12 mRNA were observed, 
whereas KCTD16 mRNA was absent. Neurons in the medial septum are mainly GABAergic 
and cholinergic and project to the hippocampus. Our data may suggest that the KCTD12 
subunit might be involved in modulation of presynaptic GABAB receptor activation in medial 
septum, in which activation has been shown to inhibit the generation of frequency rhythmic 
activity (Henderson and Jones, 2005). 
The lateral septal area (LS), a major recipient of hippocampal output, is known to express 
high levels of GABAB receptors. Our analysis shows that this particular area has moderate 
expression levels of KCTD16, whereas high levels of KCTD12 mRNA could be detected 
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(Figure 4-3G, H). The rostral part (LSr), which contains the highest levels of KCTD12 mRNA, 
is characterized by the expression of enkephalin and neurotensin and connected mainly with 
hypothalamic medial zone nuclei, especially the anterior hypothalamic nucleus, indicating 
that postsynaptically KCTD12 and 16 may be important in GABAB mediated modulation of 
hippocampal inputs and presynaptically in the maintenance of body temperature. This point 
will be revisited again in the section of the hypothalamus. KCTD8 mRNA is not expressed in 
the septal area (Figure 4-3F). Expression patterns at postnatal day 5 resemble the ones 
observed in adult mice (Table 4-2). In summary, the analysis showed that KCTD 12 and 16 
are the main subunits expressed in the septum. 
 
Figure 4-3: KCTD expression in the septal area of adult mouse brain. KCTD12 is expressed at 
very high (C), KCTD16 at moderate (D) levels in the rostral part of the lateral septum. Exclusive 
expression of KCTD16 is present in the claustrum (H). Medial septal nucleus, MS; Lateral septum: 
caudal part, LSc; rostral part, LSr; Caudoputamen, CP. CLA, Claustrum; CTX, Cortex; ec, external 
capsule. Scale bars = 200μm 
Cerebral cortex – differential expression of KCTD12 and 16 at P5 and in 
the adult 
The cortical distribution of GABAB receptors was extensively studied by in situ hybridization, 
receptor autoradiography and immunohistochemistry (Bischoff et al., 1999; Margeta-Mitrovic 
et al., 1999; Princivalle et al., 2000). All studies revealed GABAB receptor expression 
throughout the adult cortex in pyramidal cells as well as in interneurons. Binding sites were 
predominant in the outer cortical layers. In situ hybridization for KCTD8 mRNA revealed that 
its expression is hardly above background levels, but weak signals in layers II, III and layer V 
could be detected (Figure 4-4B). In contrast, KCTD12 shows a very distinct expression 
pattern; on one hand an overall weak signal in layer II and V (Figure 4-4C), on the other hand 
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strong expression in some sparsely scattered neurons in the layers I and II (Figure 4-4C, 
inserts), which become more rarely in the deeper layers. According to their appearance, 
these large spiny neurons are most likely interneurons. KCTD16 transcripts are uniformly 
distributed throughout all cortical areas. Unlike the other KCTDs, KCTD16 transcripts are 
found in all cortical layers at high levels, except the layer V, the output layer of the cortex 
containing the large pyramidal neurons (Figure 4-4D-E). The expression pattern of KCTD12 
and 16 transcripts at postnatal day 5 strikingly differ from that in the adult brain. KCTD12 
mRNA is concentrated in the inner layers of the cortex, predominantly in layer VI (Figure 
4-4H), but also distinct cells in layer I show high expression levels of KCTD12. Conversely, 
KCTD16 is only expressed strongly in layer III and IV (Figure 4-4I). 
GABAB receptors are expressed early during development and undergo changes in 
localization during pre- and postnatal development (Lopez-Bendito et al., 2002; Princivalle et 
al., 2000). The GABAB receptor antagonist CGP52432 was shown to alter the tangential 
migration of cortical neurons, which is one of multiple indications for an important role of 
GABAB receptors in the migration of cortical interneurons (Lopez-Bendito et al., 2003). What 
exactly accounts for the coordinated assembly of GABAergic interneurons and projection 
neurons is still not known. The remarkable expression patterns of KCTD12 and 16 in the 
cortex at P5 is tempting to speculate that these KCTDs are part of the mechanisms that 
underlay the last steps of migration and the establishment of synapses. 
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Figure 4-4: KCTD expression pattern within the different layers of the primary sensory area of the 
cortex. In the adult cortex KCTD12 is highly enriched in scattered interneuron-shaped cells (C), 
whereas KCTD16 is abundant at high levels in all cortical layers, except layer V (D). Haemalaun (HA) 
staining is shown on an adjacent section for comparison (E). (P5) KCTD12 mRNA is concentrated the 
inner (H) and KCTD16 in the outer cortical layers (I). Scale bar = 200µm, 50µm (insert). 
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Table 4-2: Distribution of KCTD8, 12, and 16 at postnatal day 5 in mouse brain and peripheral 
tissues. Intensities of hybridization signals were indicated as follows: ++++, very strong; +++, strong; 
++, moderate; +, weak; o, punctate staining signifying single cell expression pattern; -, no detectable 
signal. 
KCTD8 KCTD12 KCTD16 KCTD8 KCTD12 KCTD16
 Olfactory bulb - ++ -
Olfactory nerve layer (ensheating glia) - ++++ - Anterior group of the dorsal thalamus
Anterior olfactory n. - ++ +++ Anterodorsal - + -
granule cell layer - ++ - Laterodorsal - - +++
Basal forebrain Anteroventral - - +++
Caudate putamen ++ +++ +++ Medial group
Globus pallidus - +++ - Mediodorsal n. + + +++
Claustrum - - +++ Ventral group
Amygdala Ventral posteromedial - + +++
Lateral ++ ++/ o +++ Ventral posterolateral - + +++
Basolateral - + +++ Subparafascicular nucleus - + +++
Central - ++ - Posterior group - + +++
Septal area + +++ ++ Geniculate group
Hippocampal formation Medial geniculate nuclei - +++ ++
Pyramidal layer CA1 + + / o +++ Lateral geniculate nuclei - ++++ ++
Pyramidal layer CA2 - +++ +++ Hypothalamus
Pyramidal layer CA3 - +++ + Mammillary bodies - - ++++
Dentate gyrus, granular layer - +++ + Midbrain/Pons/Medulla
Hilar cells/polymorphic layer - + + Superior collicullus + ++ +
Subiculum dorsal/ventral ++ ++ + Inferior colliculus + ++++ ++
Cortex Parabigeminal nucleus - +++ -
I - +++ +++ Dorsal cochlear nucleus ++ +++ +
II-III - - + ventral cochlear nucleus ++ + +
IV - + +++ N. of the lateral lemniscus - + ++
V - + - Superior olivary complex +++ + ++
VI - +++ + Spinal nucleus of trigeminal ++ ++ +
Vib - - - Peripheral tissues
Cerebellum Retina ++++ +++ ++
Purkinje cell layer - +++ + Olfactory epithelium - ++ +++
Deep cerebellar nuclei - + +++ Spiral ganglion/ Cochlea ++ ++++ +
external granule cell layer +++ + - Trigeminal ganglion ++ +/ o ++++
internal granule cell layer - +++ + Inferior glossopharyngal ganglion - ++++ ++
Whisker - +++ -
Dental pulp - +++ -
Bone marrow - ++++ -
Thalamus
Table 2. Summary of the expression of KCTD8, 12, and 16 at postnatal day 5.
 
Amygdala - Nuclei expressing different subsets of KCTDs 
The primary functional role of the amygdala is thought to be the formation and storage of 
memories associated with emotional events. It is one of the brain structures that exemplarily 
exhibit very distinct KCTD expression patterns from low to very high levels in the different 
nuclei of the amygdala. In the lateral amygdala nucleus (LA) and the posterior basolateral 
nucleus (BLA) KCTD16 transcripts were highly abundant (Figure 4-5D, H), whereas KCTD12 
transcripts were detected primarily in the central amygdala nuclei (CEA), in a subpopulation 
of cells in the BLA (Figure 4-5C, G) and in the posterodorsal part of the medial nuclei (Table 
4-1). The lateral amygdala receives sensory input from thalamic and cortical processing 
stations, which have been implicated in the associative conditioning of fear responses to 
sensory stimuli (LeDoux, 2007). The amygdala is characterized by a strong inhibitory tone 
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that is assumed to be necessary for the appropriate response to sensory signals. GABAB 
receptors were recently shown to be involved in the inhibition of glutamatergic inputs to the 
lateral amygdala (Pan et al., 2009) and also in amygdala LTP (Shaban et al., 2006). Our data 
might suggest that KCTD16 could play a role in modulating GABAB receptor function in the 
lateral amygdala nucleus, i.e. by increasing the agonist affinity of the receptor (Schwenk et 
al., 2009). On the other hand, the sparsely scattered cells expressing KCD12 in the BLA, 
which most likely resemble local interneurons, may suggest a role of KCTD12 in the 
differential effects of GABAB autoreceptor activation observed at GABAergic synapses in the 
BLA (Silberman et al., 2009). 
Principal neurons in the LA and BLA connect to the central nucleus, which in turn projects to 
the brain stem autonomic nuclei and/or via the bed nucleus of the stria terminalis, mediating 
cardiovascular responses to sensory stimuli. GABAB receptors are critically involved in the 
strong inhibitory tone observed in the CEA (Ciriello and Roder, 1999). The central amygdala 
nucleus is one of the few amygdala nuclei which, in addition to KCTD12 and 16, also express 
low levels of KCTD8 mRNA (Figure 4-5B, arrow). CEA and the bed nucleus of the stria 
terminalis exhibited high levels of KCTD12 mRNA, which may add to the strong GABAB 
mediated functions in these nuclei (Table 4-1). 
The cortical amygdala areas express KCTD12 at high and KCTD16 at very high levels (Table 
4-1). As the cortical amygdala nuclei receive input from the olfactory bulb and olfactory 
cortex and are mainly involved in the sense of smell and pheromone-processing, the strong 
expression of KCTD12 and 16 supports a potential role in the processing of sensory 
information. 
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Figure 4-5: KCTD gene expression pattern in anterior and posterior nuclei of the adult mouse 
amygdala. The central amygdala (CEA) shows strong expression of KCTD8 (B, arrow) and very high 
levels of KCTD12 (C), whereas KCTD 16 is the predominant isoform in the lateral amygdala (LA) (D 
and H). In the basolateral amygdala (BLA) a subgroup of cells strongly express KCTD12 mRNA (C 
and G, open arrowheads). Amygdalar capsule; ec, external capsule. Scale bar = 200 µm 
Hippocampal formation – KCTD12 and 16 as main auxiliary GABABR 
subunits 
GABAB receptors are involved in many important functions, such as in long-term potentiation 
(Davies et al., 1991), in the control of frequency and synchronization of theta rhythm (Davies 
et al., 1990; Mott and Lewis, 1991), and in the mediation of the late phase of the inhibitory 
postsynaptic potentials (Dutar and Nicoll, 1988; Karlsson and Olpe, 1989; Olpe et al., 1993). 
Many studies have confirmed an ubiquitous expression of GABAB receptors in the 
hippocampus, in adult as well as during postnatal development. Some studies have focused 
on the distribution of the GABAB1a and GABAB1b subunits (Kulik et al., 2003), and have shown 
that the GABAB1a subunit mediates heterosynaptic depression at glutamatergic terminals 
(Guetg et al., 2009). Overall, GABAB receptors are localized pre- and postsynaptically at both 
glutamatergic and GABAergic synapses during postnatal development (Lopez-Bendito et al., 
2004). Similarly, comparable distribution has been observed in the adult (Kulik et al., 2003). 
Thus it is expected that the hippocampus is one of the areas with the strongest expression of 
the GABABR auxiliary subunits. 
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Indeed, our analysis shows that KCTD12 and 16 mRNA are present at very high levels in the 
pyramidal cell layer of the hippocampus and the granular layer of the dentate gyrus (DG). 
Strongest KCTD12 hybridization signals were observed in the pyramidal neurons of the CA2 
and CA3 region, and the dentate gyrus (Figure 4-6B), whereas strongest KCTD16 
expression was observed in the pyramidal neurons of the CA1 region and in the dentate 
gyrus (Figure 4-6C). In addition to pyramidal cells, there is a population of basket cells of 
various sizes and shapes that have their cell bodies located in the pyramidal cell layer, some 
of them showing strong hybridization signals for KCTD12 and 16 (Figure 4-6B, C insets). 
There are also a variety of non-pyramidal cell types in the stratum oriens, stratum radiatum, 
and stratum lacunosum-moleculare of the hippocampus known to be immunoreactive for 
GABA, and most are considered to be local circuit interneurons. Cells in these layers, as well 
as in the hilus of the dentate gyrus exhibit high expression levels of KCTD12 as well as 16 
(Figure 4-6B, C, arrows). 
In the subiculum (S) KCTD16 mRNA is present at high levels, whereas KCTD12 mRNA was 
only detected at very low levels. The neurons of the subiculum, which constitute the main 
output of the hippocampus, also contain KCTD8 mRNA (Figure 4-6A). The subiculum 
sustains afferent and efferent connections to the entorhinal cortex. The outer layers (layer II) 
of the entorhinal area contain high KCTD12 and 16 transcript levels (Table 4-1; Figure 4-3C, 
D). Layer II contains mainly stellate cells that are the principal source of fibers for the 
perforant pathway projection to the dentate gyrus and the CA3. 
At P5, KCTD8 mRNA is present in the hippocampus at moderate levels, primarily in the 
subiculum (Figure 4-6D). KCTD12 message is very high in hippocampal CA2 and CA3 
region, the dentate gyrus and in non-pyramidal cells in the stratum oriens, stratum radiatum 
and the stratum lanculosum-moleculare (Figure 4-6E). KCTD16 was mainly present in the 
pyramidal layer of the CA1 and CA2 region, but only at moderate levels (Figure 4-6F). The 
KCTD expression pattern at P5 partially overlap with the patterns observed in adult animals, 
but additionally exhibit noticeable preferences. Presumably the localization of different 
GABAB-KCTD complexes is important during hippocampal development, and in the formation 
of neuronal circuits in the hippocampus. 
  
Differential expression pattern of the novel auxiliary subunits of the GABAB receptor - KCTD8, 12, and 16 
102
 
Figure 4-6: KCTD gene expression pattern in the hippocampus of adult and P5 mice. Low levels 
of KCTD8 are expressed in the subiculum (S) and in hilar cells of the dentate gyrus (DG) (A, insert). 
KCTD 12 and 16 exhibit strong expression in the pyramidal neurons and interneurons of the 
hippocampus (B and C, arrows, inserts). (P5) KCTD8 mRNA is present in the subiculum (D). Highest 
KCTD12 mRNA levels are present in pyramidal cells of CA3 and DG (E), whereas the CA1 field shows 
highest KCTD16 expression (F). CA1, CA1 field of hippocampus; CA2, CA2 field of hippocampus; 
CA3, CA3 field of the hippocampus. Scale bar = 1000μm (A-C) ; 50μm (insert A-C); 200μm (D-F). 
Thalamus – KCTD16 is the predominant auxiliary GABABR subunit in the 
thalamus 
The thalamus is an essential relay point for the processing of somatosensory, visual, and 
auditory sensory input to the cortex. In general, the thalamus is one of the highest GABABR 
expressing areas in the brain. Porter and Nieves have demonstrated that presynaptic 
activation of GABAB receptors modulates thalamocortical excitation of inhibitory and 
excitatory neurons and provide another mechanism by which cortical inhibition can modulate 
the processing of sensory information (Porter and Nieves, 2004). Prominent mRNA 
expression was also observed for the GABAB interacting KCTDs. The nuclei in the anterior 
group of the dorsal thalamus express only one KCTD (Figure 4-7B-D). The anterodorsal 
nuclei contain low levels of KCTD12 mRNA (Figure 4-7C, arrow), whereas the laterodorsal 
and the anteroventral nuclei contain high levels of KCTD16 mRNA (Figure 4-7D, 
arrowheads). A high number of KCTD16 expressing cells were also found throughout the 
thalamic nuclei in the medial and the ventral part. The mediodorsal nucleus of the medial 
group is one of the few nuclei in the thalamus, where KCTD8, 12, and 16 are expressed, with 
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KCTD16 showing the highest expression (Figure 4-7B-D). The posterior group, the medial 
and laterodorsal geniculate nucleus, and the subparafascicular nucleus show moderate to 
high levels of KCTD16 transcripts (Figure 4-7F-H, Table 4-1). In contrast to the cortex, 
amygdala and hippocampus, expression of KCTD12 was low and only present in a few 
nuclei of the thalamus, such as the nuclei of the medial and the nuclei of the ventral group of 
the dorsal thalamus, and the medial geniculate nucleus (Table 4-1, Figure 4-7C and G). 
KCTD16 mRNA is abundant in almost all thalamic areas and nuclei at moderate to high 
levels (Figure 4-7D and H), whereas KCTD8 is absent from most thalamic nuclei (Figure 
4-7B and F). From our data, we suggest that most thalamic GABAB receptors complexes 
would contain only KCTD16 as auxiliary subunit, supporting a potential function in GABAB 
mediated modulation of the processing of sensory inputs. 
The overall expression of KCTD transcripts in the thalamus at P5 resembles the expression 
pattern observed in the adult brain (Table 4-2). In the dorsal thalamus KCTD16 is expressed 
at high levels, whereas KCTD12 is observed only in the anterodorsal nuclei of the anterior 
group, in the medial and ventral group and at low levels. What differs from the expression at 
adulthood is the strong expression of KCTD12 transcripts in the geniculate group, which 
transfers auditory and visual inputs to the thalamus. This could hint to a function of KCTD12 
in the development of sensory pathways. Especially since KCTD12 was detected in cells of 
both the cochlea and the retina (Figure 4-9B and H). 
 
Figure 4-7: KCTD gene expression pattern in the thalamus of the adult mouse. KCTDs exhibit 
distinct expression patters in the striatum and the anterior and posterior thalamus of adult mouse 
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brain. The striatum contains strong KCTD12 expression (C), KCTD16 is expressed stronly in the 
caudatoputamen (CP), but absent from the globus pallidus (GP) (D). KCTD16 shows high expression 
levels in the anterior thalamic nuclei, excluding the anterodorsal nucleus of the thalamus (D). KCTD16 
is abundant at moderat to high levels throughout the posterior thalamus (H). AD, anterodorsal n. of th.; 
AV, anteroventral n. of th. ; LD, laterodorsal n. of th.; LG, lateral geniculate n.; MD,mediodorsal n. of 
th.; V AL, mitral cell layer; PVT, paraventricular n. of th.; PO, posterior group; RH, rhomboid n.; RE, 
reunions n. ; R T, reticular thalamic n.; VPM, ventral posteromedial n. of th.. Scale bars = 1000 µm. 
Epithalamus – a brain region with strongest expression of KCTD8 and 
12b 
The medial habenula (MH) is a cholinergic nucleus projecting through the retroflex fasciculus 
to the interpeduncular nucleus (habenulointerpeduncular tract). The function of the 
habenulointerpeduncular connection is poorly understood, although there is evidence from 
rodents that it modulates complex behaviors such as avoidance, reward and feeding 
(Sutherland, 1982). However, it is among the brain areas that contain the largest amounts of 
GABAB receptors, but in contrast to most other thalamic nuclei it contains the highest levels 
of KCTD8, as well as KCTD12 mRNA (Figure 4-8B, C). Of particular interest is the exclusive 
expression of KCTD12b mRNA in this region (Figure 4-8E). The lateral habenula contain low 
levels of KCTD16 mRNA, whereas the medial habenula does not exhibit any KCTD16 
expression (Figure 4-8D). 
 
Figure 4-8: KCTD gene expression pattern in the habenula of the adult mouse. KCTD8 (B), 12 
(C), and 12b (E) are expressed highly in the medial habenula. KCTD16 (D) mRNA is only present in 
the lateral habenula. Scale bar = 200 µm. 
Hypothalamus – KCTD12 abundant at low levels 
In contrast to the thalamus, KCTD12 transcripts are more abundant in the hypothalamus 
(Figure 4-1C, Table 4-1). KCTD12 mRNA is highly expressed in the anterior part of the 
hypothalamus, in the medial and the lateral preoptic area, the nucleus of the diagonal band 
and the magnocellular preoptic nucleus. Moderate levels of KCTD12 were also detected in 
the lateral hypothalamic area and the posterior hypothalamic nuclei. As mentioned 
previously, the anterior nuclei receive input from the lateral septum and control the 
maintenance of body temperature. The specific GABAB agonist baclofen is well known to 
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induce hypothermia (Badran et al., 1997). Moreover analysis of the basal body temperature 
showed that GABAB1 knockout mice are hypothermic by approx 1°C when compared to wild-
type mice (Schuler et al., 2001). This is likely caused by the loss of GABAB function in the 
hypothalamus, where GABAB receptors are involved in the control of body temperature 
(Pierau et al., 1997). Other areas of the hypothalamus showed no or very low levels of 
KCTD12. KCTD8 and 16 were not present in most of the nuclei. High levels of KCTD16 
mRNA could only be detected in the zona incerta and very high levels in the mammillary 
bodies. These observations go in line with the hypothalamic areas that highly express 
GABAB receptors. Particularly some of the preoptic nuclei and the mammillary bodies 
(Margeta-Mitrovic et al., 1999). A strong expression of KCTD16 transcripts in the mammillary 
bodies is already present at postnatal day 5 (Table 4-2). 
Midbrain/brainstem/peripheral tissue – particular expression pattern of 
KCTDs in the sensory system 
GABAB receptors are expressed in several regions of midbrain and brainstem, as well as in 
peripheral tissues (Ong and Kerr, 1990). They are expressed in primary sensory neurons, 
the spinal cord and in several relay nuclei of sensory pathways (Durkin et al., 1999; Margeta-
Mitrovic et al., 1999). Generally KCTD12 and KCTD16 transcripts show low expression 
levels in the midbrain with few exceptions, whereas KCTD8 transcripts exhibit highest 
expression levels in certain brainstem nuclei. The strong expression of KCTDs in some of 
these areas suggests a role in modulating GABAB action in a variety of sensory modalities. 
Visual system. Similar to GABAB receptors (Koulen et al., 1998), KCTD8, 12, and 16 
transcripts are present in various neurons of the retina (Figure 4-9A-C). Our analysis 
detected KCTD12 and 16 mainly in retinal ganglion cells, whereas KCTD8 and 16 are 
present in cells of the inner nuclear layer that contains amacrine and bipolar cells. In 
addition, KCTD16 is highly expressed in the target regions of the retina, such as the anterior 
pretectal nucleus, the superior colliculus and the dorsal lateral geniculate nucleus (Table 
4-1). We found moderate levels of KCTD8 and very high levels of KCTD12 mRNA also in the 
parabigeminal nucleus (PBN), a subcortical visual center projecting to the superior colliculus 
(SC) and the amygdala (Figure 4-9D-F). The majority of cholinergic input to the superior 
colliculus originates in the parabigeminal nucleus (Mufson et al., 1986), which is also rich in 
GABAB receptors (Margeta-Mitrovic et al., 1999). 
Auditory system. Resendes et al. were the first to clone KCTD12 from a human fetal cochlea 
library and implicated an auditory system related function for KCTD12. We found KCTD12 to 
be highly expressed in the cochlea (Figure 4-9E), supporting their hypothesis. According 
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Resendes et al., the greatest number of immunostained cells in the cochlea were type I 
fibrocytes in the spiral ligament. Moreover, we found KCTD8, 12, and 16 expressed in the 
spiral ganglia of the cochlea (Figure 4-9D-F). Concordantly, functional GABAB receptors were 
demonstrated by Lin et al. to be expressed in spiral ganglion neurons. These receive 
GABAergic innervation from the lateral olivocochlear efferent system, originating from 
neurons located around the lateral superior olivary nucleus (Lin et al., 2000). Thereupon 
Maison et al. showed that GABAB receptors are present only in type I and type II ganglion 
cells, their unmyelinated dendrites within the cochlea and their afferent terminals contacting 
inner and outer hair cells (Maison et al., 2009). 
Apart from the cochlea, KCTD12 and/or KCTD16 are present in the main areas and nuclei 
that are significantly involved in the auditory pathway (Table 4-1). These comprise the 
superior olivary complex and the nucleus of the lateral lemniscus, which is known for its 
prominent GABA and glycinergic neurons. It also comprises the nucleus of the trapezoid 
body which expresses only KCTD12, and the medial geniculate nucleus which only 
expresses KCTD16 mRNA. Additionally, we found KCTDs expressed in the dorsal cochlea 
nucleus (DCN) through which auditory nerve fibers from the cochlea enter the brain. The 
DCN displays high levels of KCTD8 and 12, and low levels of KCTD16 transcripts (Figure 
4-9J-L). As the DCN projects reciprocally to the inferior colliculus and also receives efferent 
innervation from the auditory cortex, and the superior olivary complex, it is thought to be 
involved in more complex auditory processing. 
Superior and inferior colliculus also abundantly express GABAB receptors. Interestingly, both 
share low levels of KCTD12 mRNA in the adult brain, but high levels at P5. In contrast to 
mRNA levels of KCTD16, which are low postnatally, but very high during adulthood (for 
comparison see Table 4-1 and Table 4-2). The different expression levels between P5 and 
adult brain strongly suggest a role of KCTD12 and 16 in the development of visual and 
auditory pathways.  
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Figure 4-9: KCTD expression in the visual and auditory system. KCTD8 and 12 are expressed in 
the inner nuclear layer (INL), KCTD12 and 16 in the ganglion cell layer (GCL) of the retina (A-C). 
Neurons in the parabigeminal nucleus (PBG) express KCTD8 (D) and very high levels of KCTD12 
mRNA (E). All KCTDs mRNA are expressed in the spiral ganglia (SG) of the cochlea (G-I), KCTD12 at 
very high levels (H). KCTD8 and high levels of KCTD12 were found in the dorsal cochlea nucleus 
(DCN) (J and K). Scale bars = 100μm (A-I), 200μm (J-L) 
Sensorymotor system. Analogously, we observed KCTD8, 12, and 16 mRNA being present 
in structures belonging to the whisker sensorymotor system. KCTD8 and 16 are strongly 
expressed in the ganglion cells of the trigeminus (Figure 4-10A-C), whereas KCTD12 is 
individually expressed in whisker follicles (Figure 4-10D). In the whisker system, the cells of 
the trigeminal ganglion act as sensory receptor neurons. Nerve endings of the trigeminal 
ganglion convert mechanical energy sensed by mechanoreceptors in the whisker follicle into 
action potentials. We have shown KCTD12 and 16 being expressed in the ventral posterior 
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medial and the posterior nuclei of the thalamus, which receive input from the trigeminal 
nucleus and project to the barrel field of the somatosensory cortex. In addition to whisker 
follicles, high levels of KCTD12 were found in hair follicles (Figure 4-10E). 
Apart from its function in the whisker sensorymotor system, the trigeminal ganglion contains 
a wide range of sensory and motor fibers, i.e. from the ophthalmic, maxillary, and mandibular 
nerves. Among others, the anti-nociceptive effect of the GABAB receptor agonist baclofen 
indicates a modulatory role of the GABAB receptor in processing information from the 
excitatory glutamatergic nociceptive primary afferents - the terminals of glutamatergic dorsal 
root and trigeminal ganglion cells. Like the mRNA of KCTD8 and 16, the GABAB receptor is 
present in the ganglion cells of the trigeminal. Unique and very high expression of KCTD12 
was observed in the odontoblasts layer of the dental pulp of P5 animals (Figure 4-10F). 
GABAergic modulation of nociception was also here suggested by Todd et al. when they 
reported moderate GABA staining in the odontoblast layer and light staining within the 
subodontoblastic layer of pulpa and dentin which was increased in carious teeth (Todd et al., 
1997). They proposed a role for GABA as peripheral neuromodulator or growth factor in the 
dental pulp and in inhibitory pulpal nerve mechanisms and neuroinhibition, causing the lack 
of symptoms in certain dental diseases. Expression of GABAB receptors in pulpa and dentin 
still awaits confirmation. 
Among the other brainstem nuclei, moderate levels of KCTD12 were observed in the external 
cuneate nucleus, which receives fibers corresponding to the proprioceptive innervation of the 
upper-extremity, the pontine reticular nuclei, and the inferior olivary complex; all of them are 
involved in coordination of movement and project to the cerebellum. Notably the inferior 
olivary complex is the sole source of climbing fibers projecting to the cerebellum. 
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Figure 4-10: KCTD expression in the sensorymotor system. KCTD8 (A) and 16 (C) are highly 
expressed in the ganglion cells of the trigeminus nerve (5Gn). KCTD12 is strongly expressed in 
whisker follicles (D), hair follicles (E, arrowheads), and the odontoblasts layer of the dental pulp (F, 
arrows). Scale bars = 100μm (A–C), 200μm (D-F) 
Cerebellum – distinct cellular KCTD expression pattern 
While GABAB receptors are localized pre- and postsynaptically in both, GABAergic and 
glutamatergic cells of the cerebellum, the cerebellum shows very distinct expression patterns 
of KCTD8, KCTD12 and KCTD16 transcripts (Figure 4-11A-D). KCTD8 mRNA is expressed 
at moderate levels in the granule cell layer (GCL) (Figure 4-11B and F). Purkinje cells (PCs), 
which display the highest density of GABAB receptors in the cerebellum (Margeta-Mitrovic et 
al., 1999), also show the strongest KCTD12 mRNA levels Figure 4-11C, arrows). Throughout 
the cerebellum, PCs exhibit strikingly alternating stretches of labeled and non-labeled cells 
resembling the Zebrin II zonation pattern with higher density of KCTD12 positive Purkinje 
cells in the posterior than in the anterior part (Figure 4-11G). This pattern was also reported 
for the GABAB receptor (Fritschy et al., 1999; Lujan and Shigemoto, 2006) and nicely 
emphasizes the strong association between the GABAB receptor and the KCTDs. A high 
abundance of KCTD12 protein in PCs could ensure the presence of a high affinity type of 
GABAB receptor that is necessary for the enhanced long-term depression observed at 
parallel fiber - PC synapses (Kamikubo et al., 2007). KCTD16 mRNA is observed exclusively 
in large singularly scattered cells in the granular layer; the GABAergic Golgi cells (GC) 
(Figure 4-11D and H, arrowheads). In fact, also Golgi cell dendrites were reported to be 
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restricted to these Zebrin II positive Purkinje cell stripe boundaries (Sillitoe et al., 2008). The 
deep cerebellar nuclei contain low levels of KCTD8, 12, and 16 (Table 4-1). 
The cerebellum is one of the few areas in the brain that develops during late embryonic and 
early postnatal stages. From P7 onwards, intense GABAB1 immunoreactivity was reported in 
PCs, and moderate staining in the internal granular layer and the migrating granule cells 
(Lujan and Shigemoto, 2006). In contrast, KCTD12 is specifically present in the 
differentiating Purkinje cell layer and in the internal granular layer (igl), whilst KCTD8 is 
expressed in the external granular layer (egl) (Figure 4-11J and K). At P5 KCTD16 
transcripts are predominantly expressed in the deep cerebellar nuclei (Table 4-2). 
The Zebrin-like expression pattern which can be observed for KCTD12 in the adult 
cerebellum is not yet established at postnatal day 5. Most probably this occurs at later 
stages, as described for the GABAB receptor around P15 (Lujan and Shigemoto, 2006). 
 
Figure 4-11: Distinct expression of KCTDs in the cerebellum. Granule cells (GCL) express KCTD8 
(B, F), Purkinje cells (PC) KCTD12 (C, arrows), Golgi cells (GC) KCTD16 mRNA (D, H arrowheads). 
KCTD12 exhibits a Zebrin-like expression pattern in PCs (G, arrows). Hybridization of P5 brain 
sections reveals KCTD8 mRNA levels predominant in the external (egl) (J) and KCTD12 in the internal 
(igl) granular layers (K). GCL, granule cell layer; ML, molecular layer of the cerebellum. Scale bars = 
200µm (A-D), 100µm (E, F and H-L), 1000μm (G). 
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Discussion 
KCTD8, 12, and 16 were identified in immunoaffinity purification experiments using brain 
tissue as starting material and found to be tightly associated with the GABAB receptor 
(Schwenk et al., 2009). Furthermore Schwenk et al. described that these KCTDs differentially 
alter GABAB mediated activation of Kir- and Cav-channels. Thus the KCTDs may modulate 
various GABABR-mediated effects, and contribute to the diversity of GABAB receptor 
complexes with distinct functional properties. 
Detailed information about the regional expression patterns of the KCTDs is required as a 
first step towards the understanding of their functional roles. We hypothesize that the 
differential subsets of KCTDs present in a certain GABAB receptor-signaling complex 
underlie the functional and pharmacological heterogeneity observed with native GABAB 
responses. They could act either alone or in combination, thereby conferring distinct 
properties onto the neurons in which they reside. The repertoire of KCTDs that can interact 
with GABAB receptors in a given neuron or brain area varies depending on the spatial and 
temporal expression patterns of KCTD8, 12, and 16. To address the role of KCTD8, 12, and 
16 in the context of GABAB receptors we determined the expression patterns of KCTD 
transcripts in the brain, which revealed where individual KCTDs potentially interact with 
GABAB receptors. Our data demonstrate that the expression pattern of the GABAB interacting 
KCTDs overlap with those of the GABAB receptor (Bischoff et al., 1999; Durkin et al., 1999; 
Fritschy et al., 2004; Margeta-Mitrovic et al., 1999). GABAB receptor expression was 
detected throughout the brain, with highest expression in hippocampus, cerebellum, 
thalamus, and cerebral cortex. We found KCTD12 i.e. highly expressed in cerebellar Purkinje 
cells, a cell type that is known to containing high amounts of GABAB receptors. The 
observation that KCTD12 and GABABR are both restricted to ZebrinII positive cells gives 
further support for a functional role of KCTD12 as auxiliary subunit of GABAB. 
Although highly related in sructure, the individual expression patterns of the KCTDs 
examined revealed striking differences. The expression of some KCTDs partially overlapped 
with each other in particular brain areas, such as the hippocampal formation, some nuclei of 
the amygdala or the cochlear nuclei; these are brain regions in which more than one member 
of the GABAB interacting KCTDs was identified. Other brain areas, like the nuclei of the 
anterior dorsal thalamus, the globus pallidus, the claustrum, the hypothalamic preoptic areas, 
and the Purkinje or Golgi cells of the cerebellum showed distinct non-overlapping KCTD 
expression patterns. Still, in most brain regions analyzed we identified several KCTDs, albeit 
expressed at different levels. KCTD12 and 16 are the most abundant GABABR auxiliary 
subunits in the brain, whereas KCTD8 is specifically enriched in a very limited subset of cells, 
i.e., in the medial habenula, the cerebellar granule cells, and in several brain stem nuclei, 
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especially the cochlear nuclei, the spinal nucleus of trigeminal, and the hypoglossal nucleus. 
While KCTD16 exhibits a broad expression in structures like cortex, thalamus and amygdala, 
KCTD12 expression seems to be restricted to some nuclei or some subtypes of cells, but 
therein at very high levels. 
Well known differences in the composition of GABAB receptor complexes arise from the two 
GABAB1 isoforms GABAB1a and GABAB1b. According to our data and previous localization 
studies (Bischoff et al., 1999; Durkin et al., 1999; Margeta-Mitrovic et al., 1999) cerebellar 
Purkinje cells would, i.e. exhibit a distinct GABAB receptor complex containing predominantly 
the GABAB1b subunit and KCTD12, exclusively. As GABAB receptors are localized 
postsynaptically at PC dendrites, KCTD12 might likely be involved in regulating GABAB-
mediated Kir responses at postsynaptic sites. In contrast GABAB receptor complexes in the 
mammillary body may contain predominantly the GABAB1a subunit and KCTD16. Quite a 
different GABAB-KCTD complex is expected in the neurons of the medial habenula, which 
contain high amounts of GABAB receptors on their axonal processes (Bischoff et al., 1999; 
Margeta-Mitrovic et al., 1999). These GABAB receptor complexes are most likely composed 
of the GABAB1b subunit and KCTD8, 12 and 12b. Overall, these differences support our 
hypotheses that the GABAB interacting KCTD proteins display part of the heterogeneity of 
native GABAB receptors. Changes in GABAB subunit and GABAB1 isoform expression during 
postnatal development (Bischoff et al., 1999; Fritschy et al., 2004) imply an important role of 
GABAB receptor complexes in the development of inhibitory neuronal circuits. Our data 
shows that KCTDs, according their expression profiles, may also contribute to these 
functions, especially in the establishment and function of sensory pathways. 
A striking observation was the extensive and strong expression of KCTD12 in non-neuronal 
cells in the olfactory nerve layer, presumably in olfactory ensheathing cells. Olfactory 
ensheathing cells (OECs) are the principal glial cells of the olfactory bulb where axon growth 
not only occurs in response to injury but also occurs as a normal physiological process 
throughout normal life. OECs ensheath the axons within the olfactory nerve and constitute 
the major glial component of the superficially located nerve fiber layer of the olfactory bulb 
(Franklin and Barnett, 2000). Glial cells are known for the uptake and release of 
neurotransmitter and Jaffe et al. showed that GABA is released from glia cells on the 
olfactory bulb (Angulo et al, 2008; Jaffe and Cuello, 1981). Regarding the strong expression 
in OECs KCTD12 protein might likely be involved in this process. According to previous 
localization studies showing no expression of GABAB receptors in OECs, in this special case, 
GABAB receptors would not serve as interaction partners. However, GABAB receptors are 
expressed in several types of glial cells (Charles et al., 2003), and it might be assumed that 
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they regulate neuron-glial cross-talk in the nervous system (Magnaghi, 2007). Therefore re-
examination of GABAB expression in OECs is needed. 
In fact, immunolabelled GABAB receptors have been found in axon terminals of the olfactory 
nerve (Bonino et al., 1999), suggesting that activation of presynaptic GABAB receptors 
inhibits excitatory neurotransmission from olfactory nerve axons to second-order neurons. 
Apart from OECs we also observed KCTD12 mRNA in olfactory receptor neurons. A study by 
Priest and Puche revealed a function of GABAB receptors in olfactory axon growth. They 
showed that baclofen inhibits axon growth and suggested that GABA, which is often released 
prior to the formation of synaptic connections, might serve as a `stop and synapse` signal 
which acts on the GABAB receptors expressed by the ingrowing ORN growth cones (Priest 
and Puche, 2004). As olfactory sensory neurons are continuously regenerating neurons 
(Graziadei et al., 1979), this goes along with previous data suggesting a role of GABAB 
receptors in developmental events, such as neuronal migration (Behar et al., 2000; Behar et 
al., 1998; Lopez-Bendito et al., 2003), chemoattraction (Behar et al., 2001), and axonal 
pathfinding (Xiang et al., 2002). 
Western blot analysis of two-dimensional gel separations of brain membrane fractions 
showed that all GABAB receptors resolved on native gels appeared to be associated with the 
KCTD proteins. Both KCTD12 and KCTD16 strictly co-migrated with the GABAB core 
subunits, but their signals exhibited only partial overlap with each other. This suggests that a 
portion of both KCTDs may be integrated into the same GABAB complexes, while the 
remaining KCTD proteins participate in distinct GABAB receptors of either higher (KCTD16) 
or lower (KCTD12) molecular size (Schwenk et al., 2009). Recently, Tiao et al. showed that 
the GABAB interacting KCTDs are able to homo- and heteromerize which supports the 
existence of heteromeric complexes (Tiao et al., 2009). We observed overlapping distribution 
in some brain areas, as well as very distinct localization for each GABAB interacting KCTD in 
other, strengthening their suggested capability to form distinct subtypes of GABAB receptor 
complexes. Whether GABAB-mediated signaling is regulated differentially in neurons that 
express one individual KCTD or a certain subset of the GABAB interacting KCTDs still 
remains to be determined. For this the individual role of each GABAB interacting KCTD needs 
further examination; and moreover comprehensive investigation if KCTDs display synergistic 
or antagonizing effects is crucial. 
However, it might be difficult to use the KCTD subset expression for predictions of the 
GABAB-mediated signaling characteristics, as there are multiple other players involved in 
modulating the action of GABAB. In regards to the K-channel signaling, different types of Kir-
channels should be taken into account for possible heterogeneity of GABAB mediated Kir 
signaling (Aguado et al., 2008; Doupnik, 2008; Fernandez-Alacid et al., 2009). Some 
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members of the family of RGS proteins, for example, were also reported to modulate GABAB-
mediated Kir activity (Fowler et al., 2007; Labouebe et al., 2007). 
In terms of function, it also has to be considered that the here explored distribution profile 
gives an instantaneous picture of the localization of the different KCTD mRNAs. If protein 
distribution exactly overlaps and if there are changes in protein levels under certain 
circumstances like increased neuronal activity or during formation of neuronal circuitries 
needs to be investigated. Localization studies of overexpressed KCTD proteins (Tiao et al., 
2009) suggest the presence of KCTDs at presynaptic, as well as at postsynaptic sites. 
However, our data provides the basic for future studies which may elucidate preferences of 
the individual KCTDs in regulating pre- or postsynaptic GABAB-mediated actions at certain 
circuitries, like we suggested for the cerebellum. 
Conclusions 
This is the first study that reports in detail the spatial distribution of the GABAB interacting 
KCTD genes in the mouse nervous system. Knowledge of the expression patterns of these 
genes provides yet another tool to elucidate the function of the KCTD subfamily and 
moreover to explain the functional heterogeneity observed in native GABAB receptors. We 
found that KCTD12 and 16 are present throughout most brain areas, but each KCTD 
showing a high degree of regional specialization. In most brain regions at least one member 
of the KCTD subfamily is present. GABAB receptors are abundant throughout the whole brain 
and Schwenk et al. showed that literally all native GABAB receptors are associated with 
either one or more GABAB interacting KCTD (Schwenk et al., 2009). Areas that exhibit very 
high amounts of GABAB receptor protein, such as the pyramidal layers of the hippocampus, 
several amygdaloid nuclei, certain nuclei of the thalamus, or the Purkinje cells of the 
cerebellum also show high mRNA levels of either one ore more KCTD. Our study revealed 
quite distinct expression patterns of each individual KCTD subunit that may contribute to the 
diversity of GABAB receptor responses observed in vivo and strongly support their role as 
auxiliary subunits of the GABAB receptor. 
References for chapter 4 
Aguado C, Colon J, Ciruela F, Schlaudraff F, Cabanero MJ, Perry C, Watanabe M, Liss B, 
Wickman K, Lujan R. 2008. Cell type-specific subunit composition of G protein-gated 
potassium channels in the cerebellum. J Neurochem 105(2):497-511. 
Angulo MC, Le Meur K, Kozlov AS, Charpak S, Audinat E. 2008. GABA, a forgotten 
gliotransmitter. Prog Neurobiol 86(3):297-303. 
Badran S, Schmutz M, Olpe HR. 1997. Comparative in vivo and in vitro studies with the 
potent GABAB receptor antagonist, CGP 56999A. Eur J Pharmacol 333(2-3):135-142. 
  
Differential expression pattern of the novel auxiliary subunits of the GABAB receptor - KCTD8, 12, and 16
115
Behar TN, Schaffner AE, Scott CA, Greene CL, Barker JL. 2000. GABA receptor antagonists 
modulate postmitotic cell migration in slice cultures of embryonic rat cortex. Cerebral 
cortex (New York, NY 10(9):899-909. 
Behar TN, Schaffner AE, Scott CA, O'Connell C, Barker JL. 1998. Differential response of 
cortical plate and ventricular zone cells to GABA as a migration stimulus. J Neurosci 
18(16):6378-6387. 
Behar TN, Smith SV, Kennedy RT, McKenzie JM, Maric I, Barker JL. 2001. GABA(B) 
receptors mediate motility signals for migrating embryonic cortical cells. Cerebral cortex 
(New York, NY 11(8):744-753. 
Bischoff S, Leonhard S, Reymann N, Schuler V, Shigemoto R, Kaupmann K, Bettler B. 1999. 
Spatial distribution of GABA(B)R1 receptor mRNA and binding sites in the rat brain. The 
Journal of comparative neurology 412(1):1-16. 
Bonino M, Cantino D, Sassoe-Pognetto M. 1999. Cellular and subcellular localization of 
gamma-aminobutyric acidB receptors in the rat olfactory bulb. Neuroscience letters 
274(3):195-198. 
Charles KJ, Deuchars J, Davies CH, Pangalos MN. 2003. GABA B receptor subunit 
expression in glia. Molecular and cellular neurosciences 24(1):214-223. 
Chen L, Wang HT, Han XH, Li YL, Cui QL, Xie JX. 2008. Behavioral and electrophysiological 
effects of pallidal GABAB receptor activation and blockade on haloperidol-induced 
akinesia in rats. Brain research 1244:65-70. 
Ciriello J, Roder S. 1999. GABAergic effects on the depressor responses elicited by 
stimulation of central nucleus of the amygdala. Am J Physiol 276(1 Pt 2):H242-247. 
Crick FC, Koch C. 2005. What is the function of the claustrum? Philosophical transactions of 
the Royal Society of London 360(1458):1271-1279. 
Davies CH, Davies SN, Collingridge GL. 1990. Paired-pulse depression of monosynaptic 
GABA-mediated inhibitory postsynaptic responses in rat hippocampus. J Physiol 
424:513-531. 
Davies CH, Starkey SJ, Pozza MF, Collingridge GL. 1991. GABA autoreceptors regulate the 
induction of LTP. Nature 349(6310):609-611. 
Davila JC, Real MA, Olmos L, Legaz I, Medina L, Guirado S. 2005. Embryonic and postnatal 
development of GABA, calbindin, calretinin, and parvalbumin in the mouse claustral 
complex. The Journal of comparative neurology 481(1):42-57. 
Dementieva IS, Tereshko V, McCrossan ZA, Solomaha E, Araki D, Xu C, Grigorieff N, 
Goldstein SA. 2009. Pentameric assembly of potassium channel tetramerization 
domain-containing protein 5. Journal of molecular biology 387(1):175-191. 
Doupnik CA. 2008. GPCR-Kir channel signaling complexes: defining rules of engagement. 
Journal of receptor and signal transduction research 28(1-2):83-91. 
Durkin MM, Gunwaldsen CA, Borowsky B, Jones KA, Branchek TA. 1999. An in situ 
hybridization study of the distribution of the GABA(B2) protein mRNA in the rat CNS. 
Brain research 71(2):185-200. 
Dutar P, Nicoll RA. 1988. Pre- and postsynaptic GABAB receptors in the hippocampus have 
different pharmacological properties. Neuron 1(7):585-591. 
Fernandez-Alacid L, Aguado C, Ciruela F, Martin R, Colon J, Cabanero MJ, Gassmann M, 
Watanabe M, Shigemoto R, Wickman K, Bettler B, Sanchez-Prieto J, Lujan R. 2009. 
Subcellular compartment-specific molecular diversity of pre- and post-synaptic GABA-
activated GIRK channels in Purkinje cells. J Neurochem 110(4):1363-1376. 
  
Differential expression pattern of the novel auxiliary subunits of the GABAB receptor - KCTD8, 12, and 16 
116
Fowler CE, Aryal P, Suen KF, Slesinger PA. 2007. Evidence for association of GABA(B) 
receptors with Kir3 channels and regulators of G protein signalling (RGS4) proteins. J 
Physiol 580(Pt 1):51-65. 
Franklin RJ, Barnett SC. 2000. Olfactory ensheathing cells and CNS regeneration: the sweet 
smell of success? Neuron 28(1):15-18. 
Fritschy JM, Meskenaite V, Weinmann O, Honer M, Benke D, Mohler H. 1999. GABAB-
receptor splice variants GB1a and GB1b in rat brain: developmental regulation, cellular 
distribution and extrasynaptic localization. Eur J Neurosci 11(3):761-768. 
Fritschy JM, Sidler C, Parpan F, Gassmann M, Kaupmann K, Bettler B, Benke D. 2004. 
Independent maturation of the GABA(B) receptor subunits GABA(B1) and GABA(B2) 
during postnatal development in rodent brain. The Journal of comparative neurology 
477(3):235-252. 
Gamse JT, Kuan YS, Macurak M, Brosamle C, Thisse B, Thisse C, Halpern ME. 2005. 
Directional asymmetry of the zebrafish epithalamus guides dorsoventral innervation of 
the midbrain target. Development 132(21):4869-4881. 
Graziadei PP, Levine RR, Monti Graziadei GA. 1979. Plasticity of connections of the 
olfactory sensory neuron: regeneration into the forebrain following bulbectomy in the 
neonatal mouse. Neuroscience 4(6):713-727. 
Guetg N, Seddik R, Vigot R, Turecek R, Gassmann M, Vogt KE, Brauner-Osborne H, 
Shigemoto R, Kretz O, Frotscher M, Kulik A, Bettler B. 2009. The GABAB1a isoform 
mediates heterosynaptic depression at hippocampal mossy fiber synapses. J Neurosci 
29(5):1414-1423. 
Henderson Z, Jones GA. 2005. GABAB receptors in the medial septum/diagonal band slice 
from 16-25 day rat. Neuroscience 132(3):789-800. 
Jaffe EH, Cuello AC. 1981. Neuronal and glial release of [3H]GABA from the rat olfactory 
bulb. J Neurochem 37(6):1457-1466. 
Kamikubo Y, Tabata T, Kakizawa S, Kawakami D, Watanabe M, Ogura A, Iino M, Kano M. 
2007. Postsynaptic GABAB receptor signalling enhances LTD in mouse cerebellar 
Purkinje cells. J Physiol 585(Pt 2):549-563. 
Karlsson G, Olpe HR. 1989. Late inhibitory postsynaptic potentials in rat prefrontal cortex 
may be mediated by GABAB receptors. Experientia 45(2):157-158. 
Kaupmann K, Schuler V, Mosbacher J, Bischoff S, Bittiger H, Heid J, Froestl W, Leonhard S, 
Pfaff T, Karschin A, Bettler B. 1998. Human gamma-aminobutyric acid type B receptors 
are differentially expressed and regulate inwardly rectifying K+ channels. Proc Natl Acad 
Sci U S A 95(25):14991-14996. 
Koulen P, Malitschek B, Kuhn R, Bettler B, Wassle H, Brandstatter JH. 1998. Presynaptic 
and postsynaptic localization of GABA(B) receptors in neurons of the rat retina. Eur J 
Neurosci 10(4):1446-1456. 
Kulik A, Vida I, Lujan R, Haas CA, Lopez-Bendito G, Shigemoto R, Frotscher M. 2003. 
Subcellular localization of metabotropic GABA(B) receptor subunits GABA(B1a/b) and 
GABA(B2) in the rat hippocampus. J Neurosci 23(35):11026-11035. 
Labouebe G, Lomazzi M, Cruz HG, Creton C, Lujan R, Li M, Yanagawa Y, Obata K, 
Watanabe M, Wickman K, Boyer SB, Slesinger PA, Luscher C. 2007. RGS2 modulates 
coupling between GABAB receptors and GIRK channels in dopamine neurons of the 
ventral tegmental area. Nat Neurosci 10(12):1559-1568. 
LeDoux J. 2007. The amygdala. Curr Biol 17(20):R868-874. 
  
Differential expression pattern of the novel auxiliary subunits of the GABAB receptor - KCTD8, 12, and 16
117
Lin X, Chen S, Chen P. 2000. Activation of metabotropic GABAB receptors inhibited 
glutamate responses in spiral ganglion neurons of mice. Neuroreport 11(5):957-961. 
Lopez-Bendito G, Lujan R, Shigemoto R, Ganter P, Paulsen O, Molnar Z. 2003. Blockade of 
GABA(B) receptors alters the tangential migration of cortical neurons. Cerebral cortex 
(New York, NY 13(9):932-942. 
Lopez-Bendito G, Molnar Z. 2003. Thalamocortical development: how are we going to get 
there? Nature reviews 4(4):276-289. 
Lopez-Bendito G, Sanchez-Alcaniz JA, Pla R, Borrell V, Pico E, Valdeolmillos M, Marin O. 
2008. Chemokine signaling controls intracortical migration and final distribution of 
GABAergic interneurons. J Neurosci 28(7):1613-1624. 
Lopez-Bendito G, Shigemoto R, Kulik A, Paulsen O, Fairen A, Lujan R. 2002. Expression 
and distribution of metabotropic GABA receptor subtypes GABABR1 and GABABR2 
during rat neocortical development. Eur J Neurosci 15(11):1766-1778. 
Lopez-Bendito G, Shigemoto R, Kulik A, Vida I, Fairen A, Lujan R. 2004. Distribution of 
metabotropic GABA receptor subunits GABAB1a/b and GABAB2 in the rat hippocampus 
during prenatal and postnatal development. Hippocampus 14(7):836-848. 
Lujan R, Shigemoto R. 2006. Localization of metabotropic GABA receptor subunits GABAB1 
and GABAB2 relative to synaptic sites in the rat developing cerebellum. Eur J Neurosci 
23(6):1479-1490. 
Lujan R, Shigemoto R, Lopez-Bendito G. 2005. Glutamate and GABA receptor signalling in 
the developing brain. Neuroscience 130(3):567-580. 
Magnaghi V. 2007. GABA and Neuroactive Steroid Interactions in Glia: New Roles for Old 
Players? Current neuropharmacology 5(1):47-64. 
Maison SF, Casanova E, Holstein GR, Bettler B, Liberman MC. 2009. Loss of GABAB 
receptors in cochlear neurons: threshold elevation suggests modulation of outer hair cell 
function by type II afferent fibers. Journal of the Association for Research in 
Otolaryngology 10(1):50-63. 
Malitschek B, Ruegg D, Heid J, Kaupmann K, Bittiger H, Frostl W, Bettler B, Kuhn R. 1998. 
Developmental changes of agonist affinity at GABABR1 receptor variants in rat brain. 
Molecular and cellular neurosciences 12(1-2):56-64. 
Margeta-Mitrovic M, Mitrovic I, Riley RC, Jan LY, Basbaum AI. 1999. Immunohistochemical 
localization of GABA(B) receptors in the rat central nervous system. The Journal of 
comparative neurology 405(3):299-321. 
Mott DD, Lewis DV. 1991. Facilitation of the induction of long-term potentiation by GABAB 
receptors. Science (New York, NY 252(5013):1718-1720. 
Mufson EJ, Martin TL, Mash DC, Wainer BH, Mesulam MM. 1986. Cholinergic projections 
from the parabigeminal nucleus (Ch8) to the superior colliculus in the mouse: a 
combined analysis of horseradish peroxidase transport and choline acetyltransferase 
immunohistochemistry. Brain research 370(1):144-148. 
Olpe HR, Worner W, Ferrat T. 1993. Stimulation parameters determine role of GABAB 
receptors in long-term potentiation. Experientia 49(6-7):542-546. 
Ong J, Kerr DI. 1990. GABA-receptors in peripheral tissues. Life Sci 46(21):1489-1501. 
Pan BX, Dong Y, Ito W, Yanagawa Y, Shigemoto R, Morozov A. 2009. Selective gating of 
glutamatergic inputs to excitatory neurons of amygdala by presynaptic GABAb receptor. 
Neuron 61(6):917-929. 
  
Differential expression pattern of the novel auxiliary subunits of the GABAB receptor - KCTD8, 12, and 16 
118
Panzanelli P, Lopez-Bendito G, Lujan R, Sassoe-Pognetto M. 2004. Localization and 
developmental expression of GABA(B) receptors in the rat olfactory bulb. J Neurocytol 
33(1):87-99. 
Paxinos G FK. 2001. The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic 
Press. 
Pierau FK, Yakimova KS, Sann H, Schmid HA. 1997. Specific action of GABAB ligands on 
the temperature sensitivity of hypothalamic neurons. Ann N Y Acad Sci 813:146-155. 
Porter JT, Nieves D. 2004. Presynaptic GABAB receptors modulate thalamic excitation of 
inhibitory and excitatory neurons in the mouse barrel cortex. J Neurophysiol 92(5):2762-
2770. 
Priest CA, Puche AC. 2004. GABAB receptor expression and function in olfactory receptor 
neuron axon growth. Journal of neurobiology 60(2):154-165. 
Princivalle A, Regondi MC, Frassoni C, Bowery NG, Spreafico R. 2000. Distribution of 
GABA(B) receptor protein in somatosensory cortex and thalamus of adult rats and 
during postnatal development. Brain research bulletin 52(5):397-405. 
Reis GM, Duarte ID. 2006. Baclofen, an agonist at peripheral GABAB receptors, induces 
antinociception via activation of TEA-sensitive potassium channels. Br J Pharmacol 
149(6):733-739. 
Resendes BL, Kuo SF, Robertson NG, Giersch AB, Honrubia D, Ohara O, Adams JC, 
Morton CC. 2004. Isolation from cochlea of a novel human intronless gene with 
predominant fetal expression. Journal of the Association for Research in Otolaryngology 
5(2):185-202. 
Rivera JF, Chu PJ, Arnold DB. 2005. The T1 domain of Kv1.3 mediates intracellular targeting 
to axons. Eur J Neurosci 22(8):1853-1862. 
Schaeren-Wiemers N, Andre E, Kapfhammer JP, Becker-Andre M. 1997. The expression 
pattern of the orphan nuclear receptor RORbeta in the developing and adult rat nervous 
system suggests a role in the processing of sensory information and in circadian rhythm. 
Eur J Neurosci 9(12):2687-2701. 
Schaeren-Wiemers N, Gerfin-Moser A. 1993. A single protocol to detect transcripts of 
various types and expression levels in neural tissue and cultured cells: in situ 
hybridization using digoxigenin-labelled cRNA probes. Histochemistry 100(6):431-440. 
Schuler V, Luscher C, Blanchet C, Klix N, Sansig G, Klebs K, Schmutz M, Heid J, Gentry C, 
Urban L, Fox A, Spooren W, Jaton AL, Vigouret J, Pozza M, Kelly PH, Mosbacher J, 
Froestl W, Kaslin E, Korn R, Bischoff S, Kaupmann K, van der Putten H, Bettler B. 2001. 
Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) 
responses in mice lacking GABA(B(1)). Neuron 31(1):47-58. 
Schwenk J, Metz M, Zolles G, Turecek R, Bildl W, Tarusawa E, Kulik A, Unger A, Tiao J, 
Ivankova K, Seddik R, Rohde V, Gassmann M, Schulte U, Fakler B, Bettler B. 2009. 
Native GABAB receptors are heteromultimers with a family of auxiliary subunits. Nature. 
 
Shaban H, Humeau Y, Herry C, Cassasus G, Shigemoto R, Ciocchi S, Barbieri S, van der 
Putten H, Kaupmann K, Bettler B, Luthi A. 2006. Generalization of amygdala LTP and 
conditioned fear in the absence of presynaptic inhibition. Nat Neurosci 9(8):1028-1035. 
 
Sheerin AH, Nylen K, Zhang X, Saucier DM, Corcoran ME. 2004. Further evidence for a role 
of the anterior claustrum in epileptogenesis. Neuroscience 125(1):57-62. 
  
Differential expression pattern of the novel auxiliary subunits of the GABAB receptor - KCTD8, 12, and 16
119
Silberman Y, Ariwodola OJ, Weiner JL. 2009. Differential effects of GABAB autoreceptor 
activation on ethanol potentiation of local and lateral paracapsular GABAergic synapses 
in the rat basolateral amygdala. Neuropharmacology 56(5):886-895. 
Sillitoe RV, Chung SH, Fritschy JM, Hoy M, Hawkes R. 2008. Golgi cell dendrites are 
restricted by Purkinje cell stripe boundaries in the adult mouse cerebellar cortex. J 
Neurosci 28(11):2820-2826. 
Sutherland RJ. 1982. The dorsal diencephalic conduction system: a review of the anatomy 
and functions of the habenular complex. Neurosci Biobehav Rev 6(1):1-13. 
Todd WM, Kafrawy AH, Newton CW, Brown CE, Jr. 1997. Immunohistochemical study of 
gamma-aminobutyric acid and bombesin/gastrin releasing peptide in human dental pulp. 
Journal of endodontics 23(3):152-157. 
Tiao JH, Seddik R, Metz M, Christiansen B, Besseyrias V, Oertner T, Bettler B. The C-
terminus of KCTD12 promotes desensitization of GABAB receptors in neurons. (in 
preparation) 
Xiang Y, Li Y, Zhang Z, Cui K, Wang S, Yuan XB, Wu CP, Poo MM, Duan S. 2002. Nerve 
growth cone guidance mediated by G protein-coupled receptors. Nat Neurosci 5(9):843-
848. 
Xu J, Yu W, Jan YN, Jan LY, Li M. 1995. Assembly of voltage-gated potassium channels. 
Conserved hydrophilic motifs determine subfamily-specific interactions between the 
alpha-subunits. J Biol Chem 270(42):24761-24768. 
Zhang X, Hannesson DK, Saucier DM, Wallace AE, Howland J, Corcoran ME. 2001. 
Susceptibility to kindling and neuronal connections of the anterior claustrum. J Neurosci 
21(10):3674-3687. 
 
  
Differential expression pattern of the novel auxiliary subunits of the GABAB receptor - KCTD8, 12, and 16 
120
 
  
General Discussion
121
5 General Discussion 
Discussion 
GABAB receptors are involved in the fine tuning of inhibitory synaptic transmission. 
Presynaptic GABAB receptors inhibit neurotransmitter release by down-regulation of high-
voltage activated Ca2+ channels, whereas postsynaptic GABAB receptors decrease neuronal 
excitability by activating a prominent inwardly rectifying K+ conductance that underlies the 
late inhibitory postsynaptic potentials. In physiological conditions, investigators have 
observed a large variability in the kinetics and pharmacology of GABAB receptors that are not 
present when expressed in recombinant systems. One of the main issues of GABAB research 
is to elucidate the causes that lead to the heterogeneity of native GABAB receptors. 
Identification of the GABAB1 isoforms, 1a and 1b, was in line with the expectation that there 
exists a variety of distinct receptor subtypes as reported e.g. for the metabotropic glutamate 
receptors.  But the absence of functional or pharmacological differences of GABAB(1a,2) and 
GABAB(1b,2) in vitro made clear that  the two receptor subtypes do not account for the 
functional heterogeneity of native GABAB receptors. This suggests the existence of 
alternative factors that can modify receptor activity or pharmacology. To this end, our 
laboratory initiated a proteomics’ based approach to screen for GABAB receptor interacting 
molecules. GPCRs have been shown to mediate signaling through large multiprotein 
complexes. Unexpectedly, there is so far no evidence for large protein complexes containing 
GABAB receptors. This is particularly surprising when one considers that macromolecular 
complexes have been described for classic effectors of GABAB receptors such as the 
voltage-dependent Ca2+ channel. In this particular instance, Ca2+ channels have been shown 
to function as adaptor proteins for multiple molecules that bind the channel and signal to 
downstream components following GABAB receptor activation (Richman et al., 2004). 
Possible reasons for the difficulty in identifying macromolecular complexes associated with 
GABAB receptors may lie within the receptor heterodimer itself. Most likely, the formation of a 
compact dimer between GABAB1 and GABAB2 results in the exposure of novel molecular 
surfaces for protein interactions, probably absent in the individual subunits, a factor that has 
hitherto been hindering identification of native GABAB receptor interactors. In addition, only a 
limited number of receptor domains have been used to search for specific interacting 
proteins, probably due to the low signal-to-noise ratio of some recombinant techniques. The 
search for components of a macromolecular complex involved in the direct modulation of 
GABAB receptor signaling may therefore require the use of new biochemical approaches 
using native GABAB receptor heterodimers. Using such a proteomic approach, we identified 
KCTD8, 12, 12b, and 16 as novel interacting proteins of the GABAB receptor. Subsequently 
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they were shown to be auxiliary subunits of the receptor which are integrated in native 
GABAB receptor complexes and profoundly alter the signaling properties of the receptor. 
KCTD proteins significantly enlarge the functional spectrum of GABAB receptors and have 
the potential to generate receptors with distinct properties. This dissertation describes the 
subtype-specific properties of the KCTDs and the distinct KCTD-GABAB complexes that are 
possible. Furthermore, we give evidence that the assembly of KCTDs in native GABAB 
receptor complexes may account for the differences in kinetics and pharmacology observed 
in native GABAB receptors. 
Chapter two contains two main findings. First, we showed that native GABAB receptors exist, 
not as heterodimers as believed to date, but as heteromultimers. Second, we describe four 
novel proteins that are stably associated within this native receptor complex. We investigated 
the structural determinants and the putative stoichiometry of the GABAB-KCTD complex, and 
present an expression profile of the KCTD proteins in the brain as well as their subcellular 
localization. Functionally, we examined the modulating effects on the main effector systems 
of the GABAB receptor, Kir and Cav channels. 
Dynamically assembled macromolecular protein complexes that localize into discrete 
membrane microdomains resemble more and more the contemporary picture of GPCR and 
ion channel signaling and replace the traditional concept of GPCRs conceptualized as 
monomeric or dimeric proteins. Macromolecular protein complexes that transduce biological 
signals across the cell membrane have several advantages over their dissociated 
components functioning through random collisions. At first, the assembled complex provides 
a more rapid response time because the protein participants are not diffusion-limited or 
dependent on bulk concentration. Second, signaling complexes reduce noise or "cross-talk" 
that occurs with nonspecific collision events. And finally, they are metabolically more efficient 
because energy costs associated with the synthesis and maintenance of the localized protein 
complex are significantly lower than those required for collision-coupled signaling over the 
entire cell volume. The group of J. P. Pin has specialized in the investigation of GPCR 
oligomerization by the use of energy transfer technologies, such as fluorescence energy 
transfer (FRET) or bioluminescence energy transfer (BRET) combined with snap-tag 
technology and thus provided evidence that GABAB receptors at the cell surface assemble 
into higher order structures (Pin et al., 2009). We have now demonstrated that native GABAB 
receptors indeed form heteromultimeric complexes. 
The results in chapter two suggest that KCTDs regulate the G-protein cycle upon activation 
of GABAB receptors. KCTD mediated effects require the direct interaction between the KCTD 
and the GABAB2 subunit. KCTD12 and 16 were shown to increase agonist affinity, which is in 
agreement with the assumption that the KCTD action takes place at the receptor. For notion, 
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RGS proteins were not shown to alter agonist binding on any GPCRs. Similarly they are not 
found to bind directly to GPCRs. By resolving the onset and activation phase of the GABAB-
mediated Kir response we found that all KCTDs accelerate the GABAB response. This 
acceleration could be explained by an expedited activation of the effector channels due to a 
faster GDP/GTP exchange at the receptor bound Gα which would suggest that KCTDs 
modulate guanine nucleotide exchange factor (GEF) activity of GABAB receptors. KCTD12 
and 12b, but not KCTD8 and 16, showed a significant effect in receptor desensitization, 
which encouraged our hypotheses that the decrease of receptor activity during sustained 
agonist application is based on a subsequent transition of the receptor into an inactivated 
state that precludes further GDP/GTP exchange. This inactive state is presumably achieved 
by conformational changes in the receptor and/or the KCTDs. KCTD8 and 16 differ from 
KCTD12 and 12b in an additional c-terminal element, which makes conformational changes 
very comprehensible. GABAB2-KCTD binding was not affected by agonist application in Co-
IP as well as in FRET-interaction studies. Therefore, we consider the possibility of 
dissociation of KCTDs and GABAB2 as unlikely. However, suggestions and hypotheses for 
mechanisms underlying the KCTD-mediated effects presented in this chapter remain to be 
verified. 
The third chapter includes data showing that the KCTDs form homo- and heterodimers 
among themselves as well as with the GABAB receptor and puts emphasis on the structural 
requirements for these interactions. We thoroughly investigated the functions of the 
conserved KCTD domains in respect to dimerization and physiological properties. The ability 
of the KCTDs to simultaneously bind to themselves and the GABAB receptor via different 
domains provides the molecular prerequisites for the formation of differentially composed 
complexes. It also presents parallels to T1 domains of Kv channel subunits which were 
shown to mediate subunit specific assembly and thus serve as a control mechanism for 
correct channel forming. The observation that none of the two domains of KCTD8 is sufficient 
to bind to the receptor suggests the existence of further specific interaction properties of the 
KCTDs encoded by their amino acid sequence, their secondary or tertiary structure. The 
electrophysiological data presented in the third chapter go beyond the ones presented in the 
second, particularly in two points. On one hand, it identifies the domains, necessary for 
KCTD-KCTD and KCTD-GABAB interactions, which provide the means to form higher order 
structures composed of the GABAB receptor and its auxiliary subunits. Secondly, the 
experimental setup using hippocampal slice cultures closer resembles the physiological 
structures with preserved neuronal networks.  The effects of KCTD overexpression are, 
compared to the ones observed in heterologous cells or dissociated neuronal cultures, less 
pronounced which suggest that more factors, like other binding partners or phosphorylation, 
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may add to the complexity of native GABAB receptor signaling. Similarly to chapter two, the 
underlying mechanisms, which most likely involve modulation of the G-protein cycle, remain 
to be elucidated. 
In the fourth chapter we describe the spatial and temporal expression pattern of KCTD8, 12, 
and 16 in the CNS, examined by in situ hybridization. We show that the distribution of the 
KCTDs is widely overlapping with the hitherto described distribution of GABAB receptors. The 
study concentrates on the identification of brain areas which exhibit expression of distinct 
subsets of one ore more KCTDs. The overall KCTD mRNA levels are coherent with the 
affinity purification data presented in chapter two, showing KCTD12 and 16 being copurified 
with the GABAB receptor at high yields, whereas KCTD8 in slightly smaller and KCTD12b in 
markedly smaller amounts. Moreover the two dimensional gel separation (Figure 2-1d) 
suggested that KCTD12 and 16 are part of the same GABAB receptor complex, but 
additionally participate in distinct GABAB receptor complexes. These assumptions could be 
affirmed by the revealed expression patterns of the KCTDs, which are partially overlapping, 
but in wide ranges very distinct. 
GABAB receptors mediate their actions throughout the whole CNS and are located at various 
cellular compartments. This is one of the reasons which makes the exploration of specific 
effects of the receptor difficult and also renders the specific therapeutic targeting of GABAB 
receptor mediated actions very demanding. It also underlines the importance to identify how 
variety in the GABAB system is achieved and its relevance for basic research and drug 
development.  
Perspectives 
One of the most interesting points for further research remains with the exact elucidation of 
the mechanism of KCTD action on the G-protein cycle. This question will be addressed by 
means of different GTPγS assays and BRET/ FRET studies, which are currently established 
in our laboratory. The dose-response curves described in chapter two have revealed that 
KCTD12 and 16 increase the apparent agonist affinity of GABAB receptors. Radioligand 
binding assays and [35S]-GTPγS binding assays will be performed to show how KCTDs 
exert this effects. A decrease of the EC50 determined by electrophysiology could result from a 
higher agonist affinity due to a conformational change of the receptor, an increase in cell 
surface receptors, or from a change in G-protein activation/deactivation. The agonist binding 
affinity of the receptor and the number of surface receptors can be measured by competitive 
and saturating radioligand binding assays, respectively. Furthermore, in [35S]-GTPγS binding 
assays the effects on the activation rate is determined by measuring the binding of the non-
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hydrolyzable GTP analogue, [35S]-GTPγS, bound to Gα, which is the first step of the G-
protein cycle. FRET/ BRET studies will allow us to investigate if KCTDs have effects on the 
dissociation and re-association rate of the Gα with the Gβ and Gγ subunits, or of the Gα with 
the GABAB receptor. Affinity purifications showed that KCTDs interact with Gαo, Gβ, several 
subunits of Cav and Kir channels. BRET assays will be used to examine which of these are 
direct interactions. Importantly, we will test whether KCTDs induce a conformational change 
in the GABAB receptor by means of homogeneous time-resolved FRET, where the interaction 
between the two receptor subunits will be measured in presence and absence of KCTDs. 
These assays will enable us to identify and discriminate between possible KCTD-mediated 
effects. 
In regards to the homo- and heteromeric assembly of KCTDs and GABAB receptors it would 
be interesting to know if KCTDs compete in the binding of GABAB receptors or if a certain 
composition is favored. In native receptors the composition of the complex is predetermined 
by the KCTD subset expressed by a neuron, but could in addition be conditioned by different 
affinities or could involve other binding partners. 
Our laboratory has made large efforts to generate specific knockout animals for KCTD8, 12, 
12b, and 16. These animals will soon provide very useful tools to further investigate the 
functions and the underlying mechanism of KCTD actions. In addition they will give hints on 
the main physiological impacts of the KCTDs. In spite of the fact that the knockout animals 
can serve as controls in various analyses, in detail there are several experiments pending. In 
regards to the localization studies we will add an immunohisto-/cytochemical approach to 
identify subsets of KCTDs in certain cell types, like certain glutamatergic or cholinergic 
neurons, or subpopulations of GABAergic interneurons. As we are so far not able to 
confidently exclude a cross reactivity of our specific KCTD antibodies in tissue or cell culture 
preparations, we aim to validate existing data by taking advantage of knockout animals. 
Knowledge of the KCTD subset present in certain cell types would allow us to investigate 
and compare their GABAB receptor modulating properties and moreover relate them to the 
known characteristics of the certain cell populations, e.g. expression of certain GPCRs or Kir 
subtypes. The distribution data identified brain structures that strongly express KCTDs and 
might show strongest defects in the knockout animals. Therefore these data are important to 
predict changes in potentially affected structures or behavioral skills that are connected with 
them. Certainly the data might help to understand possible phenotypes. 
For the electrophysiological characterization of the knockout animals this analysis gives us 
the ability to target specifically cells that express only one single KCTD, which should make it 
more feasible to identify effects mediated by the certain KCTDs. In terms of function, we 
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would like to closer define the electrophysiological properties of different KCTD-GABAB 
combinations in heterologous and neuronal cells, respectively and later on compare them 
with the corresponding complexes in vivo.  
A major goal is the identification of KCTD interaction partners, which will help to shed light on 
the mechanisms and signaling pathways through which KCTDs mediate their actions and 
might open up new concepts of the functions of KCTD proteins. In particular, novel 
interaction partners of KCTD12 could give hints to the role of KCTD12 in neuronal 
development. As KCTDs are part of a GABAB receptor complex and also form dimers and 
heterodimers by themselves, the search for putative interaction partners will encounter 
similar difficulties as described previously for GABAB receptor heterodimers. Therefore we 
will again focus on the proteomic approach in collaboration with Bernd Fakler, similar to the 
reverse affinity purifications with specific KCTD antibodies described in chapter two. Being 
able to acquire comparable data from knockout animals will add further specificity and value 
to these experiments. In general, the null-mutant animals should clarify, if KCTDs are 
essential for GABAB receptor-mediated functions. They should display putative impacts of 
KCTDs in brain development and function. However, it would not be surprising, if KCTD 
knockout animals show only very mild impairments. The redundancy among different KCTDs 
might complicate the analysis of KCTD function, which would make it necessary to generate 
double/ triple knockouts to circumvent compensatory effects.  
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